UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2015  

 

  Synergy CHC Corp.  
  (Exact name of registrant as specified in its charter)  

 

Nevada   000-55098   99-0379440
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
ID Number)

 

865 Spring Street, Westbrook, ME   04092
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (615) 939-9004

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

UrgentRx Stock Purchase Agreement

 

On November 12, 2015 (the “UrgentRx Closing Date”), we entered into a Stock Purchase Agreement (the “UrgentRx SPA”) with Breakthrough Products, Inc., a Delaware corporation (the “Company”), URX ACQUISITION TRUST, a Delaware statutory trust, (the “Trust”), Jordan Eisenberg, the chief executive officer and a shareholder of the Company (“Eisenberg”), and the other shareholders of the Company (Eisenberg and such other shareholders collectively referred to as the “UrgentRx Sellers”) for the purchase of all the issued and outstanding capital stock of the Company for 6,000,000 shares of our common stock (“UrgentRx Equity Consideration”).

 

In addition to the UrgentRx Equity Consideration, we have agreed to pay a royalty to the Trust, for the benefit of the UrgentRx Sellers, equal to 5% of gross sales of the UrgentRx (as defined below) following the first $5,000,000 in gross sales by the UrgentRx Products, on a quarterly basis for a period of seven years from the UrgentRx Closing Date.

 

The Company is engaged in the business of developing and selling medications for headache, heart burn, allergy attack, ache and pain, and upset stomach in the form of powders (“UrgentRx”).

 

The UrgentRx SPA contains customary representations and warranties and covenants by the respective parties.

 

Flat Tummy Tea Stock Purchase Agreement

 

On November 15, 2015 (the “Flat Tummy Tea Closing Date”), we entered into a Stock Purchase Agreement (the “Flat Tummy Tea SPA”) with TPR Investments Pty Ltd ACN 128 396 654 as trustee for Polmear Family Trust (the “Flat Tummy Tea Seller”), Timothy Polmear and Rebecca Polmear and NomadChoice Pty Limited ACN 160 729 939 trading as Flat Tummy Tea, an Australian proprietary limited company (“NomadChoice”) for the purchase of all the issued and outstanding capital stock of NomadChoice for $4,000,000 (AUD) in cash consideration (the “Cash Consideration”) and 3,571,428 shares of our common stock (“Flat Tummy Tea Equity Consideration”).

 

In addition to the Cash Consideration and the Flat Tummy Tea Equity Consideration, we have also agreed to pay the Flat Tummy Tea Seller certain earn-out payments of up to $3,500,000 (AUD) in aggregate upon certain EBITDA thresholds are met as of June 30, 2016, as described in the Flat Tummy Tea SPA.

 

Flat Tummy Tea is engaged in the business of developing, manufacturing, and selling herbal detox tea (“Flat Tummy Tea”).

 

The Flat Tummy Tea SPA contains customary representations and warranties and covenants by the respective parties.

 

2
 

 

Loan and Warrants

 

In connection with the UrgentRx SPA and the Flat Tummy Tea SPA, on November 12, 2015 we entered into a first amendment to loan agreement (the “New Loan Agreement”) with a subsidiary of Knight Therapeutics Inc. (“Knight”) for $5,500,000. The New Loan Agreement amended the loan agreement we entered into with Knight on January 21, 2015 for $6,000,000, as we disclosed on a Form 8-K filed January 27, 2015 and Amended on February 9, 2015. The New Loan Agreement’s borrowings were used in acquiring UrgentRx and Flat Tummy Tea.

 

This New Loan Agreement bears interest at 15% per annum plus other additional consideration. The interest rate will decrease to 13% if we meet certain equity-fundraising targets. The New Loan Agreement matures on November 11, 2017.

 

In connection with the New Loan Agreement, we issued Knight a warrant that entitles Knight to purchase 5,550,625 shares of our common stock (“Knight Warrant Shares”) representing approximately 6.5% of our fully diluted capital, which Knight exercised in full on November 12, 2015. Knight also received a 10-year warrant entitling Knight to purchase up to 4,547,243 shares of our common stock at $0.49 per share (“Knight Warrants”). In addition, Knight obtained the exclusive sales rights to Flat Tummy Tea and UrgentRx in Canada, Israel, Romania, Russia and Sub-Saharan Africa.

 

The foregoing descriptions of the UrgentRx SPA, the Flat Tummy Tea SPA and the New Loan Agreement are not complete and are qualified in their entirety by reference to the UrgentRx SPA, the Flat Tummy Tea SPA and the New Loan Agreement, which are filed as Exhibits 10.13, 10.14 and 10.15, respectively, to this Current Report on Form 8-K, and are incorporated into this report by reference.

 

Item 2.01. Completion of Acquisition or Disposition of Assets.

 

The information in Item 1.01 of this Report under “UrgentRx Stock Purchase Agreement” and “Flat Tummy Tea Stock Purchase Agreement” is incorporated herein by reference.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information in Item 1.01 of this Report under “Loan and Warrants” is incorporated herein by reference.

 

Item 3.02. Unregistered Sale of Equity Securities.

 

The information regarding the issuance of shares of our common stock that constitute UrgentRx Equity Consideration and Flat Tummy Tea Equity Consideration in Item 1.01 of this Report is incorporated herein by reference. The shares of common stock issued to the UrgentRx Sellers and the Flat Tummy Tea Seller were sold in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on Section 4(a)(2) thereof. The shares of our common stock issued to the UrgentRx Sellers and the Flat Tummy Tea Seller may not be offered or sold in the United States absent registration or exemption from registration under the Securities Act of 1933, as amended, and any applicable state securities laws.

 

3
 

 

The information regarding the Knight Warrant Shares and the Knight Warrants under the caption “Loan and Warrants” in Item 1.01 of this Report is incorporated herein by reference. The Knight Warrant Shares, the warrant to purchase the Knight Warrant Shares and the Knight Warrants were sold in a transaction exempt from registration under the Securities Act, in reliance on Section 4(a)(2) thereof. None of the Knight Warrant Shares, the warrant to purchase the Knight Warrant Shares or the Knight Warrants may be offered or sold in the United States absent registration or exemption from registration under the Securities Act and any applicable state securities laws.

 

Item 8.01 Other Events.

 

On November 16, 2015, we issued a press release announcing our entry into the UrgentRx SPA. A copy of the press release is attached hereto as Exhibit 99.1.

 

On November 16, 2015, we issued a press release announcing our entry into the Flat Tummy Tea SPA. A copy of the press release is attached hereto as Exhibit 99.2.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial Statements of Businesses Acquired.

 

If and to the extent required, the financial statements required by Item 9.01(a) of Form 8-K will be filed by amendment no later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed.

 

(b) Pro Forma Financial Information.

 

If and to the extent required, the financial statements required by Item 9.01(b) of Form 8-K will be filed by amendment no later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed.

 

(d) Exhibits

 

  Exhibit No.   Description
       
  4.4   Synergy CHC Corp. Common Stock Purchase Warrant, dated November 12, 2015.
       
  4.5   Synergy CHC Corp. Common Stock Purchase Warrant (10-Year Warrant), dated November 12, 2015.
       
  10.13   Stock Purchase Agreement, dated November 12, 2015, by and between Synergy CHC Corp., Breakthrough Products, Inc., URX ACQUISITION TRUST, Jordan Eisenberg, and the other shareholders listed on Exhibit A thereto.
       
  10.14  

Stock Purchase Agreement, dated November 15, 2015, by and between Synergy CHC Corp., TPR Investments Pty Ltd ACN 128 396 654 as trustee for Polmear Family Trust, Timothy Polmear and Rebecca Polmear, and NomadChoice Pty Limited ACN 160 729 939.

       
  10.15  

First Amendment to Loan Agreement, dated November 12, 2015, between Knight Therapeutics (Barbados) Inc. and Synergy Strips Corp.

       
  99.1   Press release dated November 16, 2015.
       
  99.2   Press release dated November 16, 2015.

 

4
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SYNERGY CHC CORP.
   
Date: November 18, 2015 /s/ Jack Ross
  Jack Ross
  President and Chief Executive Officer

 

5
 

 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO REGISTRATION OF TRANSFER OF THIS WARRANT OR THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF WILL BE MADE ON THE BOOKS OF THE ISSUER UNLESS SUCH TRANSFER IS MADE IN CONNECTION WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT OR SUCH ACT DOES NOT APPLY.

 

COMMON STOCK PURCHASE WARRANT

 

SYNERGY chc CORP.

 

Warrant Shares: 5,550,625 Issue Date: November 12, 2015

 

THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) certifies that, for value received, Knight Therapeutics (Barbados) Inc. (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions set forth in this Warrant, at any time on or after November 12, 2015 (the “ Exercise Date ”) and on or prior to the close of business on December 31, 2015 (the “ Termination Date ”) but not thereafter, to subscribe for and purchase from Synergy CHC Corp, a Nevada corporation (the “ Company ”), 5,550,625 fully paid and nonassessable shares (the “ Warrant Shares ”) of the Company’s Common Stock (the “ Common Stock ”), represent six and one-half percent (6.5%) of the Company’s issued and outstanding Common Stock on a Fully Diluted Basis. The purchase price for the Common Stock under this Warrant is equal to the Exercise Price.

 

Section 1 . Exercise .

 

(a) Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time on or after the Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto. Prior to the sending of a Notice of Exercise Form, the Holder may request, and the Company shall be obligated to deliver, a certificate signed by a senior officer of the Company setting forth the number of issued and outstanding shares of Common Stock on a Fully Diluted Basis at such time, and any such other evidence as may be reasonably requested by the Holder in order to establish the number of Warrant Shares that the Holder is entitled to purchase hereunder at such time. On the date of exercise, the Holder shall deliver the Exercise Price for the Common Stock and shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the Notice of Exercise is delivered to the Company. The Company shall deliver any objection to any Notice of Exercise Form within one (1) Business Day of receipt of such notice.

 

(b) Exercise Price . The exercise price for the purchase of all of the shares of Common Stock under this Warrant is US$1.00 in the aggregate and not on a per share basis, (the “ Exercise Price ”).

 

 
 

 

(c) Mechanics of Exercise .

 

i. Delivery of Warrant Shares Upon Exercise . The Company shall use best efforts to cause the Warrant Shares purchased hereunder to be issued in book-entry format on the records of the transfer agent and registrar of the Company, or, if the Warrant Shares cannot be issued in book-entry format, then by physical delivery of a stock certificate to the address specified by the Holder in the Notice of Exercise, by the date that is three (3) Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise, (B) surrender of this Warrant (if required) and (C) payment of the Exercise Price as set forth above (such date, the “ Warrant Share Delivery Date ”). The Warrant Shares will be deemed to have been issued, and the Holder or any other person so designated to be named therein will be deemed to have become a holder of record of such shares for all purposes, as of the date on which the Warrant has been exercised, with payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, pursuant to Section 1(d)(iv) prior to the issuance of such shares having been paid.

 

ii. No Fractional Shares or Scrip . No fractional shares or scrip representing fractional shares may be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round up to the next whole share.

 

iii. Charges, Taxes and Expenses . Issuance of Warrant Shares will be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses will be paid by the Company, and such Warrant Shares will be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided , however , that in the event Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise must be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise.

 

2
 

 

Section 2 . Fundamental Transaction

 

(a) Fundamental Transaction . The Company may not enter into or be a party to a Fundamental Transaction without providing the Holder with the opportunity to exercise this Warrant in advance of consummating such Fundamental Transaction.

 

Section 3 . Transfer of Warrant .

 

(a) Transferability . This Warrant and all rights hereunder are transferable upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant in the name of the assignee specified in such instrument of assignment, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

(b) Transfer to Comply with the Securities Act . This Warrant may not be exercised, and neither this Warrant nor any of the Warrant Shares may be disposed of except in compliance with applicable United States federal and state securities or “blue sky” laws and the terms and conditions hereof. Any new Warrant issued upon transfer of this Warrant will bear a legend in substantially the same form as the legend set forth on the first page of this Warrant, unless the Holder delivers to the Company an opinion of counsel reasonably satisfactory to the Company that such new Warrant need no longer be subject to the restriction contained herein. Each certificate for Warrant Shares issued upon exercise of this Warrant (or subsequently issued in substitution or exchange for such Warrant Shares), unless either (i) at the time of exercise such Warrant Shares are registered under the Securities Act of 1933, as amended (the “ Securities Act ”), or (ii) the Warrant Shares are no longer subject to the restriction contained herein, will bear a legend substantially in the following form:

 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO REGISTRATION OF TRANSFER OF SUCH SECURITIES WILL BE MADE ON THE BOOKS OF THE ISSUER UNLESS SUCH TRANSFER IS MADE IN CONNECTION WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT OR SUCH ACT DOES NOT APPLY.

 

(c) The provisions of this Section 3 are binding upon all subsequent holders of certificates for Warrant Shares bearing the above legend and all subsequent holders of this Warrant, if any.

 

3
 

 

(d) New Warrants . This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 3(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges will be dated the initial issuance date of this Warrant and will be identical to this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(e) Warrant Register . The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “ Warrant Register ”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 4 . Definitions . For purposes of this Warrant, the following capitalized terms have the meanings specified in this Section 4 :

 

(a) “ Business Day ” means a day other than Saturday, Sunday, or any other day on which commercial banks in New York, New York are authorized or required to by law to close.

 

(b) A “ Fully-Diluted Basis ” means the number of shares of Common Stock outstanding at a given time plus that number of shares of Common Stock that are issuable upon the conversion, exercise or exchange of all securities of the Company that are convertible or exchangeable or excercisable into shares of Common Stock based on the applicable conversion, exchange or exercise rate, including any warrants and any options to purchase shares of Common Stock granted by the Company.

 

(c) A “ Fundamental Transaction ” occurs if (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group (other than Alan M. Meckler and his affiliates) acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination).

 

4
 

 

(d) “ Person ” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or a government or any department or agency thereof.

 

(e) “ Successor Entity ” means the Person formed by, resulting from or surviving any Fundamental Transaction or the Person with which such Fundamental Transaction has been entered into.

 

(f) “ Trading Day ” means a day on which the principal Trading Market is open for trading.

 

(g) “ Trading Market ” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).

 

Section 5. Miscellaneous .

 

(a) No Rights as Stockholder Until Exercise . This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 1, except as expressly set forth in Section 2.

 

(b) Loss, Theft, Destruction or Mutilation of Warrant . The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor, in lieu of such Warrant or stock certificate.

 

(c) Saturdays, Sundays, Holidays, etc . If the last or appointed day for the taking of any action or the expiration of any right required or granted herein is not a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

(d) Authorized Shares .

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. If at any time the number of authorized but unissued shares of Common Stock is not sufficient to effect in full the exercise of this Warrant, in addition to such other remedies as are available to the Holder, the Company will promptly take such corporate action as may, in the opinion of its counsel, be necessary to increase the number of authorized but unissued shares of Common Stock to such number of shares as are sufficient for such purposes, including, without limitation, using its best efforts to obtain the requisite shareholder approval necessary to increase the number of authorized shares of Common Stock. The Company further covenants that its issuance of this Warrant constitutes full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

5
 

 

Except and to the extent as waived or consented to by the Holder, the Company may not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.

 

(e) Jurisdiction . The validity, interpretation, construction and performance of this Warrant, and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto, shall be governed, construed and interpreted in accordance with the laws of the state of New York.

 

(f) Nonwaiver and Expenses . No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

(g) Notices . Any notice, consent or report required or permitted to be given or made under this Warrant by one Party to the other Party will be in writing, delivered personally or by U.S. first class mail or express courier providing evidence of receipt, postage prepaid (where applicable), or by electronic mail, to the address set forth on the signature page hereto. All such notices will be effective upon receipt.

 

(h) Limitation of Liability . No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, will give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

(i) Remedies . The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(j) Successors and Assigns . Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby will inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and are enforceable by the Holder or any holder of Warrant Shares.

 

(k) Amendment . This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(l) Severability . Wherever possible, each provision of this Warrant must be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant is prohibited by or invalid under applicable law, such provision will be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(m) Headings . The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

6
 

 

IN WITNESS WHEREOF, each of the Company and the Holder has caused this Warrant to be executed as of the date first above indicated.

 

  Synergy CHC corp.
     
  By: /s/ Jack Ross
  Name: Jack Ross
  Title: President and Chief Executive Officer
  Address:  
     
  Attn: President

 

  KNIGHT THERAPEUTICS (BARBADOS) INC.
   
  By: /s/ Michel Loustric
  Name: Michel Loustric
  Title: President
  Address: The Business Centre, Upton, St. Michael BB11103, Barbados, WI

 

  With a copy to:
   
  Davies Ward Phillips & Vineberg LLP
  900 Third Avenue, 24 th Floor
  New York, NY 10022
  Attention: Hillel W. Rosen

 

 
 

 

NOTICE OF EXERCISE

 

To: synergy CHC corp.

 

(1) The undersigned hereby elects to purchase all of the Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of US$1.00, representing the aggregate exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

 

The Warrant Shares shall be delivered as follows:

 

_______________________________

 

_______________________________

 

_______________________________

 

SIGNATURE OF HOLDER

 

If an Individual ( Print Name ): ________________________________________________ _

 

If an Entity ( Print Name of Investing Entity ): _____________________________________ _

 

Signature of Authorized Signatory of Investing Entity : ________________________________________________________________________

 

Name of Authorized Signatory: ________________________________________________

 

Title of Authorized Signatory: _________________________________________________

 

Date: ___________________________________________________________________ _

 

 
 

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute
this form and supply required information.
Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, _______ shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________ whose address is

 

_______________________________________________________________.

 

_______________________________________________________________

 

      Dated: ______________, _______
       
  Holder’s Signature: __________________________________
       
  Holder’s Address: __________________________________
       
    __________________________________

 

Signature Guaranteed: ___________________________________________  

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

 
 

 

 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO REGISTRATION OF TRANSFER OF THIS WARRANT OR THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF WILL BE MADE ON THE BOOKS OF THE ISSUER UNLESS SUCH TRANSFER IS MADE IN CONNECTION WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT OR SUCH ACT DOES NOT APPLY.

 

COMMON STOCK PURCHASE WARRANT

(10-YEAR WARRANT)

 

SYNERGY CHC CORP.

 

Warrant Shares: 4,547,243 Issue Date: November 12, 2015

 

THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) certifies that, for value received, Knight Therapeutics (Barbados) Inc. (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions set forth in this Warrant, at any time on or after the date hereof (the “ Issue Date ”) and on or prior to the close of business on the tenth anniversary following the Issue Date (the “ Termination Date ”) but not thereafter, to subscribe for and purchase from Synergy CHC Corp, a Nevada corporation (the “ Company ”), up to 4,547,243 fully paid and nonassessable shares (as subject to adjustment hereunder, the “ Warrant Shares ”) of the Company’s Common Stock (the “ Common Stock ”), represent 5% of the Company’s Common Stock on a Fully Diluted Basis. The purchase price of one share of Common Stock under this Warrant is equal to the Exercise Price, as defined in Section 1(b).

 

Section 1 . Exercise .

 

(a) Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Issue Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto. Except for cashless exercises pursuant to Section 1(c) below, on the date of exercise, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States or Canadian chartered bank. Notwithstanding anything herein to the contrary, the Holder is not required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder will have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

 
 

 

(b) Exercise Price . The exercise price per share of the Common Stock under this Warrant is US$0.49, subject to adjustment hereunder (the “ Exercise Price ”).

 

(c) Cashless Exercise . Upon the prior written approval of the Company, which approval may be withheld or conditioned in its sole discretion, this Warrant may be exercised, in whole or in part, by means of a “cashless exercise” in which the Holder will be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

  (A) = the Closing Price on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;
     
  (B) = the Exercise Price of this Warrant, as adjusted hereunder; and
     
  (X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

(d) Mechanics of Exercise .

 

i. Delivery of Warrant Shares Upon Exercise . The Company shall use best efforts to cause the Warrant Shares purchased hereunder to be issued in book-entry format on the records of the transfer agent and registrar of the Company, or, if the Warrant Shares cannot be issued in book-entry format, then by physical delivery of a stock certificate to the address specified by the Holder in the Notice of Exercise, by the date that is three (3) Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise, (B) surrender of this Warrant (if required) and (C) payment of the aggregate Exercise Price as set forth above (including by cashless exercise, if permitted) (such date, the “ Warrant Share Delivery Date ”). The Warrant Shares will be deemed to have been issued, and the Holder or any other person so designated to be named therein will be deemed to have become a holder of record of such shares for all purposes, as of the date on which the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 1(d)(iv) prior to the issuance of such shares having been paid.

 

2
 

 

ii. Delivery of New Warrants Upon Exercise . If this Warrant is exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant will be, in all other respects, identical with this Warrant.

 

iii. No Fractional Shares or Scrip . No fractional shares or scrip representing fractional shares may be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

iv. Charges, Taxes and Expenses . Issuance of Warrant Shares will be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses will be paid by the Company, and such Warrant Shares will be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided , however , that in the event Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise must be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise.

 

Section 2 . Certain Adjustments .

 

(a) Stock Dividends and Splits . If the Company, at any time while this Warrant is outstanding: (i) declares or pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity-equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, does not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price will be multiplied by a fraction, the numerator of which is the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and the denominator of which is the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant will be proportionately adjusted such that the aggregate Exercise Price of all shares of Common Stock for which this Warrant is then exercisable remains unchanged. Any adjustment made pursuant to this Section 2(a) will become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and will become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

3
 

 

(b) Issuance of Common Stock . If, at any time while this Warrant has not been exercised in full, the Company issues (i) shares of Common Stock for consideration per share less than a price equal to the Exercise Price or (ii) warrants to purchase shares of Common Stock at an exercise price that is lower than the Exercise Price (the foregoing price per share of Common Stock and/or exercise price being hereinafter referred to as the “ Dilutive Price ”), the Exercise Price shall be reduced to the Dilutive Price. For greater certainty, the Exercise Price shall at all times be the lowest Dilutive Price at which shares of Common Stock or warrants to purchase shares of Common Stock have been issued by the Company, as the case may be.

 

(c) Fundamental Transaction . The Company may not enter into or be a party to a Fundamental Transaction unless the Successor Entity makes appropriate provision for the continuation of this Warrant by either assumption of this Warrant or by substitution of this Warrant with an equivalent right, in either case pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, such approval not to be unreasonably withheld, conditioned or delayed.

 

(d) Calculations . No adjustment in the number of Warrant Shares purchasable hereunder is required unless such adjustment would result in an increase or decrease of at least 0.1% of the number of Warrant Shares for which this Warrant is exercisable; provided that any adjustments which by reason of this Section 2(c) are not required to be made will be carried forward and taken into account in any subsequent adjustment. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/1000th of a share, as the case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding on a Fully Diluted Basis.

 

(e) Notice to Holder .

 

i. Adjustment to Exercise Price . Whenever the Exercise Price is adjusted pursuant to any provision of this Section 2, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

4
 

 

ii. Notice to Allow Exercise by Holder . If (A) the Company declares or pays a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company declares or pays a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company authorizes the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company is required in connection with any Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it appears upon the Warrant Register of the Company, at least five calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined, or (y) the date on which such Fundamental Transaction is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such Fundamental Transaction; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Section 3 . Transfer of Warrant .

 

(a) Transferability . This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

5
 

 

(b) Transfer to Comply with the Securities Act . This Warrant may not be exercised, and neither this Warrant nor any of the Warrant Shares may be disposed of, in whole or in part, except in compliance with applicable United States federal and state securities or “blue sky” laws and the terms and conditions hereof. Any new Warrant issued upon transfer of this Warrant will bear a legend in substantially the same form as the legend set forth on the first page of this Warrant, unless the Holder delivers to the Company an opinion of counsel reasonably satisfactory to the Company that such new Warrant need no longer be subject to the restriction contained herein. Each certificate for Warrant Shares issued upon exercise of this Warrant (or subsequently issued in substitution or exchange for such Warrant Shares), unless either (i) at the time of exercise such Warrant Shares are registered under the Securities Act of 1933, as amended (the “ Securities Act ”), or (ii) the Warrant Shares are no longer subject to the restriction contained herein, will bear a legend substantially in the following form:

 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO REGISTRATION OF TRANSFER OF SUCH SECURITIES WILL BE MADE ON THE BOOKS OF THE ISSUER UNLESS SUCH TRANSFER IS MADE IN CONNECTION WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT OR SUCH ACT DOES NOT APPLY.

 

(c) The provisions of this Section 3 are binding upon all subsequent holders of certificates for Warrant Shares bearing the above legend and all subsequent holders of this Warrant, if any.

 

(d) New Warrants . This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 3(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges will be dated the Issue Date and will be identical to this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(e) Warrant Register . The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “ Warrant Register ”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

6
 

 

Section 4 . Definitions . For purposes of this Warrant, the following capitalized terms have the meanings specified in this Section 4 :

 

(a) “ Business Day ” means a day other than Saturday, Sunday, or any other day on which commercial banks in New York, New York are authorized or required to by law to close.

 

(b) “ Closing Price ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the closing price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC Bulletin Board is not a Trading Market, the closing price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by a majority of the independent directors of the Company in their reasonable good faith judgment.

 

(c) A “Fully-Diluted Basis” means the number of shares of Common Stock outstanding at a given time plus that number of shares of Common Stock that are issuable upon the conversion, exercise or exchange of all securities of the Company that are convertible or exchangeable or exercisable into shares of Common Stock based on the applicable conversion, exchange or exercise rate, including any warrants and any options to purchase shares of Common Stock granted by the Company.

 

(d) A “ Fundamental Transaction ” occurs if (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination).

 

7
 

 

(e) “ Person ” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or a government or any department or agency thereof.

 

(f) “ Successor Entity ” means the Person formed by, resulting from or surviving any Fundamental Transaction or the Person with which such Fundamental Transaction has been entered into.

 

(g) “ Trading Day ” means a day on which the principal Trading Market is open for trading.

 

(h) “ Trading Market ” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).

 

Section 5. Miscellaneous .

 

(a) No Rights as Stockholder Until Exercise . This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 1, except as expressly set forth in Section 2.

 

(b) Loss, Theft, Destruction or Mutilation of Warrant . The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor, in lieu of such Warrant or stock certificate.

 

(c) Saturdays, Sundays, Holidays, etc . If the last or appointed day for the taking of any action or the expiration of any right required or granted herein is not a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

(d) Authorized Shares .

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. If at any time the number of authorized but unissued shares of Common Stock is not sufficient to effect in full the exercise of this Warrant, in addition to such other remedies as are available to the Holder, the Company will promptly take such corporate action as may, in the opinion of its counsel, be necessary to increase the number of authorized but unissued shares of Common Stock to such number of shares as are sufficient for such purposes, including, without limitation, using its best efforts to obtain the requisite shareholder approval necessary to increase the number of authorized shares of Common Stock. The Company further covenants that its issuance of this Warrant constitutes full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

8
 

 

Except and to the extent as waived or consented to by the Holder, the Company may not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations thereof, exemptions therefor, or consents thereto as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

(e) Jurisdiction . The validity, interpretation, construction and performance of this Warrant, and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto, shall be governed, construed and interpreted in accordance with the laws of the state of New York.

 

(f) Nonwaiver and Expenses . No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

9
 

 

(g) Notices . Any notice, consent or report required or permitted to be given or made under this Warrant by one Party to the other Party will be in writing, delivered personally or by U.S. first class mail or express courier providing evidence of receipt, postage prepaid (where applicable), or by electronic mail, to the address set forth on the signature page hereto. All such notices will be effective upon receipt.

 

(h) Limitation of Liability . No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, will give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

(i) Remedies . The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(j) Successors and Assigns . Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby will inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and are enforceable by the Holder or any holder of Warrant Shares.

 

(k) Amendment . This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(l) Severability . Wherever possible, each provision of this Warrant must be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant is prohibited by or invalid under applicable law, such provision will be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(m) Headings . The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

 
 

 

IN WITNESS WHEREOF, each of the Company and the Holder has caused this Warrant to be executed as of the date first above indicated.

 

  Synergy CHC corp.
   
  By: /s/ Jack Ross
  Name: Jack Ross
  Title: President and Chief Executive Officer
  Address:  
     
  Attn: President

 

  KNIGHT THERAPEUTICS (BARBADOS) INC.
     
  By : /s/ Michel Loustric
  Name: Michel Loustric
  Title: President
  Address: The Business Centre, Upton, St. Michael BB11103, Barbados, WI

 

  With a copy to:
   
  Davies Ward Phillips & Vineberg LLP
  900 Third Avenue, 24 th Floor
  New York, NY 10022
  Attention: Hillel W. Rosen

 

 
 

 

NOTICE OF EXERCISE

 

To: synergy CHC corp.

 

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United States; or

 

[  ] if permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 1(c) of the Warrant, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the “cashless exercise” procedure set forth in such subsection 1(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

 

The Warrant Shares shall be delivered as follows:

 

_______________________________

 

_______________________________

 

_______________________________

 

SIGNATURE OF HOLDER

 

If an Individual ( Print Name ): _____________________________________________________

 

If an Entity ( Print Name of Investing Entity ): ____________________________________________________________________________

 

Signature of Authorized Signatory of Investing Entity : ____________________________________________________________________________

 

Name of Authorized Signatory: ________________________________________________________________________ ____

 

Title of Authorized Signatory: _____________________________________________________

 

Date: _______________________________________________________________________ _

 

 
 

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute
this form and supply required information.
Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, _______ shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________ whose address is

 

_______________________________________________________________.

 

_______________________________________________________________

 

      Dated: ______________, _______
       
  Holder’s Signature: __________________________________
       
  Holder’s Address: __________________________________
       
    __________________________________

 

Signature Guaranteed: ___________________________________________

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

 
 

 

 

 

STOCK PURCHASE AGREEMENT

 

THIS STOCK PURCHASE AGREEMENT (the “ Agreement ”) dated as of November 12, 2015, by and among Breakthrough Products, Inc., a Delaware corporation (the “ Company ”), URX ACQUISITION TRUST, a Delaware statutory trust, (the “ Trust ”), Jordan Eisenberg, the chief executive officer and a shareholder of the Company (“ Eisenberg ”), the other shareholders of the Company listed on Exhibit A (Eisenberg and such other shareholders being sometimes collectively referred to as the “ Sellers ,” and individually as a “ Seller ”), and Synergy CHC Corp., a Nevada corporation (the “ Buyer ”). Company, Trust, Sellers, and Buyer are sometimes referred to collectively as the “ Parties ” and individually as a “ Party ”.

 

BACKGROUND

 

Sellers, either directly or indirectly, collectively own all of the issued and outstanding capital stock of the Company.

 

The Company, operating as UrgentRx, is engaged in the business of developing and selling medications for headache, heart burn, allergy attack, ache and pain, and upset stomach in the form of powders (the “ Products ”) (the Products and the business related to the manufacture, sale, marketing and distribution of the Products is collectively the “ Business ”).

 

Buyer desires to purchase all of the outstanding capital stock of the Company (the “ Stock Purchase ”), and Sellers desire to sell such outstanding capital stock to Buyer, in each case upon the terms and subject to the conditions set forth in this Agreement.

 

The Trust was formed for the sole purpose of holding, collecting, and managing the Purchase Consideration (as defined below) payable with respect to the Stock Purchase (including voting the shares issued as purchase price consideration and exercising all shareholder rights with respect thereto while being held by the Trust), enforcing the rights of the Sellers with respect to this Agreement, payment of any expenses and any liabilities of the Sellers under this Agreement, and distributing the assets of the Trust to the Sellers.

 

In consideration of the foregoing and the respective covenants and agreements hereinafter contained, the Parties hereto hereby agree as follows:

 

1. Definitions . As used in this Agreement (including the recitals and Disclosure Schedules hereto), the following selected terms shall have the following meanings (such meanings to be applicable equally to both singular and plural forms of the terms defined):

 

Action ” means any claim, action, cause of action, demand, lawsuit, arbitration, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or otherwise, whether formal or informal, whether public or private and whether at law or in equity;

 

Affiliate ” shall mean, as to any Person, any other Person which directly or indirectly controls, or is under common control with, or is controlled by, such Person. As used in this definition, “control” (including, with its correlative meanings, “controlled by” and “under common control with”) shall mean possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by Contract or otherwise) of such Person;

 

    1  
     

 

Closing ” shall mean the consummation of the transactions contemplated by this Agreement;

 

Code ” means the Internal Revenue Code of 1986, as amended;

 

Commercially Reasonable Efforts means the commercially reasonable efforts that a prudent Person desirous of achieving a result and having an incentive to and interest in achieving such result would use to achieve that result as expeditiously as reasonably possible under the circumstances;

 

Company Equityholder ” means the holder of any capital stock of the Company or any options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other Contracts or commitments that could require the Company to issue, sell, or otherwise cause to become outstanding any of its capital stock;

 

Contract ” means any agreement, contract, indenture, instrument, obligation, promise or undertaking (whether written or oral and whether express or implied) that is legally binding;

 

Customers ” means all of the customers of Company during each of Company’s 2012, 2013, and 2014 fiscal years and during the period ended as of September 30, 2015;

 

Disclosure Schedules ” means the disclosure letter delivered by Sellers concurrently with the execution and delivery of this Agreement;

 

Employee ” means an employee of Company employed in connection with the Business;

 

Employee Benefit Plan ” means any pension, profit sharing, retirement, deferred compensation, stock purchase, stock option or other equity based compensation plans, incentive, bonus, vacation, employment agreement, independent contractor agreement, severance, disability, hospitalization, sickness, death, medical insurance, dental insurance, life insurance and any other material employee benefit plan (whether provided on a funded or unfunded basis, or through insurance or otherwise), agreement, program, policy, trust, fund, Contract or arrangement;

 

Environmental Laws ” means all Laws concerning pollution or protection of the environment and natural resources, including without limitation all those relating to the presence, use, production, generation, handling, transportation, treatment, storage, control or cleanup of any hazardous materials, substances or wastes, pesticides, pollutants or byproducts, asbestos, polychlorinated biphenyls, or radiation, each as amended and as now or hereafter in effect;

 

Fundamental Representations ” shall mean the representations and warranties set forth in (i) Sections 3(a), 3(b), 3(c), and 3(d); (ii) Sections 4(a), 4(c), 4(d), and 4(e); (iii) Sections 5(a), 5(b), 5(c), 5(d), 5(g), 5(h), (5(i) and 5(j); and Sections 6(a), 6(b), 6(c), and 6(d).

 

    2  
     

 

Government ” shall mean any agency, division, subdivision, audit group or procuring office of the Government of the United States, any state of the United States, including the employees or agents thereof;

 

Guarantee ” means any Contract of guarantee, indemnification, assumption or endorsement or any other like commitment of the obligations, liabilities (fixed, contingent or otherwise) or indebtedness of another Person;

 

Intellectual Property ” means all intellectual property rights whether protected, created or arising under the Laws of the United States or any other jurisdiction, including the following: (i) patents and patent applications; (ii) trademarks and service marks, including all applications and registrations and goodwill related to the foregoing; (iii) copyrights, including all applications and registrations related to the foregoing (including, without limitation, for all designs); (iv) Internet domain names; (v) telephone numbers, electronic mail addresses and social media accounts and registrations, including but not limited to accounts and registrations with Facebook, LinkedIn, Twitter, and other similar services; and (vi) trade secrets, know-how, ideas, creative works, inventions, discoveries, methods, processes, technical data, specifications, research and development information, technology, software or computer programs, and data base;

 

Knowledge of Company ” or “ Company’s Knowledge ” or a similar phrase shall mean, with respect to any matter, the actual knowledge the Eisenberg, Lynn Millheiser (COO), Kimber Ward (VP Marketing), and Genevieve Bucsek (Controller), or facts regarding such matter which reasonably should have been known by such persons after making a diligent inquiry with respect to such matter;

 

Laws ” means all statutes, laws, codes, ordinances, regulations, rules, orders, judgments, writs, injunctions, acts or decrees of any Government entity;

 

Liability ” means any liability or obligation of whatever kind or nature (whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued or unaccrued, whether liquidated or unliquidated, and whether due or to become due), including without limitation any liability for Taxes;

 

Lien ” shall mean any mortgage, pledge, security interest, encumbrance, lien (statutory or other) or conditional sale agreement, and including claims on title and liens in favor of contractors, carriers, warehousemen, mechanics, materialmen, and subcontractors and statutory or common law liens to secure claims for labor, materials or supplies, and other similar liens and encumbrances;

 

Material Adverse Effect ” shall mean, when used in connection with an entity means any change, event, circumstance, condition or effect that is or is reasonably likely to be, individually or in the aggregate, materially adverse to: (i) the condition (financial or otherwise), capitalization, properties, prospects, products, assets (including intangible assets), Intellectual Property, liabilities, business, operations or results of operations of such entity and its subsidiaries, taken as a whole, or (ii) such entity’s ability to consummate the Stock Purchase or to perform its obligations under this Agreement;

 

    3  
     

 

Material Adverse Event ” means any untoward or negative occurrence (including, without limitation, physical injury) related to the Business or the use of the Products that would result in a Material Adverse Effect;

 

Person ” shall mean and include any individual, corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, and any other unincorporated organization or Government;

 

Regulations ” means the Treasury Regulations (including Temporary Regulations) promulgated by the United States Department of Treasury with respect to the Code;

 

Taxes ” shall mean (i) all federal, state, local or foreign taxes, including, but not limited to, income, gross income, gross receipts, capital, production, excise, employment, sales, use, transfer, transfer gain, ad valorem, premium, profits, license, capital stock, franchise, severance, stamp, withholding, Social Security, employment, unemployment, disability, worker’s compensation, payroll, utility, windfall profit, custom duties, personal property, real property, environmental, registration, alternative or add-on minimum, estimated and other taxes, governmental fees or like charges of any kind whatsoever, and (ii) any interest, penalties, fines, loss, damages, liability, expense or additions thereto whether disputed or not; and (iii) any transference liability in respect of any items described in clauses (i) or (ii) payable by reason of contract assumption, transference liability, operation of law, or otherwise;

 

Tax Return ” means any return, declaration, report, claim for refund, information return or statement relating to any taxes, including any schedule or attachment thereto and including any amendment therof;

 

Transaction Documents ” shall mean this Agreement, the Share certificates, and the other exhibits and schedules hereto and thereto, and all other agreements, instruments, certificates and other documents to be entered into or delivered by any Party in connection with the transactions contemplated to be consummated pursuant to any of the foregoing.

 

2. Stock Purchase .

 

(a) Purchase and Sale of the Company’s Capital Stock . Upon the terms and subject to the conditions herein set forth, Sellers agree to sell, convey, transfer, assign and deliver to Buyer, and Buyer agrees to purchase and accept from Sellers, at the Closing, all of the issued and outstanding capital stock of the Company (the “ Shares ”).

 

(b) Consideration .

 

(i) Upon the terms and subject to the conditions set forth in this Agreement, in reliance on the representations, warranties, covenants and agreements of Sellers contained herein, the consideration payable to Sellers for the Stock Purchase shall be the right to receive the corpus of the Trust pursuant to the governing documents of the Trust.

 

    4  
     

 

(ii) In consideration of the Stock Purchase, Buyer shall:

 

1. Issue and deliver to the Trust for the benefit of the Sellers Six Million (6,000,000) shares of the common stock of Buyer, with a deemed value of $0.85 per share (the “ Equity Consideration ”); and

 

2. Following the first Five Million Dollars ($5,000,000) in gross sales of the Products by Buyer or its Affiliates (including the Company), on a quarterly basis for a period of seven (7) years from the date of this Agreement, pay a royalty to the Trust for the benefit of the Sellers equal to five percent (5%) of gross sales of the Products by Buyer or its Affiliates (including the Company) (the “ Royalty Consideration ” and together with the Equity Consideration, the “ Purchase Consideration ”). For purposes of clarity, the $5 million gross sales threshold before Royalty Consideration becomes due and payable shall only apply once during the seven year period when Royalty Consideration is or may become due and payable by Buyer.

 

(c) Closing . The Closing will take place contemporaneously with the execution of this Agreement at the offices of Smith, Gambrell & Russell, LLP, 1230 Peachtree Street, N.E., Suite 3100, Atlanta, Georgia 30309. The Parties agree that the Closing may occur electronically through the delivery of facsimile or electronic copies of any and all other ancillary documents or documents required to be delivered under the terms of this Agreement, unless specifically set forth herein.

 

(d) Closing Deliverables. At the Closing:

 

(i) Each Seller will deliver to Buyer either (i) the certificates representing all of the Shares owned by such Seller, duly endorsed in blank or with appropriate stock powers with respect thereto duly endorsed in blank, or (ii) if such certificates are not available at Closing, stock powers for such unavailable certificates, duly endorsed in blank. All certificates will be delivered to Buyer no later than ten (10) days following the Closing. If any certificates cannot be located, such Seller will deliver to the Buyer, no later than ten (10) days following the Closing, an affidavit of such Seller reasonably satisfactory to Buyer stating that the certificates representing all of the Shares owned by such Seller have been lost, stolen or otherwise cannot be located.

 

(ii) The Company will deliver to Buyer evidence that the officers and directors of the Company in office immediately prior to the Closing have resigned as officers and directors of the Company effective as of the Closing, unless otherwise requested by Buyer; excluding Jordan Eisenberg, who shall have entered into an employment agreement with the Company.

 

(iii) The Company will deliver to Buyer evidence that the Shares can be transferred from the Sellers to Buyer free from any rights of first refusal, registration rights, rights of co-sale or other restrictions or conditions relating to transfer of the Shares.

 

(iv) The Company will deliver to Buyer evidence that all options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other Contracts or commitments that could require the Company to issue, sell, or otherwise cause to become outstanding any of its capital stock have been terminated.

 

    5  
     

 

(v) The Company will deliver to Buyer a Release Agreement in the form of Exhibit B duly executed by each Company Equityholder who is not also a Seller.

 

(vi) The Company will deliver to Buyer a certificate executed by the authorized person of the Company certifying as to the truthfulness, completeness and accuracy of attached copies of resolutions of the directors and shareholders of the Company authorizing this Agreement and the transactions contemplated hereby; and such other documents relating to the transactions contemplated by the Transaction Documents to be consummated at the Closing as counsel to Buyer shall reasonably request in order to complete the Stock Purchase by Buyer.

 

(vii) The Company will deliver to Buyer a certificate of the State of Delaware dated reasonably close to the Closing Date, as to the legal existence and good standing of Company in Delaware.

 

(viii) The Trust will deliver to Buyer its duly executed governing instrument(s).

 

(ix) The Trust will deliver to Buyer a certificate executed by its trustee, certifying the satisfaction by the Company of the conditions specified in Section 5 and certifying as to the truthfulness, completeness and accuracy of attached copies the Trust Documents (as defined below) authorizing this Agreement and the transactions contemplated hereby; and such other documents relating to the transactions contemplated by the Transaction Documents to be consummated at the Closing as counsel to Buyer shall reasonably request in order to complete the Stock Purchase by Buyer.

 

(x) Buyer shall issue and deliver to the Trust for the benefit of the Sellers the Equity Consideration.

 

3. Representations And Warranties Of Sellers . As a material inducement to Buyer to enter into this Agreement and to consummate the transactions contemplated hereby, each Seller severally represents and warrants to the Buyer that the statements contained in this Section 3 are true and correct as of the date hereof, with respect to itself, except as set forth in the Disclosure Schedules.

 

(a) Authority of Sellers . Each Seller has all requisite power and authority to enter into the Transaction Documents to which such Seller is a party and to carry out such Seller’s obligations thereunder. The execution and delivery of the Transaction Documents and the performance of each Seller’s obligations thereunder have been duly authorized by all necessary corporate, shareholder, partnership or member action of such Seller (if such Seller is a corporation or an entity with shareholders, partners or members), and no other proceedings on the part or in respect of such Seller is necessary to authorize such execution, delivery and performance. The Transaction Documents to which a Seller is identified as a party thereto have been duly executed by or on behalf of such Seller and assuming due authorization, execution and delivery by the other parties thereto, constitute such Seller’s valid and binding obligations, enforceable against such Seller in accordance with their respective terms, except as may be limited by applicable bankruptcy, insolvency, moratorium or similar laws of general application relating to or affecting creditors’ rights generally and except for the limitations imposed by general principles of equity.

 

    6  
     

  

(b) No Conflicts; Consents . The execution, delivery and performance by Seller of the Transaction Documents to which such Seller is a party does not and will not: (a) result in a violation or breach of any provision of the governing documents of Seller, if applicable; (b) result in a violation or breach of any provision of any Law or Governmental order, judgment or decree applicable to Seller; or (c) require the consent, notice or other action by any Person under, conflict with, result in a violation or breach of, constitute a default under, or result in the acceleration of any agreement to which Seller is a party. No consent, waiver, approval, order, or authorization of, or registration, declaration, or filing with, any court, administrative agency, or commission or other governmental authority or instrumentality (“ Governmental Entity ”), or any other Person, is required by or with respect to Seller in connection with the execution and delivery of the Transaction Documents to which Seller is a party or the consummation of the transactions contemplated hereby.

 

(c) Title to Shares . Seller is the legal owner of the number and class of the Shares listed on Exhibit A hereto with respect to such Seller, free and clear of all Encumbrances.

 

(d) Legal Proceedings . There are no actions, suits, claims, investigations or other legal proceedings pending or, to Seller’s knowledge, threatened against or by Seller that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.

 

(e) Brokers . Except for Creo Capital Advisors LLC, who was hired by the Company, no broker, finder, or investment banker is entitled to any brokerage, finder’s, or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Seller.

 

4. Representations and Warranties of the Company . As a material inducement to Buyer to enter into this Agreement and to consummate the transactions contemplated hereby, the Company represents and warrants to the Buyer that the statements contained in this Section 4 are true and correct as of the date hereof, except as set forth in the Disclosure Schedules.

 

(a) Corporate Organization. The Company is a corporation duly organized, validly existing and in good standing under the laws of its jurisdiction of formation. The organizational documents which have been furnished to Buyer reflect all amendments made thereto at any time prior to the date of this Agreement and are correct and complete. The minute books and other books and records of the Company, to the extent such minutes exist, have been furnished to Buyer. The Trust is a statutory trust duly organized, validly existing and in good standing under the laws of its jurisdiction of formation.

 

(b) Qualification to Do Business . The Company has full corporate power and authority to carry on its business as now being conducted and is entitled to own, lease, or operate the properties and assets now owned, leased, or operated by it. The Company is qualified to do business, is in good standing, and has all required and appropriate licenses in each jurisdiction except jurisdictions in which failure to obtain or maintain such qualification, good standing, or licensing would not, individually or in the aggregate, have a Material Adverse Effect. The Company is duly qualified to conduct the Business as presently conducted by the Company as a foreign corporation in the jurisdictions listed in the Disclosure Schedule. No consent, waiver, approval, order, or authorization of, or registration, declaration, or filing with, any Governmental Entity or any other Person, is required to be made or obtained by the Company in connection with the execution and delivery of this Agreement by the Company, or the consummation by the Company of the transactions contemplated hereby, except for such consents, authorizations, filings, approvals and registrations that, if not obtained or made, would not have a Material Adverse Effect on the Company.

 

    7  
     

  

(c) Authorization and Validity of Agreement . The Company has all requisite power and authority to enter into the Transaction Documents to which it is a party and to carry out its obligations thereunder. The execution and delivery of the Transaction Documents and the performance of the Company’s obligations thereunder have been duly authorized by all necessary corporate action of the Company, and no other proceedings on the part or in respect of the Company is necessary to authorize such execution, delivery and performance. The Transaction Documents to which the Company is a party have been duly executed by or on behalf of the Company and assuming due authorization, execution and delivery by the other parties thereto constitute the valid and binding obligations of, and enforceable in accordance with their respective terms against, the Company, except as may be limited by applicable bankruptcy, insolvency, moratorium or similar laws of general application relating to or affecting creditors’ rights generally and except for the limitations imposed by general principles of equity.

 

(d) No Conflict or Violation . Subject to obtaining any consents and approvals identified in the Disclosure Schedules, the execution, delivery and performance by the Company of the Transaction Documents to which it is a party does not and will not (i)(A) conflict with or result in a breach of the terms, conditions, or provisions of, (B) constitute a default under (whether with or without the passage of time, the giving of notice or both), (C) give any third party the right to modify, terminate or accelerate any obligation under, (D) result in a violation of, or (E) require any consent, exemption or other action by or notice or declaration to, or filing with, any third party of any Government Entity pursuant to (1) any organizational documents of Company; (2) any provision of law, rule or regulation, or any order, judgment or decree of any court or other governmental or regulatory authority; or (3) any Contract, lease, sublease, occupancy agreement, loan agreement, mortgage, security agreement, trust indenture or other agreement or instrument to which Company is a party or by which Company is bound or to which any of Company’s properties or assets is subject; (ii) result in the creation of any Lien or Tax upon the equity or assets of Company; or (iii) otherwise interfere in any material manner with the Business. All of the Contracts and Permits of Company will continue without penalty, adjustment, breach of any such Contract or Permit, or the right of the customer or any Governmental Entity to terminate or modify any such Contract or Permit as a result of the Stock Purchase.

 

(e) Capitalization . The authorized capital stock of the Company, the issued and outstanding shares of capital stock of the Company, and the par value per share of all of the authorized capital stock of the Company, are set forth in the Disclosure Schedule. All of the Shares are duly authorized, validly issued, fully paid and nonassessable. There are no outstanding or authorized options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other Contracts or commitments that could require the Company to issue, sell, or otherwise cause to become outstanding any of its capital stock. Except as set forth in the Disclosure Schedule, there is no outstanding or authorized stock appreciation, phantom stock, profit participation, or similar rights with respect to the Company. Except as described in the Disclosure Schedule, there are no voting trusts, proxies, or other agreements or understandings with respect to the voting of the capital stock of the Company. Following the Closing, Buyer may freely terminate any voting trusts, proxies, or other agreements or understandings with respect to the voting of the capital stock of the Company. All actions have been properly authorized such that the Shares can be transferred to Buyer free from any rights of first refusal, registration rights, rights of co-sale or other restrictions or conditions relating to transfer of the Shares. All holders of Company capital stock are able to receive the Equity Consideration by virtue of an exemption to the Securities Act of 1933, as amended (the “ 1933 Act ”).

 

    8  
     

  

(f) Assets. The Company has good and marketable title to, or a valid leasehold interest in, all of its assets and properties, free and clear of all Encumbrances, except those identified in the Disclosure Schedule, and except for liens for Taxes not yet due and payable, and mechanics’ liens, materialmen’s liens, and other liens arising by operation of law, which liens do not in any case materially and adversely affect the Company’s title to its assets, the Company’s use of its assets or the value of such assets. Except as set forth on the Disclosure Schedule, the obligations giving rise to the Encumbrances identified in the Disclosure Schedule may be prepaid at any time by the Company without penalty, premium or other special charge Except as disclosed in the Disclosure Schedule, to the Company’s Knowledge, the Company’s assets which are tangible personal property are in reasonably good and serviceable condition, normal wear and tear excepted, have been maintained in accordance with normal industry practice, and are suitable for the purposes for which they are presently used. The Company owns or leases all equipment or other tangible assets that are necessary for the conduct of the Business as presently conducted. No assets are used in the Business that are not owned or leased or licensed by the Company and not included in the Assets. The Company operates no business other than the Business and related activities.

 

(g) Subsidiaries. The Company does not own, directly or indirectly, any stock or other interests in any other entity.

 

(h) Financial Statements . Set forth in the Disclosure Schedules and provided to the Buyer are the Company’s most recent unaudited balance sheet, and unaudited income statement, as of October 31, 2015 (the “ Financial Statements ”). The Financial Statements have been prepared in accordance with Generally Accepted Accounting Principles (“ GAAP ”), are complete and fairly represent in all material respects all of the assets, liabilities, transactions, and results of operations of the Business and the Company as of the dates thereof; subject, however, to normal year-end adjustments consistent with past practice, and further subject to the absence of footnotes, statements of cash flow, and changes in equity. The Company shall have a minimum cash balance of One Million Five Hundred Seventy-Five Thousand Dollars ($1,575,000) at Closing after payment of, or reservation on the Financial Statements for, all debts, fees, liabilities, payables, Taxes, claims, costs and expenses of or against the Company including, without limitation, all costs, expenses, payables, debts and liabilities arising out of the operations of the Company incurred or arising prior to the Closing.

 

(i) Absence of Certain Changes or Events . Except as otherwise provided in the Disclosure Schedule, since October 31, 2015, the Company has conducted the Business only in the ordinary course consistent with past practices. Without limiting the generality of the foregoing, since October 31, 2015, except as disclosed pursuant to the Disclosure Schedule:

 

    9  
     

 

(i) there has been no increase in the compensation or benefits paid or payable by the Company, other than in the ordinary course of business and consistent with past practices, to any of its officers, directors, employees, agents, consultants or shareholders, including any grant of severance or termination pay to any director, officer or employee of the Company, or any deferred compensation or similar agreement (or any amendment to any such existing agreement) with any director, officer or employee of the Company;

 

(ii) there has been no declaration, setting aside, or payment of dividends or distributions in respect of the capital stock of the Company, any split up or other recapitalization in respect of the capital stock of the Company or any direct or indirect redemption, purchase by the Company, or other acquisition by the Company of any such capital stock, except dividends declared and paid, or distributions made, prior to the Closing Date to Seller in the ordinary course of business consistent with the past practices of the Company;

 

(iii) the Company has not waived or compromised any right of material value or any payment, direct or indirect, of any material debt, liability, or other obligation;

 

(iv) there has been no Material Adverse Effect on the Company;

 

(v) there has been no issuance, transfer, sale, or pledge by the Company of any shares of its capital stock or other securities or any commitment, option, right, or privilege under which the Company is or may become obligated to issue any shares of its capital stock or other securities; there has been no indebtedness for borrowed money incurred by the Company except such as may have been incurred or entered into in the ordinary course of business; no loan has been made or agreed to be made by the Company, nor has the Company become liable or agreed to become liable as a guarantor with respect to any loan or other indebtedness of the Company or Seller, or any third party;

 

(vi) the Company has not waived or compromised any right of material value or any payment, direct or indirect, of any material debt, liability, or other obligation;

 

(vii) there has been no sale, assignment, or transfer of, or royalty arrangement with respect to the Company’s trade names, trademarks, service marks, domain names, web addresses, copyrights (or any interest therein), patent, or logos of material value, or any patent, trademark, service mark, domain name or web address or copyright applications (or any interest therein) used (or that were, or are intended to be used) in the operations of the Business;

 

(viii) there has been no sale, lease or disposition of, any material property or asset, tangible or intangible, of the Company;

 

(ix) there has been no actual or, to the Company’s Knowledge, threatened termination or loss of any (A) material contract, lease, license, permit or other agreement to which the Company was or is a party other than terminations of contracts upon completion of work; (ii) certificate, license, or other authorization required for the continued operation by the Company of any material portion of the Business; or (B) customer or other revenue source, which termination or loss could reasonably be expected to result in loss or revenues to the Company in excess of Twenty-five Thousand Dollars ($25,000.00) per year, and there is no event known to the Company (including, without limitation, the transactions contemplated hereby) that could reasonably be expected to result in any such termination or loss ;

 

    10  
     

  

(x) there has been no resignation or termination of employment of any key officer or employee of the Company or, to any Company’s Knowledge, any impending resignation or termination of employment of any such officer or employee;

 

(xi) there has been no agreement or commitment by the Company or Seller to do any of the things described in this Section 4(i) .

 

(j) Tax Matters .

 

(i) The Company has timely filed all material Tax Returns that it was required to file. All such Tax Returns as so filed are materially accurate, and, to the Company’s Knowledge, disclose all Taxes required to be paid for the periods covered thereby. All material Taxes due and owing by the Company (whether or not shown on any Tax Return) have been paid. The Company is not currently the beneficiary of any extension of time within which to file any Tax Return. There are no Liens for Taxes (other than Taxes not yet due and payable) upon any of the assets of the Company. The Company has withheld and paid all Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party, and all Tax Returns and forms required with respect thereto have been properly completed and timely filed.

 

(ii) There is no material dispute or claim concerning any Tax liability of the Company either (A) claimed or raised by any authority in writing or (B) to the Knowledge of Company.

 

(iii) The Disclosure Schedule identifies all federal, state, local and foreign income Tax returns filed with respect to the Company for taxable periods ended on or after December 31, 2011, indicates those Tax Returns that have been audited, and indicates those Tax Returns that currently are the subject of audit. The Company has delivered to Buyer correct and complete copies of all federal income Tax Returns, examination reports, and statements of deficiencies assessed against or agreed to by the Company since December 31, 2011. The Company has not waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency.

 

(iv) The Company has not made any material payments, is not obligated to make any material payments, and is not a party to any agreement that under certain circumstances (including without limitation the performance of the transactions contemplated by this Agreement) could obligate it to make any material payments that will not be deductible under Code section 280G. The Company is not a party to any Tax allocation or sharing agreement. The Company (A) has not been a member of an affiliated group (within the meaning of Code section 1504(a)) filing a consolidated federal income Tax Return (other than a group the common parent of which was the Company) and (B) does not have any liability for the Taxes of any Person under Regulations section 1.1502-6 (or any similar provision of state, local, or foreign law), as a transferee or successor, by contract, or otherwise.

 

    11  
     

  

(v) The unpaid Taxes of the Company (A) did not, as of the most recent fiscal month end, exceed the reserve for Tax liability (rather than any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the face of the most recent Financial Statements (rather than in any notes thereto) and (B) will not exceed that reserve as adjusted for operations and transactions through the Closing Date in accordance with the past custom and practice of the Company in filing its Tax Returns.

 

(vi) The Company has not distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Code section 355 or Code section 361.

 

(vii) At all times since its formation, the Company has been classified as a corporation for federal, state, local and foreign income Tax purposes.

 

(viii) The Company is not a “foreign person” as that term is used in Regulations section 1.1445-2.

 

(k) Absence of Undisclosed Liabilities; Indebtedness . Except as identified pursuant to the Disclosure Schedule, or reflected on the Financial Statements, or incurred in the ordinary course of business, the Company has no indebtedness or liability, absolute or contingent, involving, affecting or relating to the Business or the Products.

 

(l) Intellectual Property.

 

(i) “ IP Assets ” shall mean all of the following materials owned or licensed by the Company with respect to the Business: (A) the proprietary formulas for the Products; (B) the domain names listed on Schedule 4(l) (collectively, the “ Domain Names ”); (C) all the content on and accessible through the websites associated with the Domain Names, including demos (collectively, the “ Website Content ”); and (D) the entire Business marketing database consisting of all available customer information and all marketing, advertising and promotional materials, including logos, colors, videos, booklet designs, catalogs, solicitations, email templates, advertisements and all other Business marketing materials (whether in draft or final form) (collectively, the “ Marketing Materials ”).

 

(ii) Schedule 4(l) lists all patented, registered, applied-for, and other Intellectual Property used in the Business and all Intellectual Property of the Company licensed to any third Person (collectively, the “ Business Intellectual Property ”), including the registration and application information, date of application or issuance and relevant jurisdiction as to each, and whether or not the Business Intellectual Property is owned or licensed. Business Intellectual Property that is licensed by the Company from a third party is “ Licensed Intellectual Property ”.

 

(iii) The Company owns all right, title and interest in and to or has a valid and enforceable license to use, all IP Assets, Business Intellectual Property, and the Licensed Intellectual Property, free and clear of all Liens, and all patented or registered Business Intellectual Property is valid and enforceable. To the Company’s Knowledge, it has taken commercially reasonable steps to maintain the confidentiality of all information that constitutes a trade secret of the Business.

 

    12  
     

  

(iv) Except as set forth on Schedule 4(l) , (A) the conduct of the Business, including the delivery and distribution of the Products, has not infringed and does not infringe on any Intellectual Property or any other proprietary rights of any Person, including but not limited to the rights of privacy or publicity; (B) to the Knowledge of the Company, no Person is infringing, violating or misappropriating any Business Intellectual Property; (C) the Company has not taken any action, or failed to take any action, during prosecution of any application that could reasonably be expected to result in the invalidation or unenforceability of any registered Business Intellectual Property; (D) the Company is not currently a party to any pending suit, claiming any alleged infringement or misappropriation of any Business Intellectual Property; (E) the Company has not received within the prior three (3) years any written notice, and is not currently a party to any pending suit, claiming any alleged infringement or misappropriation of the Intellectual Property rights of other Persons with respect to its or their use of Intellectual Property or the Products; (F) the Company has not entered into any Contract that includes a forbearance to sue or settlement Contract with respect to any Intellectual Property and (G) the Company has not received any written notice of any claim within the prior three (3) years, and is not currently a party to any pending suit, which challenges the validity or enforceability of, the Company’s ownership of or right to use, any Intellectual Property (excluding, for clarity, office actions) or the Products. The Company has secured, and has in place a policy to secure, valid written confidentiality Contracts and assignments of Intellectual Property from all consultants, contractors, Employees and customers who contribute or have contributed to the creation, conception, reduction to practice or other development of any Intellectual Property developed on behalf of Company.

 

(v) No Product provided or distributed by the Company in its conduct of the Business: (A) violates any material Law; (B) includes any information or material that, to the Knowledge of the Company, is defamatory; or (C) infringes any right of privacy of any Person. Each Person whose name, image, voice or likeness is incorporated into any Marketing Materials has executed a written release consenting to the Company’s use of such Person’s name, image, voice and/or likeness (as applicable) and releasing the Company from any claims with respect thereto (a “ Release ”), each of such Releases are fully assignable to Buyer without further consent of any Person.

 

(vi) The Company has operated the Business and provided all Products in compliance with any posted privacy policies and all applicable Laws relating to privacy, data protection, anti-spam, telemarketing, personally identifiable information and similar consumer protection Laws (“ Information Privacy Laws ”). The Company has not received written notice of any claims or been charged with violation of any Information Privacy Law. To the Knowledge of Company, the Company is not under investigation with respect to any violation of any Information Privacy Laws.

 

    13  
     

  

(m) Compliance with Law . Except as identified in the Disclosure Schedule, the manufacture and sale of the Products and the operation of the Business has been conducted in material compliance with all applicable material Laws and other requirements of all courts and other governmental or regulatory authorities having jurisdiction over the Company and its assets, properties and operations. Except as set forth in the Disclosure Schedule, the Company has not received notice of any violation (or possible violation) of any such Law or other legal requirement, and the Company is not in default with respect to any order, writ, judgment, award, injunction or decree of any federal, state or local court or Governmental Entity or regulatory authority, applicable to the Company, the Business, the Products or the Shares. Without limiting the foregoing, the Company has not received any warning letter or untitled letter, report of inspectional observations, including FDA Form 483s, establishment inspection reports, notices of violation, clinical holds, enforcement notices or other documents from the FDA or any other similar Governmental entity or any institutional review board or independent ethics committee alleging a lack of material compliance by Company with any Laws. The Company holds all Permits required for the conduct of the Business and the ownership of its properties except where the absence thereof would not result in a Material Adverse Effect. No written notices have been received by the Company alleging the failure to hold any Permit. The Company is in material compliance with all terms and conditions of all such Permits. All of such Permits shall be available for use by Buyer immediately after the Closing. Without limiting the foregoing, the Company has not received any warning letter or untitled letter, report of inspectional observations, establishment inspection reports, notices of violation, clinical holds, enforcement notices or other documents from any Governmental Entity or any institutional review board or independent ethics committee alleging a lack of material compliance by Company with any Laws. No “bulk sales” or similar Law applies to the transactions contemplated by this Agreement.

 

(n) Litigation . Except as set forth on Schedule 4(n) , there are no claims, Actions, suits, proceedings, complaints or investigations pending or, to the Knowledge of Company, threatened before any federal, state, provincial, court or governmental or regulatory authority, domestic or foreign, or before any arbitrator of any nature, brought by or against the Company or any of its officers, directors, employees, agents or Affiliates, or the Sellers, involving, affecting or relating to the Company, the Business, the Products, the Shares, or the transactions contemplated by the Transaction Documents.

 

(o) Brokers . Except for Creo Capital Advisors LLC, who was hired by the Company, no broker, finder, or investment banker is entitled to any brokerage, finder’s, or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company.

 

(p) Insurance . The Company is currently insured by insurers unaffiliated with the Company with respect to its properties, assets and operation of the Business in such amounts and against such risks which to the Knowledge of Company are appropriate and customary for the type of business conducted by the Company with customary deductibles and retained amounts. In addition, the Company has maintained comparable insurance for all prior periods. With respect to each insurance policy held by the Company (the “ Insurance Policies ”) (i) to the Knowledge of Company such Insurance Policy is legal, valid, binding and in full force and effect; (ii) the Company is not in default under such Insurance Policy; and (iii) the Company has delivered a true and correct copy of such Insurance Policy to Buyer. There are no claims by the Company pending under any such Insurance Policies and the Company has not been informed that coverage has been questioned, denied or disputed by the underwriters of such Insurance Policies with respect to any such claims.

 

    14  
     

  

(q) Employment Matters .

 

(i) The Disclosure Schedule identifies all of the Employees as of the date hereof, including for each such Employee: name, job title, FLSA classification, work location (identified by street address), current compensation paid or payable, all wage and fringe benefit arrangements. Except as set forth on the Disclosure Schedule, each Employee is employed by the Company at will and may be terminated by the Company without cause on thirty (30) days or less notice without penalty or severance. To the Knowledge of Company, no Employee is a party to, or is otherwise bound by, any Contract or arrangement, including any confidentiality or non-competition Contract, that in any way adversely affects or restricts the performance of such Employee’s duties. Each current Employee has executed a nondisclosure and assignment-of-rights Contract for the benefit of the Company vesting all rights in work product created by the Employee, during the Employee’s employment or affiliation with the Company, in the Company. To the Knowledge of Company and except as set forth in the Disclosure Schedule, no Employee intends to terminate his or her employment with the Company. In accordance with its normal payroll policies the Company has paid all salaries, bonuses, commissions, wages, and severance that are owed to the Employees as of the Closing and maintained adequate reserves, as reflected in the Financial Statements, for all salaries, bonuses, commissions, wages, and severance not yet due and payable as of the Closing. The Company is in compliance, in all material respects, with all Laws governing the employment of labor.

 

(ii) Except as identified in the Disclosure Schedule, to the Knowledge of Company, each Employee is (i) a United States citizen, (ii) a lawful permanent resident of the United States, or (iii) an alien authorized to work in the United States either specifically for the Company or for any United States employer. The Company is in compliance in all material respects with applicable Law, has completed a Form I-9 (Employment Eligibility Verification) for each Employee and each such Form I-9 has since been updated as required by applicable Law and, to the Knowledge of the Company, is correct and complete as of the date hereof.

 

(iii) The Company is in compliance, in all material respects, with all Laws governing the employment of labor, including but not limited to, all such Laws relating to wages, hours, leaves of absence, affirmative action, collective bargaining, discrimination, civil rights, safety and health, workers’ compensation and the collection and payment of withholding and/or Social Security Taxes and similar Taxes, including, but not limited to, the Age Discrimination in Employment Act, as amended, Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Employee Retirement Income Security Act, the Fair Labor Standards Act (29 U.S.C. 201, et seq.) (“ FLSA ”), the Americans with Disabilities Act, the Sarbanes-Oxley Act of 2002, the Worker Adjustment and Retraining Notification Act, as amended, the Occupational Safety and Health Act, as amended, the Family and Medical Leave Act (29 U.S.C. 2601, et seq.), as amended, the National Labor Relations Act of 1935, as amended, Executive Order 11246 and any other executive orders or regulations governing affirmative action, EEO and VETS-100 reporting obligations, the Immigration Nationality Act (8 U.S.C. 1324a, et seq.), as amended, and all similar applicable Laws (collectively the “ Labor Laws ”). The Company has, during the five (5) year period prior to the date hereof, conducted the Business in material compliance with all applicable Labor Laws. The Company has withheld all amounts required by Law or Contract to be withheld from the wages or salaries of its Employees and is not liable for the payment of any arrears of wages or other Taxes, penalties, fines or other compensation of any kind, however designated, for failure to comply with any of the foregoing. The Company has maintained adequate and suitable records regarding the service of each Employee including records of working time, where available. Each Employee of the Company has been properly classified as “exempt” or “non-exempt” under the FLSA and all other applicable Laws. The Company is not, and in the last three (3) years has not been, a government contractor.

 

    15  
     

  

(iv) The Company has not at any time during the last three (3) years had, nor to the Knowledge of Company is there now threatened, any walkout, strike, union activity, picketing, work stoppage, work slowdown, any effort to organize or any other similar occurrence or any attempt to organize or represent the labor force of the Company. There are no controversies pending or overtly threatened between the Company, on the one hand, and any of its Employees (or former Employees) or any labor union or other collective bargaining unit representing or purporting to represent any of its Employees, on the other hand. The Company is not a party to, bound by, or subject to any collective bargaining agreement or other Contract, written or oral, with any union representing or purporting to represent the Company’s Employees. No union or other collective bargaining unit or Employee organizing entity has been certified or recognized by Seller as representing any of its Employees.

 

(v) No investigation, review, complaint or proceeding by any Government entity or Employee or former Employee with respect to the Company in relation to any actual or alleged violation of any Labor Laws is pending or, to the Knowledge of Company, threatened, nor has the Company or Seller received any notice from any Government entity indicating an intention to conduct the same.

 

(vi) Within the past five (5) years, the Company has not implemented any mass layoff, plant closing, or other termination of employees that could implicate the Worker Adjustment and Retraining Notification Act (WARN Act) or any similar state or local Law.

 

(vii) The Company has identified in the Disclosure Schedule and provided to Buyer all employment, change in control, severance, retention, termination, non-competition, non-solicitation and other similar Contracts, arrangements or policies, whether written or oral, between Seller and any individual other than at-will employment arrangements but including all Contracts, arrangements or policies that affect at-will Employees. The Company is in material compliance with its obligations under all such Contracts.

 

(r) Contractor Matters . The Company has identified in the Disclosure Schedule the name and contact information of each independent contractor, consultant, freelancer or other service provider (i) utilized by the Company as of the date hereof or (ii) utilized by the Company relating to the development, modification or creation of any proprietary formulas for the Products within the three (3) years immediately preceding such date (collectively, “ Contractors ”). A copy of each Contract relating to the services any Contractor provides or provided to the Business has been made available to the Buyer. To the Knowledge of Company, no Contractor used by the Company is a party to, or is otherwise bound by, any Contract or arrangement with any third party, including any confidentiality or non-competition Contract, that in any way adversely affects or restricts the performance of such Contractor’s duties for Seller. Each Contractor ever retained by the Company to create, modify or develop with respect to the proprietary formulas for the Products has executed a nondisclosure and assignment-of-rights Contract for the benefit of the Company and the Company is the owner of all rights in and to all Intellectual Property created by such Contractor in performing services for the Company vesting all rights in work product created in the Company. All individuals who have been treated by the Company as independent contractors in the five (5) years immediately preceding the date hereof were, to the Knowledge of Company, correctly classified as such for purposes of the Code and all other applicable Laws.

 

    16  
     

  

(s) Employee Benefits .

 

(i) The Disclosure Schedule lists all Employee Benefit Plans maintained or contributed to by the Company or under which the Company has or could have any obligations (other than obligations to make current wage or salary payments or sales commissions terminable on notice of thirty (30) days or less) or liabilities, actual or contingent, whether or not legally binding, in respect of any of the current or former officers, Employees or independent contractors of the Company who provided services in respect of the Business or their dependents or beneficiaries (individually referred to as a “ Company Benefit Plan ” and collectively referred to as the “ Company Benefit Plans ”). The Company has delivered or provided to Buyer true and complete copies of the plan documents, as they may have been amended through the date hereof, for each company Employee Benefit Plan, as well as, to the extent applicable, Forms 5500 and actuarial valuations for the last three plan years, plan documents, trust agreements, insurance Contracts, administrative services agreements, most recent determination letters and other documents required under ERISA.

 

(ii) Each Company Benefit Plan has been established, maintained and administered in accordance with its terms and in material compliance with all applicable provisions of (including rules and regulations thereunder) ERISA, the Code and other applicable Law, and neither the Company nor any “party in interest” or any “disqualified person” with respect to any Company Benefit Plan has engaged in a “prohibited transaction” within the meaning of Section 4975 of the Code or Section 406 of ERISA with respect to any Company Benefit Plan. Each Company Benefit Plan that is intended to be qualified within the meaning of Section 401(a) of the Code has received a favorable determination letter from the Internal Revenue Service (or, if such plan is a prototype or volume submitter plan document, such prototype or volume submitter plan document has received a favorable opinion from the IRS that the form meets the tax qualification requirements) to the effect that such Company Benefit Plan satisfies the requirements of Section 401(a) of the Code and that its related trust is exempt from taxation under Section 501(a) of the Code and there are no facts or circumstances that could reasonably be expected to cause the loss of such qualification or the imposition of Liability, penalty or Tax under ERISA, the Code or other applicable Laws (including the rules and regulations under any of them).

 

(iii) No Company Benefit Plan is, and neither the Company nor any of its ERISA Affiliates has ever sponsored an Employee Benefit Plan that is or was, subject to Title IV of ERISA. No Company Benefit Plan is, and neither the Company nor any of its ERISA Affiliates has ever contributed, or been obligated to contribute, to any “multiemployer plan” (within the meaning of Sections 3(37) or 4001(a)(3) of ERISA) under Subtitle E of ERISA.

 

    17  
     

  

(iv) The Disclosure Schedule identifies each Company Benefit Plan that is a “non-qualified deferred compensation plan”, within the meaning of Section 409A of the Code (each, a “ Section 409A Plan ”), and identifies each Section 409A Plan in connection with which the Company or it successors may have Liability with respect to Employees, Contractors or directors. No such plan has assets set aside directly or indirectly in the manner described in Section 409A(b)(1) of the Code or contains a provision that would be subject to Section 409A(b)(2) of the Code. Each Section 409A Plan (i) was, since the date of the inception of such Company Benefit Plan, (or since January 1, 2005, if later) administered in good faith compliance with the requirements of Section 409A of the Code and applicable guidance issued thereunder, (ii) has been, since the date of inception of such Company Benefit Plan (or since January 1, 2005, if later), administered in compliance, in all material respects, with the requirements of Section 409A of the Code and the final regulations issued and outstanding thereunder. In the event of an audit by the IRS of either the Company or any individual participating in such Company Benefit Plan, the additional Tax described in Section 409A(a)(1)(B) would not be assessed against any such participant with respect to benefits due or accruing under such Company Benefit Plan.

 

(v) Except as identified in the Disclosure Schedule, neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (either alone or in combination with another event): (i) result in any payment becoming due, or increase the amount of any compensation due, to any Employee; (ii) increase any benefits otherwise payable under any Company Benefit Plan; or (iii) result in the acceleration of the time of payment or vesting of any such compensation or benefits.

 

(vi) The Company does not currently sponsor any Company Benefit Plan that is intended to be qualified within the meaning of Section 401(a) of the Code, including but not limited to any 401(k) plan. Company Employees are currently able to participate in a 401(k) plan sponsored by a professional employer organization (TriNet Group, Inc., or one of its affiliates), subject to the terms of such plan.

 

(t) Environmental and Safety Matters . The Company has complied in all material respects and is in material compliance with all Environmental Laws, including but not limited to all Permits required by Environmental Laws for the conduct of the business operations of the Company and the disposition of all hazardous materials in accordance with all applicable Environmental Laws. The Company has not received any outstanding and unresolved written or oral notices, reports or other information regarding any actual or alleged violation of Environmental Laws by the Company, or any Liabilities or potential Liabilities, including any remedial obligations, relating to any of them or their facilities arising under Environmental Laws. The Company is not a potentially responsible party under the federal Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended, or any analogous state, local or foreign applicable Laws arising out of events occurring prior to the Closing Date. To the Knowledge of Company, no facts, events or conditions relating to the past or present facilities, properties or operations of the Company, or any geologically or hydrologically adjoining properties, shall prevent, hinder or limit the Company’s continued compliance with Environmental Laws, give rise to any remedial obligations of the Company pursuant to Environmental Laws, or give rise to any other Liabilities of the Company pursuant to Environmental Laws, including, without limitation, any relating to onsite or offsite releases or threatened releases of hazardous materials, personal injury, property damage or natural resources damage. To the Knowledge of Company, there have not been in the past and are not now any underground tanks or underground improvements, including treatment or storage tanks, sumps, or water, gas or oil wells; polychlorinated biphenyls; or asbestos or asbestos-containing materials at, on or under any of the Leased Real Property. The Company has delivered to Buyer true and complete copies and results of any reports, studies, analyses, tests, or monitoring possessed or initiated by the Company pertaining to hazardous materials in, on, under, or migrating to or from any of the Leased Real Property, or concerning compliance by the Company, or any other Person for whose conduct the Company is or may be held responsible, under Environmental Law.

 

    18  
     

  

(u) Real Property . The Disclosure Schedule identifies the address of each leased real property of the Company (the “ Leased Real Property ”). Seller has provided to Buyer a true and complete copy of all leases and subleases (including all amendments, extensions, renewals, Guarantees and other Contracts with respect thereto) for each such Leased Real Property (the “ Leases ”), and in the case of any oral Lease, a written summary of the material terms of such Lease. With respect to each of the Leases except as disclosed pursuant to the Disclosure Schedule: (i) to the Knowledge of Company, such Lease is legal, valid, binding, enforceable and in full force and effect; (ii) the transactions set forth in this Agreement do not require the consent of any other Person to such Lease, or such consent has been obtained, shall not result in a breach of or default under such Lease, or otherwise cause such Lease to cease to be legal, valid, binding, enforceable and in full force and effect on identical terms following the Closing; (iii) Seller’s possession and quiet enjoyment of the Leased Real Property under such Lease has not been disturbed, and there are no disputes with respect to such Lease; (iv) the Company, and any other party to the Lease, is not in breach or default under such Lease, and no event has occurred or circumstance exists which, with the delivery of notice, the passage of time or both, would constitute such a breach or default, or permit the termination, modification or acceleration of rent under such Lease; (v) no security deposit or portion thereof deposited with respect to such Lease has been applied in respect of a breach or default under such Lease which has not been redeposited in full; (vi) the Company does not owe, or shall owe in the future, any brokerage commissions or finder’s fees with respect to such Lease; (vii) the other party to such Lease is not an Affiliate of, and otherwise does not have any economic interest in, the Company; (viii) the Company has not subleased, licensed or otherwise granted any Person the right to use or occupy such Leased Real Property or any portion thereof; (ix) the Company has not collaterally assigned or granted any other security interest in such Lease or any interest therein; (x) there are no Liens on the estate or interest created by such Lease; and (xi) to the Knowledge of Company, all buildings, structures, improvements, fixtures, building systems and equipment, and all components thereof, included in the applicable Leased Real Property are in good condition and repair (reasonable wear and tear excepted). The Company does not own any real property, nor has it ever owned any real property.

 

(v) Affiliate Transactions . Except as identified in the Disclosure Schedule, to the Knowledge of Company, no shareholder, officer, director, member or Affiliate of a Seller or any individual related by blood, marriage or adoption to any such individual or any entity in which any such Person or individual owns any beneficial interest, is a party to any Contract or transaction with Seller or has any interest in any real, tangible or intangible asset or property used by Seller.

 

(w) Customer and Vendor Relations . The Disclosure Schedule identifies a correct and complete list of the names of the top ten (10) Customers and Vendors and the amount of net revenues to or purchases from each such Customer or Vendor during the each of the 2013 and 2014 fiscal years and the period ended as of September 30, 2015 (each a “ Key Relationship ”). The Company maintains commercially reasonable relations with each of its Key Relationships and no event has occurred that would reasonably be expected to affect materially and adversely the Company’s relations with any Key Relationship. Except as disclosed pursuant to the Disclosure Schedule, no Customer or Vendor has during the last twelve (12) months cancelled, terminated, materially decreased the rate of, materially altered the terms with respect to or, to the Knowledge of Company, made any threat to cancel or otherwise terminate any of its Contracts with the Company or to decrease its usage or supply of the Company’s services or products, excluding for avoidance of doubt, discrete projects performed by the Company for Customers, for which the Company’s services terminated solely by virtue of the Company’s having completed the project to the Customers’ satisfaction. To the Knowledge of Company, except as identified in the Disclosure Schedule no current Customer or Vendor may terminate or materially alter its business relations with the Company, either as a result of the transactions contemplated hereby or otherwise.

 

    19  
     

  

(x) Product and Service Warranties; Adverse Events . Except as set forth in the Disclosure Schedule, the Company has made no express warranty or Guarantee to any Customer (or end user of the Company’s goods) as to services or goods provided by the Company. There is no pending or, to the Knowledge of Company, threatened claim alleging any breach of any warranty or Guarantee. The Company does not have any Liability under any such a warranty or Guarantee that would reasonably be expected to result in Liability to the Company, individually or in the aggregate, in excess of $10,000. There have not been any Material Adverse Events with respect to the Products or the Business.

 

(y) Guaranties . The Company is not a guarantor or otherwise liable for any liability, indebtedness or other obligation of any other Person.

 

(z) Disclosure . No representation or warranty by the Company contained in this Agreement, and no statement contained in the Disclosure Schedules or any other document, certificate or other instrument delivered to or to be delivered by or on behalf of the Company pursuant to this Agreement, contains or will contain any untrue statement of a material fact or omits or will omit to state any material fact necessary, in light of the circumstances under which it was or will be made, in order to make the statements herein or therein not misleading.

 

(aa) Inventory . All inventory of the Company, whether or not reflected in the Balance Sheet, consists of a quality and quantity usable and salable in the ordinary course of business consistent with past practice, except for obsolete, damaged, defective or slow-moving items that have been written off or written down to fair market value or for which adequate reserves have been established. All such inventory is owned by the Company free and clear of all encumbrances, and no inventory is held on a consignment basis. The quantities of each item of inventory are not excessive, but are reasonable in the present circumstances of the Company.

 

(bb) Contracts; Agreements .

 

(i) Except as disclosed in the Disclosure Schedule, the Company is not a party to or bound by:

 

1. any customer, license, sale, distribution, commission, marketing, agent, franchise, technical assistance or similar Contract relating to or providing for the marketing and/or sale of products or services to which the Company is a party or by which it is otherwise bound;
     
2. any Contract involving the license of any patent, copyright, trade secret or other proprietary right constituting Intellectual Property to or from the Company;

 

    20  
     

  

3. any Contract providing for the development of any software, content (including textual content and visual, photographic or graphics content), technology or intellectual property for (or for the benefit or use of) use by the Company, or providing for the purchase by or license to (or for the benefit or use of) it of any hardware, software, content (including textual content and visual, photographic or graphics content), technology or intellectual property, which hardware, integrated circuits, software, content, technology or intellectual property is in any manner used or incorporated (or is contemplated by it to be used or incorporated) in connection with any aspect or element of any product or service provided by or technology used by the Company;
     
4. any agreement, contract or commitment relating to the acquisition or disposition of any business (whether by merger, sale of stock, sale of assets or otherwise);
     
5. (A) any agreement relating to Indebtedness or (B) any mortgages, indentures, loans or credit agreements, security agreements or other agreements or instruments relating to indebtedness;
     
6. any joint venture or partnership or other similar agreement;
     
7. any agreement with any Affiliate of the Company, with any director or officer of the Company, or with any “associate” or any member of the “immediate family” (as such terms are respectively defined in Rules 12b-2 and 16a-1 of the 1934 Act) of any such director or officer, other than employment, invention assignment and equity-related agreements provided to Buyer;
     
8. any employment or consulting agreement, contract or commitment with an employee or individual consultant or salesperson or consulting or sales agreement, contract or commitment with a firm or other organization not otherwise disclosed on the Disclosure Schedule or not cancellable on thirty (30) days notice or less without penalty;
     
9. any agreement or plan, including, without limitation, any stock option plan, stock appreciation rights plan or stock purchase plan, any of the benefits of which will be increased, or the vesting of benefits of which will be accelerated, by the occurrence of any of the transactions contemplated by this Agreement or the value of any of the benefits of which will be calculated on the basis of any of the transactions contemplated by this Agreement not otherwise disclosed on the Disclosure Schedule;
     
10. any other oral or written Contract or obligation that individually has a value in excess of $15,000 or is otherwise material to the Company or its businesses, operations, financial condition, properties or assets.

 

    21  
     

  

(ii) Each agreement, contract, plan, lease, arrangement or commitment required to be disclosed, and which would be required to be disclosed absent disclosure elsewhere, pursuant to Section 4(bb)(i) above (each, a “ Material Contract ”) is a valid and binding agreement the Company and is in full force and effect with respect to the Company and, to the Knowledge of Company, each other party thereto, and neither the Company, nor to the Knowledge of Company, any other party thereto, is in default or breach in any material respect under the terms of any such Material Contract, and, to the Knowledge of Company, no event or circumstance has occurred that, with notice or lapse of time or both, would reasonably be expected to constitute any event of default thereunder. True and complete copies of each such Material Contract have been provided to Buyer. The Company has fulfilled all material obligations required pursuant to each Material Contract to have been performed by the Company prior to the date hereof.

 

(iii) Except in the ordinary course of business, no Person is renegotiating or seeking to renegotiate, or, to the Knowledge of Company, has a right (absent any default or breach of a Material Contract) pursuant to the terms of any Material Contract to renegotiate, any material amount paid or payable to the Company under any Material Contract or any other material term or provision of any Material Contract. The Company has not received any written indication or, to the Knowledge of the Company, verbal indication of an intention to terminate or renegotiate the terms of any of the Material Contracts by any of the parties to any of the Material Contracts.

 

(cc) Trust . No representation or warranty by the Trust contained in this Agreement, and no statement contained in the Disclosure Schedules or any other document, certificate or other instrument delivered to or to be delivered by or on behalf of the Trust pursuant to this Agreement, contains or will contain any untrue statement of a material fact or omits or will omit to state any material fact necessary, in light of the circumstances under which it was or will be made, in order to make the statements herein or therein not misleading.

 

5. Representations And Warranties of the Trust . As a material inducement to Buyer to enter into this Agreement and to consummate the transactions contemplated hereby, the Trust hereby represents and warrants to the Buyer that the statements contained in this Section 5 are true and correct as of the date hereof.

 

(a) Organization . The Trust is a statutory trust duly organized, validly existing and in good standing under the laws of its jurisdiction of formation. The Trust has provided to the Buyer duly executed copies of its organizational and governing documents (collectively, the “ Trust Documents ”).

 

    22  
     

  

(b) Authorization and Validity of Agreement . The Trust has full power and authority to carry out its purpose as now being conducted or contemplated and is entitled to own, lease, or operate the assets it will own in accordance with this Agreement. No consent, waiver, approval, order, or authorization of, or registration, declaration, or filing with, any Governmental Entity or other Person is required to be made or obtained by the Trust in connection with the execution and delivery of this Agreement by the Trust, or the consummation by the Trust of the transactions contemplated hereby, except for such consents, authorizations, filings, approvals and registrations that, if not obtained or made, would not have a Material Adverse Effect on the Trust. The Trust has all requisite power and authority to enter into the Transaction Documents to which it is a party and to carry out its obligations thereunder. The execution and delivery of the Transaction Documents and the performance of the Trust’s obligations thereunder have been duly authorized by all necessary trustee action of the Trust, and no other proceedings on the part or in respect of the Trust is necessary to authorize such execution, delivery and performance. The Transaction Documents to which the Trust is a party have been duly executed by or on behalf of the Trust and assuming due authorization, execution and delivery by the other parties thereto constitute the valid and binding obligations of, and enforceable in accordance with their respective terms against, the Trust, except as may be limited by applicable bankruptcy, insolvency, moratorium or similar laws of general application relating to or affecting creditors’ rights generally and except for the limitations imposed by general principles of equity.

 

(c) No Conflict or Violation . The execution, delivery and performance by the Trust of the Transaction Documents to which it is a party does not and will not (i)(A) conflict with or result in a breach of the terms, conditions, or provisions of, (B) constitute a default under (whether with or without the passage of time, the giving of notice or both), (C) give any third party the right to modify, terminate or accelerate any obligation under, (D) result in a violation of, or (E) require any consent, exemption or other action by or notice or declaration to, or filing with, any third Person or any Government Entity pursuant to (1) any organizational documents of the Trust; (2) any provision of law, rule or regulation, or any order, judgment or decree of any court or other governmental or regulatory authority; or (3) any Contract, security agreement, trust indenture or other agreement or instrument to which the Trust is a party or by which the Trust is bound or to which any of the Trust’s properties or assets is subject; (ii) result in the creation of any Lien or Tax upon the equity or assets of Trust; or (iii) otherwise interfere in any material manner with the Business.

 

(d) Governing Documents . The Trust Documents provide that the Equity Consideration will be held by the Trust and not distributed to the Sellers for a period of three (3) years from the Closing. The allocation scheme in the Trust documents for disbursement and distribution of the Purchase Consideration is identical in all respects to the current Certificate of Incorporation of the Company, as amended, such that all Sellers will receive the identical portion of the Purchase Consideration as would have been received had he Buyer paid the Purchase Consideration directly to the Sellers, after adjust for any expenses of the Trust and indemnification claims by Buyer.

 

(e) Assets . The assets held by the Trust, until such time as no further Royalty Consideration is due, will consist solely of the Purchase Consideration and remain free and clear of all Encumbrances.

 

(f) Legal Proceedings . There are no actions, suits, claims, investigations or other legal proceedings pending or, to the Trust’s knowledge, threatened against or by the Trust that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.

 

    23  
     

  

(g) Status of Trust and Its Beneficiaries . (i) The Trust and its beneficiaries have had an opportunity to discuss the business, management and financial affairs of Buyer, have had access to, the management of Buyer, and have had the opportunity to review the information set forth in Buyer’s public filings and any other information requested by the Trust or any beneficiary, (ii) Buyer will be relying upon the Trust’s representations and warranties set forth herein in offering the Equity Consideration to it in its own right and for the benefit of Sellers, and (iii) the Trust and its beneficiaries recognize that ownership of the Equity Consideration involves substantial risks, including a risk of total loss of the value of the Equity Consideration, and have taken full cognizance of and understand all of the risk factors related to the ownership of the Equity Consideration; (iv) the Trust and its beneficiaries have an adequate net worth and means of providing for its current needs and possible contingencies to sustain a complete loss in the Equity Consideration; and (v) the Trust and its beneficiaries are able to receive the Equity Consideration by virtue of an exemption to the 1933 Act.

 

(h) Acquisition for Sellers’ Account . This Agreement is made with the Trust in reliance upon the Trust’s representations to Buyer, that the Equity Consideration to be issued to and held by the Trust for the benefit of the Sellers (in accordance with the terms of the Trust), was acquired for investment, and not with a view to the sale or distribution of any part thereof other than as permitted under the 1933 Act and that the Trust has no present intention of selling, granting participation in, or otherwise distributing the same other than what is permitted under the 1933 Act. Except as set forth in the Trust Documents, the Trust does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person, or to any third person, with respect to the Equity Consideration.

 

(i) No Intention to Distribute . The Trust and its beneficiaries understand that the Equity Consideration shares have not been registered under the 1933 Act on the grounds that the sale provided for in this Agreement and the issuance of the Equity Consideration is exempt from registration under the 1933 Act, and that Buyer’s reliance on such exemption is predicated in part on the representations set forth herein. The Trust and its beneficiaries realize that the basis for the exemption may not be present if, notwithstanding such representations, the Trust and its beneficiaries have in mind merely acquiring the Equity Consideration for a fixed or determined period in the future, or for a market rise, or for sale if the market does not rise. The Trust and its beneficiaries do not have any such intention.

 

(j) No Registration . The Trust and its beneficiaries understand that the Equity Consideration may not be sold, transferred or otherwise disposed of without registration under the 1933 Act or an exemption therefrom, and that in the absence of an effective registration statement covering the shares or an available exemption from registration under the 1933 Act, the Equity Consideration must be held indefinitely. In particular, the Trust and its beneficiaries are aware that the shares may not be sold pursuant to Rule 144 promulgated under the 1933 Act unless all of the conditions of that Rule are met. Among the conditions for use of Rule 144 may be the availability of current information to the public about Buyer. The Trust represents that, in the absence of an effective registration statement covering the Equity Consideration shares, it will not sell, transfer, or otherwise dispose of such shares except in a manner consistent with its representations set forth herein.

 

    24  
     

  

(k) Brokers . Except for Creo Capital Advisors LLC, who was hired by the Company, no broker, finder, or investment banker is entitled to any brokerage, finder’s, or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Seller.

 

(l) Disclosure . No representation or warranty by the Trust contained in this Agreement, and no statement contained in the Disclosure Schedules or any other document, certificate or other instrument delivered to or to be delivered by or on behalf of the Trust pursuant to this Agreement, contains or will contain any untrue statement of a material fact or omits or will omit to state any material fact necessary, in light of the circumstances under which it was or will be made, in order to make the statements herein or therein not misleading.

 

6. Representations And Warranties of the Buyer . As a material inducement to Buyer to enter into this Agreement and to consummate the transactions contemplated hereby, Buyer hereby represents and warrants to Sellers and Trust as follows:

 

(a) Corporate Organization . Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada, and has all requisite power and authority and all necessary governmental authority to own, operate or lease the properties that it purports to own, operate or lease and to carry on its businesses as now conducted. Buyer is duly qualified to do business as a foreign company, and is in good standing in each jurisdiction where the character of its properties owned, operated or leased or the nature of its activities makes such qualification necessary. Buyer’s capitalization is sufficient to satisfy is obligation to issue the Equity Consideration.

 

(b) Authorization and Validity of Agreement . Buyer has all requisite power and authority to enter into the Transaction Documents and to carry out its obligations thereunder. The execution and delivery of the Transaction Documents and the performance of Buyer’s obligations thereunder have been duly authorized by all necessary company action by Buyer, and no other proceedings on the part of Buyer are necessary to authorize such execution, delivery and performance. Each of the Transaction Documents has been duly executed by Buyer and, assuming due authorization, execution and delivery by the other parties thereto, constitutes its valid and binding obligation, enforceable against it in accordance with its terms, except as may be limited by applicable bankruptcy, insolvency, moratorium or similar laws of general application relating to or affecting creditors’ rights generally and except for the limitations imposed by general principles of equity.

 

(c) No Conflict or Violation . The execution, delivery and performance by Buyer of the Transaction Documents (i) does not and will not violate or conflict with any provision of the organizational documents of Buyer; (ii) does not and will not violate any provision of law, rule or regulation, or any order, judgment or decree of any court or other governmental or regulatory authority; (iii) does not violate or will not result in a breach of or constitute (with due notice or lapse of time or both) a default under, or give rise to any acceleration of remedies or any right of termination under, any Contract, lease, sublease, occupancy agreement, loan agreement, mortgage, security agreement, trust indenture or other agreement or instrument to which Buyer is a party or by which Buyer is bound or to which any of Buyer’s properties or assets is subject, except for such breaches, defaults and accelerations as would not have a Material Adverse Effect on the ability of Buyer to consummate the transactions contemplated hereby.

 

    25  
     

  

(d) Investment Purpose . Buyer is acquiring the Shares solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof. Buyer acknowledges that the Shares are not registered under the Securities Act of 1933, as amended, or any state securities laws, and that the Shares may not be transferred or sold except pursuant to the registration provisions of the Securities Act of 1933, as amended or pursuant to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable.

 

(e) Litigation . There are no claims, Actions, suits, proceedings, complaints or investigations pending or, to the knowledge of Buyer, threatened before any federal, state, provincial, court or governmental or regulatory authority, domestic or foreign, or before any arbitrator of any nature, brought by or against the Buyer or any of its officers, directors, employees, agents or Affiliates, involving, affecting or relating to the Buyer, its business, the Equity Consideration, or the transactions contemplated by the Transaction Documents. No event has occurred or circumstances exist that may give rise or serve as a basis for any such Action.

 

(f) SEC Documents; Financial Statements . (a) Since [December 31, 2012], Buyer has filed with or furnished to the Securities and Exchange Commission (the “ SEC ”) all reports, schedules, forms, statements and other documents required to be so filed or furnished (the “ Buyer SEC Documents ”). All of the Buyer SEC Documents (other than preliminary material), as of their respective filing dates, complied as to form in all material respects with all applicable requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”) and, in each case, the rules and regulations promulgated thereunder applicable to such the Buyer SEC Documents. None of the Buyer SEC Documents at the time of filing contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except to the extent such statements have been modified or superseded by later Buyer SEC Documents. As of their respective dates, the consolidated financial statements of Buyer included in the Buyer SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, have been prepared in accordance with GAAP (except, in the case of unaudited statements, as permitted by Form 10-Q of the SEC) applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and fairly presented in all material respects in accordance with the applicable requirements of GAAP, the financial position of Buyer as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to notes and to normal and recurring year-end audit adjustments). There are no outstanding or unresolved comments from the SEC with respect to any of the Buyer SEC Documents. Buyer and its subsidiaries maintain systems of “internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply in all material respects with the requirements of the Exchange Act. No stop order suspending the sale of the Buyer’s securities in any jurisdiction has been issued within the previous year, and no investigation or proceeding for that purpose has been commenced or is pending or threatened.

 

    26  
     

  

(g) Disclosure . No representation or warranty by the Buyer contained in this Agreement, and no statement contained in the Buyer SEC Documents or any other document, certificate or other instrument delivered to or to be delivered by or on behalf of the Buyer pursuant to this Agreement, contains or will contain any untrue statement of a material fact or omits or will omit to state any material fact necessary, in light of the circumstances under which it was or will be made, in order to make the statements herein or therein not misleading.

 

7. Post Closing Covenants .

 

(a) Noncompetition, Nonsolicitation and Nondisparagement .

 

(i) Noncompetition . Eisenberg acknowledge that (i) Buyer would not have entered into this Agreement but for the agreements and covenants contained in this Section 7 ; and (ii) the agreements and covenants contained in this Section 7 are essential to protect the Business and are reasonable and appropriate in scope; (iii) the Business is national in scope, and as such the “ Territory ” for purposes of this Section 7 is the United States of America; and (iv) the business of Buyer is worldwide in time, territory, scope and all other respects. To induce Buyer to enter into this Agreement, Eisenberg covenants and agrees that during the period commencing on the Closing Date and ending on the third (3rd) anniversary of the Closing Date (the “ Restricted Period ”), Eisenberg shall not (A) engage in any business or activity that competes with the Business in the Territory; (B) render any services to any Person for use in competing with Company in the Territory in connection with the Business; (C) have an interest in any Person engaged in any business that competes with Buyer in the Territory in connection with the Business, directly or indirectly, in any capacity, including, without limitation, as a shareholder, officer, director, principal, agent, trustee or consultant or any other relationship or capacity; or (D) interfere with business relationships (whether formed heretofore or hereafter) between Company and customers, suppliers or prospects of the Business; provided , however , Eisenberg may own, directly or indirectly, solely as an investment, securities of any Person which are publicly traded if Eisenberg (I) is not a controlling Person of, or a member of a group which controls, such Person; and (II) does not, directly or indirectly, own two percent (2%) or more of any class of securities of such Person.

 

(ii) Employees of the Business . During the Restricted Period, Eisenberg shall not, directly or indirectly, solicit or encourage any Employee or consultant performing services in connection with the Business to leave the employment or retention of the Company.

 

(iii) Customers of the Business . During the Restricted Period, Eisenberg shall not, directly or indirectly, (i) persuade or attempt to persuade any customer, prospective customer, client, prospective client, supplier or vendor of Company not to hire or do business with Company or any successor thereto; or (ii) solicit for himself or any Person other than Company, the business of any Person who is a customer, client, supplier or vendor of Company, or was its customer or supplier within one (1) year prior to the time of such solicitation to the extent that such business is similar to the business conducted by such customer or supplier with Company.

 

    27  
     

  

(iv) Confidential Information . From and after the Closing, Eisenberg shall keep secret and retain in strictest confidence, and shall not use for the benefit of himself or others, all confidential matters relating to the Business, the Buyer or Company, including, but not limited to, “know how”, trade secrets, customer lists, supplier lists, details of consultant and employment Contracts, pricing policies, operational methods, marketing plans or strategies, product development techniques or plans, business acquisition plans, technical processes, designs and design projects, processes, inventions, software, source codes, object codes, systems documentation and research projects and other business affairs (“ Confidential Information ”), and shall not disclose them to anyone outside of Buyer and its Affiliates (including Company); provided , however , this covenant shall not apply to any information which is or becomes generally available to the public other than as a result of an improper disclosure by Eisenberg. Eisenberg may disclose Confidential Information if required to do so in any legally required government or securities filings, legal proceedings, subpoena, civil investigative demand or other similar process; provided , that the Eisenberg (i) provides Buyer with prompt notice of such required disclosure so that Buyer may attempt to obtain a protective order, (ii) cooperates with Buyer, at Buyer’s expense, in obtaining such protective order, and (iii) only discloses that Confidential Information which it is absolutely required to disclose as advised by counsel.

 

(v) Nondisparagement . After the Closing Date, Eisenberg will not disparage Buyer, any of Buyer’s Affiliates (including Company) or any of such parties’ shareholders, directors, officers, employees or agents.

 

(vi) Tolling of Covenant Periods . The Restricted Period provided in this Section 7 shall not include and shall be extended beyond, any time during which Eisenberg is failing to comply with any provision of this Section 7 , as finally determined by a court of competent jurisdiction or arbitrator, with respect to such Party.

 

(vii) Blue Penciling . If any term or other provision of this Section 7 is invalid, illegal, or incapable of being enforced by any rule of Law or public policy, all other conditions and provisions of this Section 7 shall nevertheless remain in full force and effect. Upon determination that any term or other provision is invalid, illegal, or incapable of being enforced, Eisenberg and Buyer shall negotiate in good faith to, or the arbitrator making such a determination shall, modify this Section 7 so as to effect the original intent of Eisenberg and Buyer as closely as possible to the maximum extent allowed by Law to the end that the transactions contemplated hereby are fulfilled to the extent possible.

 

(b) Employees . Buyer agrees to offer, or cause the Company to offer, continued employment, on an “at will” basis to all the Employees as of the Closing, including all management Employees, and if any such Employee accepts such offer of employment, he or she shall become an employee of Buyer or Company, as applicable, after the Closing Date (such Employees are referred to hereinafter as the “ Retained Employees ”). Retained Employees shall be credited for past service toward all benefits offered by Buyer or Company for purposes of determining eligibility and benefit accrual.

 

(c) Securities Law Compliance . The Trust agrees that it will not transfer or dispose of any of the Equity Consideration other than pursuant to an effective registration statement under the Securities Act or a Rule 144 sale in compliance with the terms of such Rule or pursuant to an exemption from the 1933 Act. Buyer shall file and maintain such additional Buyer SEC Documents as may be necessary such that the representations and warranties set forth in Section 6(f) continue to remain true for all periods that the Equity Consideration is held by the Trust or Sellers, and Buyer shall cooperate with the Trust (and any Seller receiving a distribution of the any Equity Consideration) and any applicable transfer agent, in the removal of any legend on the shares constituting the Equity Consideration to permit the trade or liquidation thereof in the marketplace as permitted under Rule 144 (as promulgated under the Securities Act and in effect as of the applicable time), if requested by the Trust or applicable Seller.

 

    28  
     

  

(d) Trust Operation . From and after the Closing, all undertakings and actions of the Trust will carried out as set forth in this Agreement and the Trust Documents.

 

(e) Return of Trust Property by Sellers . In the event the Trust distributes the assets of the Trust to the Sellers in violation of this Agreement or the Trust Documents, each Seller covenants to promptly return such assets to the Trust.

 

(f) Product Sales Information . Within thirty (30) days after the end of each calendar quarter, Buyer will furnish to Trust, a complete and accurate written statement in a form reasonably acceptable to Trust, certified by Buyer’s authorized financial officer, showing the total number of Products (the volume and sales of each Product expressed in dollars, volume, and SKUs) sold and distributed by Buyer during the preceding calendar quarter. Buyer will keep at a location within the continental United States, reasonably detailed, complete and accurate books of account and records covering all transactions relating to the Products. Upon at least five (5) Business Days prior notice to Buyer, Trust and/or its authorized representatives will have the right, during regular business hours, to examine and copy such books of account and records and all other documents and material in the possession or under the control of Buyer insofar as they relate to the Products sold in the last two (2) years, in order to determine the accuracy of the periodic statements delivered or which should have been delivered by Buyer to Trust as provided above. In the event such examination indicates any under or overpayment of Royalty Consideration, an appropriate credit or refund will be promptly issued. If any such examination reveals an underpayment of Royalty Consideration, of more than five percent (5%) of the amount paid by Buyer, or if such examination is in connection with Buyer’s failure to deliver any periodic statement or pay any amounts due hereunder, then Buyer will bear all costs and expenses incurred by Trust in connection with the examination and collection of any such unpaid amounts (including, without limitation, all reasonable attorney’s fees and expenses). The full amount of any underpayment of Royalty Consideration, and related costs and expenses will be due and payable upon demand by Trust. All books of account and records of Buyer relating to the Products will be kept available for inspection by or on behalf of Trust for at least two (2) years after the expiration or termination of the seven-year Royalty Consideration period. All information received, reviewed and copied by Trust or its representatives in connection with or pursuant to this Section 7(f) shall be kept confidential and not disclosed to any other Person.

 

(g) Adoption of Release . By its execution hereof, each of the Sellers hereby agrees that it is bound by the terms of the Release Agreement attached as Exhibit B , the terms of which are incorporated herein by this reference.

 

    29  
     

  

8. Indemnification .

 

(a) Indemnification with Respect to a Seller’s Breach .

 

(i) To the extent the assets of the Trust are sufficient but subject to Section 8(f) , the Trust shall indemnify and save and hold the Buyer, any Affiliate of the Buyer and their respective directors, officers, managers, employees, successors, and assigns (the “ Buyer Indemnitees ”), harmless from and against any and all damages, claims, demands, obligations, Liabilities, losses, costs, expenses (including all reasonable attorneys’ fees and expenses of investigation incurred by the Buyer Indemnitees in any Action or proceeding between a Seller and the Buyer Indemnitees or between the Buyer Indemnitees and any other Person or otherwise), deficiencies, interests, penalties, impositions, assessments and/ or fines (collectively, “ Buyer Losses ”), whether or not in connection with a third-party claim, arising out of, resulting from, or related to (i) a breach of any representation or warranty made by a Seller in this Agreement or the other Transaction Documents to which a Seller is a party; or (ii) a Seller’s breach of any covenant made by a Seller in this Agreement or the other Transaction Documents to which such Seller is a party; or (iii) any Liability relating to common law or statutory dissenter’s rights, appraisal rights, or any similar rights of a Seller arising with respect to the transactions which are the subject of this Agreement; provided that such indemnification shall not extend to the Covenantors breach of Section 7(a) , or the breach of any employment agreement or the like to which a Seller may be a party.

 

(ii) To the extent the assets of the Trust are not sufficient to indemnify the Buyer Indemnitees for any Buyer Losses under Section 8(a)(i) above, but subject to Section 8(f) , each Seller shall, severally but not jointly, indemnify and save and hold the Buyer Indemnitees harmless from and against any and all Buyer Losses whether or not in connection with a third-party claim, arising out of, resulting from, or related to (i) a breach of any representation or warranty made by such Seller in this Agreement or the other Transaction Documents to which such Seller is a party; or (ii) such Seller’s breach of any covenant made by a Seller in this Agreement or the other Transaction Documents to which such Seller is a party; or (iii) any Liability relating to common law or statutory dissenter’s rights, appraisal rights, or any similar rights of such Seller arising with respect to the transactions which are the subject of this Agreement; provided that such indemnification shall not extend to Eisenberg’s breach of Section 7(a) , or the breach of any employment agreement or the like to which such Seller may be a party.

 

(b) Indemnification with Respect to the Company’s Breach .

 

(i) To the extent the assets of the Trust are sufficient, but subject to Section 8(f) , the Trust shall indemnify and save and hold the Buyer Indemnitees, harmless from and against any and all Buyer Losses, whether or not in connection with a third-party claim, arising out of, resulting from or related to (i) the Company’s breach of any representation or warranty made by the Company in this Agreement or the other Transaction Documents to which the Company is a party; or (ii) any Liability relating to common law or statutory dissenter’s rights, appraisal rights, or any similar rights of a Seller arising with respect to the transactions which are the subject of this Agreement or of any party other than a Seller claiming to be a shareholder arising with respect to the transactions which are the subject of this Agreement.

 

    30  
     

  

(ii) To the extent the assets of the Trust are not sufficient to indemnify the Buyer Indemnitees for any Buyer Losses under Section 8(b)(i) above, but subject to Section 8(f) , each Seller shall, severally but not jointly, indemnify and save and hold the Buyer Indemnitees harmless from and against any and all Buyer Losses whether or not in connection with a third-party claim, arising out of, resulting from, or related to (i) the Company’s breach of any representation or warranty made by the Company in this Agreement or the other Transaction Documents to which the Company is a party; or (ii) any Liability relating to common law or statutory dissenter’s rights, appraisal rights, or any similar rights of a Seller arising with respect to the transactions which are the subject of this Agreement or of any party other than a Seller claiming to be a shareholder arising with respect to the transactions which are the subject of this Agreement.

 

(c) Indemnification with Respect to the Trust’s Breach . To the extent the assets of the Trust are sufficient, but subject to Section 8(f) , the Trust shall indemnify and save and hold the Buyer Indemnitees, harmless from and against any and all Buyer Losses, whether or not in connection with a third-party claim, arising out of, resulting from or related to (i) the Trust’s breach of any representation or warranty made by the Trust in this Agreement or the other Transaction Documents to which the Trust is a party; or (ii) the Trust’s breach of any covenant made by the Trust in this Agreement or the other Transaction Documents to which the Trust is a party; or (iii) the Trust’s breach of the Trust Documents.

 

(d) Indemnification by Buyer . Buyer shall indemnify and save and hold the Sellers, the Trust, any Affiliate of a Seller or the Trust and their respective directors, officers, managers, trustees, employees, advisors, successors, and assigns (the “ Seller Indemnitees ”), harmless from and against any and all damages, claims, demands, obligations, liabilities, losses, costs, expenses (including all reasonable attorneys’ fees and expenses of investigation incurred by the Seller Indemnitees in any Action or proceeding between the Buyer and the Seller Indemnitees or between the Seller Indemnitees and any third party or otherwise), deficiencies, interests, penalties, impositions, assessments and/ or fines (collectively, “ Seller Losses ”), whether or not in connection with a third-party claim, arising out of, resulting from or related to (i) Buyer’s breach of any representation or warranty made by Buyer in this Agreement or the other Transaction Documents to which the Buyer is a party, or (ii) Buyer’s breach of any covenant made by Buyer in this Agreement or the other Transaction Documents to which the Buyer is a party; or (iii) any Liability relating to common law or statutory dissenter’s rights, appraisal rights, or any similar rights of a shareholder of Buyer arising with respect to the transactions which are the subject of this Agreement.

 

(e) Set-Off by Buyer . Amounts that (i) the Trust and the Buyer agree in writing are due or (ii) upon a final determination by a court of competent jurisdiction or arbitrator that such amounts are due to the Buyer Indemnities under Sections 8(a) , (b) and (c) may be satisfied by set-off by the Buyer Indemnities, at their sole election, against any Royalty Consideration then due or to become due in the future.

 

(f) Limitations . The indemnification provided for in Sections 8(a) , (b) and (c) shall be subject to the following limitations and provisions:

 

(i) The Trust and the Sellers shall not be liable to the Buyer Indemnitees for indemnification (other than with respect to a claim for indemnification based upon, arising out of, with respect to, or by reason of any inaccuracy in or breach of a Fundamental Representation or fraud) until the aggregate amount of Buyer Losses in respect of indemnification exceeds $50,000 (the “ Basket ”), in which event Trust and the Sellers, as applicable, shall be required to pay or be liable for the Buyer Losses in excess of the Basket in accordance with this Section 8 ;

 

    31  
     

  

(ii) The Trust and the Sellers shall not be liable to the Buyer Indemnitees for indemnification (other than with respect to a claim for indemnification based upon, arising out of, with respect to or by reason of any inaccuracy in or breach of a Fundamental Representation or fraud) for any Buyer Losses that, in the aggregate, are in excess of fifty percent (50%) of the Purchase Consideration.

 

(iii) The Trust shall not be liable to the Buyer Indemnitees for indemnification (other than with respect to a claim for indemnification based upon, arising out of, with respect to, or by reason of fraud) for any Buyer Losses that, in the aggregate, are in excess of the Purchase Consideration.

 

(iv) Each Seller shall not be liable to the Buyer Indemnitees for indemnification (other than with respect to a claim for indemnification based upon, arising out of, with respect to, or by reason of fraud) for any Buyer Losses that, in the aggregate, are in excess of the Purchase Consideration received by such Seller through distributions from the Trust.

 

(v) All claims for indemnification shall be paid either from the Equity Consideration or the set-off in Section 8(e) , if elected by Buyer, unless the Trust elects to pay such claim in cash. For purposes of the foregoing each share of Equity Consideration will be valued at the greater of $0.85, or its Fair Market Value on the date the claim is paid. For purposes hereof, the Fair Market Value means, as of any particular date, (A) the volume weighted average of the closing sales prices of a security of the type that comprises the Equity Consideration for such day on all domestic securities exchanges on which such security may at the time be listed, (B) if there have been no sales of such security on any such exchange on any such day, the average of the highest bid and lowest asked prices for such security on all such exchanges at the end of such day, (C) if on any such day such security is not listed on a domestic securities exchange, the closing sales price of such security as quoted on the Financial Industry Regulatory Authority OTC Bulletin Board electronic inter-dealer quotation system (the “ OTC Bulletin Board ”), the OTC Markets Group Inc. electronic inter-dealer quotation system, including OTCQX, OTCQB and OTC Pink (the “ Pink OTC Markets ”) or similar quotation system or association for such day or (D) if there have been no sales of such security on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association on such day, the average of the highest bid and lowest asked prices for such security quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association at the end of such day; in each case, averaged over twenty (20) consecutive Business Days ending on the Business Day immediately prior to the day as of which “Fair Market Value” is being determined, and (ii) “ Business Day ” means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of New York, New York, are authorized or obligated by law or executive order to close; provided, that if such security is listed on any domestic securities exchange, the term “ Business Day ” as used herein means Business Days on which such exchange is open for trading. If at any time a security is not listed on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association, the market value of such security shall be the fair market value per share as determined by mutual agreement of the Trust and Buyer; provided, that if the Trust and Buyer are unable to agree on the market value per share of such security within 14 calendar days, such market value shall be determined by a nationally recognized investment banking, accounting or valuation firm jointly selected by the Trust from a list of at least three (3) provided by the Buyer. The determination of such firm shall be final and conclusive, and the fees and expenses of such valuation firm shall be borne by the Party whose proposed valuation is furthest from that reach by the firm.

 

    32  
     

  

(vi) Prior to or contemporaneously with, and as a condition to, pursuing any claim for indemnification for Buyer Losses under this Section 8 against any Seller or the Trust, a Buyer Indemnitee shall assert and pursue a claim for recovery under any policy of insurance that provides coverage for such Buyer Losses. Any recovery by a Buyer Indemnitee under such policy of insurance shall offset and reduce the amount of Buyer Losses for which the Trust or any Seller must indemnify the Buyer Indemnitee under this Section 8 . To the extent any Seller or the Trust pays a Buyer Indemnitee for any Buyer Losses or Buyer exercises its right of set-off under Section 8(e) and the Buyer Indemnitee also recovers under a policy of insurance for such Buyer Losses, the Buyer Indemnitee shall promptly pay to the Trust or such Seller, as applicable, the amount (if any) by which the total recovery by Buyer Indemnitee exceeds the amount of such Buyer Losses.

 

(vii) To the extent such Buyer Losses arise from or were caused by acts or omissions by any of the Buyer Indemnitees after the Closing. For purposes of clarity, the limitation of this Section 8(f)(vii) shall not apply to any products liability claims relating to inventory of the Products existing as of the Closing and sold by the Company following the Closing in the ordinary course of business and consistent with past practices.

 

(g) Survival . All representations, warranties, covenants and obligations contained in this Agreement and the other Transaction Documents shall survive the Closing for eighteen (18) months, except that: (i) all covenants and agreements which by their terms contemplate performance after the Closing shall survive the Closing indefinitely, unless specified otherwise by their terms; (ii) for breaches of Sections 4(j) or 4(s) , the survival shall be the applicable statute of limitations; (iii) for breaches of any Fundamental Representations, the survival period shall be indefinite; and (iv) for breaches based upon, arising out of, with respect to, or by reason of fraud, the survival period shall be the applicable statute of limitations. Notwithstanding the above, any claim for indemnification made in accordance with this Section 8 prior to the expiration of the applicable indemnification period set forth in this paragraph shall survive until such matter is resolved.

 

(h) Exclusive Remedy . The indemnification afforded by this Section 8 shall be the sole and exclusive remedy of the Seller Indemnitees and Buyer Indemnitees in respect of claims for any misrepresentation, breach of warranty or nonfulfillment or failure to be performed of any covenant or agreement contained in this Agreement or the other Transaction Documents, except for (i) Eisenberg’s breach of Section 7(a) ; (ii) the breach of any employment agreement or the like to which a Seller may be a party; (iii) the Trust’s breach of any representations, warranties, covenants or obligations contained in this Agreement and the other Transaction Documents which by their terms contemplate performance after the Closing; (iv) any Seller’s breach of the covenants in Section 7(e) ; or (v) Buyer’s breach of the covenants in Section 7(f) .

 

(i) Materiality . For purposes of determining the amount of Buyer Losses under this Section 8 , and not for purposes of determining whether or not a breach has occurred, any inaccuracy in or breach of any representation or warranty shall be determined without regard to any materiality, Material Adverse Effect or other similar qualification contained in or otherwise applicable to such representation or warranty.

 

    33  
     

  

(j) Procedures for Indemnification.

 

(i) Notice of Claims . If any misrepresentation, breach of warranty or nonfulfillment or failure to be performed of any covenant or agreement contained in this Agreement or the other Transaction Documents occurs or is alleged and either (i) a Buyer Indemnitee asserts that Trust or any Seller(s), has become obligated to such Buyer Indemnitee pursuant to Section 8 hereof, or (ii) a Seller Indemnitee asserts that Buyer, has become obligated to such Seller Indemnitee pursuant to Section 8 hereof (“ Direct Claim ”), or if any suit, Action, investigation, claim or proceeding is threatened, begun, made or instituted by a third party (a “ Third Party Proceeding ”) as a result of which the Trust or any Seller(s) may become obligated to a Buyer Indemnitee hereunder, or Buyer may become obligated to a Seller Indemnitee, such Buyer Indemnitee or Seller Indemnitee, as applicable, shall give written notice thereof to the Trust or Buyer, as the case may be (the “ Claims Notice ”). For purposes of this Section 8(j) a Buyer Indemnitee or Seller Indemnitee sending a Claims Notice shall be referred to as an “ Indemnitee .” A failure or delay in providing a Claims Notice shall not relieve Buyer, any Seller(s) or Trust of its indemnification obligations under this Section 8 except to the extent that such Party is materially prejudiced as a result thereof.

 

(ii) Response to Direct Claims . Any Seller(s), the Trust or Buyer as the indemnifying party under this Section 8 (the “ Indemnitor ”) shall have thirty (30) days after receipt of the Claims Notice for a Direct Claim to reject or accept the claim as an indemnifiable claim under Section 8 . If, within thirty (30) days after receipt by the Indemnitor of such a Claims Notice, the Indemnitor delivers notice to the Indemnitee containing a written objection to the claim (or a portion thereof) by the Indemnitee, stating the nature of and grounds for such objection in reasonable detail, then such claim (or portion thereof) shall be deemed to be a “ Disputed Claim ” and such claim shall be resolved in accordance with this Section 8(j). If, within thirty (30) days after actual receipt by an Indemnitor of a Claims Notice for a Direct Claim, Indemnitor delivers notice to the Indemnitee containing a written acceptance of the claim, (or a portion thereof) then such claim (or portion thereof) shall be deemed an indemnifiable claim under this Section 8 (the “ Indemnifiable Claim ”), and unless such notice includes a reservation of rights, Indemnitor will be conclusively deemed to have consented to recovery by the Indemnitee of the full amount of Buyer Losses or Seller Losses, as applicable, subject to the limitations set forth in the Section 8 , as applicable.

 

(iii) Dispute Resolution . Any disputes arising under this Section 8 shall be resolved as follows: (i) first, the Buyer and the Trust shall attempt in good faith for thirty (30) days to resolve the dispute, and (ii) if the dispute remains unresolved after such thirty (30) day period, the Buyer and the Trust agree that either the Buyer or the Trust may file suit in any court or other adjudicative body having jurisdiction pursuant to this Agreement in order to resolve the dispute.

 

    34  
     

  

(iv) Third Party Proceeding . Indemnitor shall have twenty (20) days from receipt of a Claims Notice for a Third Party Proceeding to provide the Indemnitee with notice that it wishes to assume the defense in the Third Party Proceeding, in which event the Indemnitee shall have the right to participate in the defense at its own expense; provided , however , that the Indemnitee is hereby authorized prior to and during such time to file any motion, answer or other pleading that it shall deem necessary or appropriate to protect its interests and that is not prejudicial to Indemnitor. If Indemnitor fails to give the Indemnitee timely notice as provided herein, the Indemnitee shall have the right to defend against such Third Party Proceeding. If Indemnitor assumes the defense in a Third Party Proceeding, the Indemnitor shall not agree to any settlement, compromise or discharge of a Third-Party Claim without the Indemnitee’s prior written consent, which shall not be unreasonably withheld. If the Indemnitor does not assume the defense of a Third-Party Claim, the Indemnitee shall be entitled to undertake any settlement, compromise or discharge of such Third-Party Claim without the Indemnitor’s prior consent. Notwithstanding anything herein to the contrary, an Indemnitor shall not be entitled to assume control of the defense in a Third Party Proceeding, and shall pay the reasonably documented fees and expenses of legal counsel retained by the Indemnitee if: (i) Indemnitee reasonably believes that an adverse determination of such claim could be detrimental to its interests; (ii) Indemnitee reasonably believes that the Indemnitor lacks the financial capability to pay any adverse monetary judgment being sought in the Third Party proceeding; (iii) Indemnitee reasonably believes that a conflict of interest exists or could reasonably arise which, under applicable principles of legal ethics, could prohibit a single legal counsel from representing both the parties in such proceeding, other than a conflict which may exist due to the underlying nature of the duty to indemnify; (iv) a court of competent jurisdiction rules that Indemnitor has failed or is failing to prosecute or defend such claim; or (v) such claim seeks damages other than monetary damages.

 

(v) Consent to Jurisdiction . Notwithstanding any other provision of this Section 8 , Indemnitor hereby consents to the nonexclusive jurisdiction of any court in which an Action or claim in respect of a Third Party Proceeding is brought against an Indemnitee for purposes of any claim that an Indemnitee may have under this Agreement with respect to such Action or claim or the matters alleged therein and agrees that process may be served on Indemnitor with respect to such a claim anywhere in the world.

 

(vi) Indemnification Binds Successors and Assigns . All of the indemnification rights of the Parties arising pursuant to this Section 8 shall survive any sale, assignment or other transfer by a Party of all or part of their respective title to or interest in all or part of the Transaction Documents and shall apply to and bind each and every successor and assign of a Party hereto.

 

(vii) Fraud. For purposes of this Section 8 , the term “fraud” shall only be deemed to refer to willful and intentional misrepresentations or omissions made, or intentional concealment performed, with the intent to deceive and shall not be deemed to include negligent misrepresentation, omissions or similar claims.

 

9. Appointment of the Trust as Representative of Sellers .

 

(a) By approving this Agreement and the transactions contemplated hereby, each Seller shall have irrevocably authorized, directed and appointed the Trust to act as sole and exclusive agent, attorney-in-fact and representative of such Seller, with full power of substitution with respect to all matters under this Agreement and the transactions contemplated hereby, including, without limitation, determining, giving and receiving notices and processes hereunder, receiving distributions of the Purchase Consideration to or for the benefit of Sellers, contesting and settling any and all claims for indemnification pursuant to Article 8 , resolving any other disputes hereunder, performing the duties expressly assigned to the Trust hereunder and under the Trust Documents and incur such other expenses as the Trust shall reasonably deem necessary or prudent in connection with the foregoing.

 

    35  
     

  

(b) The Trust shall have the sole and exclusive right on behalf of each Seller to take any action or provide any waiver, or receive any notice with respect to any claims for indemnification under Article 8 and to settle any claim or controversy arising with respect thereto. Any such actions taken, exercises of rights, power or authority, and any decision or determination made by the Trust, shall be absolutely and irrevocably binding on each Seller as if such Seller personally had taken such action, exercised such rights, power or authority or made such decision or determination in such Seller’s individual capacity, and no Seller shall have the right to object, dissent, protest or otherwise contest the same. Any action required to be taken by any Seller hereunder or any action that any Seller, at its election, has the right to take hereunder, shall be taken only by the Trust and no Seller acting on its own shall be entitled to take any such action. After Closing, Buyer shall be entitled to deal exclusively with the Trust on all matters relating to this Agreement and shall be entitled to rely conclusively (without further evidence of any kind whatsoever) on any document executed or purported to be executed on behalf of any Seller by the Trust, and on any other action taken or purported to be taken on behalf of any Seller by the Trust, as being fully binding upon such Seller. Notices or communications to or from the Trust shall constitute notice to or from each Seller. Any decision or action by the Trust hereunder, including any agreement between the Trust and Buyer relating to the defense, payment or settlement of any claims for indemnification hereunder, shall constitute a decision or action of any or all Sellers, as applicable, and shall be final, binding and conclusive upon each such Seller. No Seller shall have the right to object to, dissent from, protest or otherwise contest the same. The provisions of this Section 9 , including the power of attorney granted hereby, are independent and severable, are irrevocable and coupled with an interest and shall not be terminated by any act of any one or Sellers or by operation of Law.

 

(c) The Trust may resign at any time; provided, however, in no event shall the Trust resign without having first appointed a new representative to serve in the same capacity and with the same authority as the Trust, who shall assume such duties immediately upon the resignation or removal of the Trust. Notice of the appointment of such new representative shall be sent to Buyer, such appointment to be effective upon the later of the date indicated in such notice or the date such notice is received by Buyer; provided , that until such notice is received, Buyer shall be entitled to rely on the decisions and actions of the Trust as described in Sections 9(a) and (b) above.

 

(d) The Trust shall not be liable to any Seller for actions taken pursuant to this Agreement, except to the extent such actions shall have been determined by a court of competent jurisdiction to have constituted gross negligence or involved fraud, intentional misconduct or bad faith (it being understood that any act done or omitted pursuant to the advice of counsel, accountants and other professionals and experts retained by the Trust shall be conclusive evidence of good faith).

 

10. Miscellaneous .

 

(a) Successors and Assigns . Any Party hereto may assign this Agreement or any rights or obligations hereunder without the prior written consent of the other Parties hereto; provided that this Agreement shall inure to the benefit of and shall be binding upon the successors and assigns of the Parties hereto.

 

    36  
     

  

(b) Governing Law; Jurisdiction . This Agreement shall be construed, performed and enforced in accordance with, and governed by, the laws of the State of North Carolina, United States, without giving effect to the principles of conflicts of laws thereof. The Parties hereto irrevocably consent to the jurisdiction of, the federal and state courts of the State of North Carolina located in Wake County, North Carolina for such purpose.

 

(c) Expenses . Except as otherwise provided herein, each of the Parties hereto shall pay all its own expenses in connection with this Agreement and the transactions contemplated hereby, including, without limitation, any legal and accounting fees, whether or not the transactions contemplated hereby are consummated.

 

(d) Severability . In the event that any part of this Agreement is declared by any court or other judicial or administrative body to be null, void or unenforceable, said provision shall survive to the extent it is not so declared, and all of the other provisions of this Agreement shall remain in full force and effect.

 

(e) Notices . All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) on the date of service if served personally on the Party to whom notice is to be given, or (ii) on the day of delivery by Federal Express or similar overnight courier or the Express Mail service maintained by the U.S. Postal Service, to the Party as follows:

   

  If to Trust: [Insert Address]
     
  Copy to: Smith, Gambrell & Russell, LLP
    Suite 3100, Promenade
    1230 Peachtree Street, NE
    Atlanta, Georgia 30309
    Attention: John C. Ethridge, Jr.
     
  If to Buyer: Synergy CHC Corp.
    865 Spring Street
    Westbrook, ME 04092
    Attn: President
     
  Copy to: Wyrick Robbins Yates & Ponton LLP
    4101 Lake Boone Trail, Suite 300
    Raleigh, North Carolina 27607
    Attention: W. David Mannheim

 

Any Party may change its address for the purpose of this Section by giving the other Party written notice of its new address in the manner set forth above.

 

    37  
     

  

(f) Amendments; Waivers . This Agreement may be amended or modified, and any of the terms, covenants, representations, warranties or conditions hereof may be waived, only by a written instrument executed by the Parties hereto, or in the case of a waiver, by the Party waiving compliance. Any waiver by any Party of any condition, or of the breach of any provision, term, covenant, representation or warranty contained in this Agreement, in any one or more instances, shall not be deemed to be nor construed as further or continuing waiver of any such condition, or of the breach of any other provision, term, covenant, representation or warranty of this Agreement.

 

(g) Public Announcements . Sellers and the Trust shall not make any public statement regarding this Agreement or the transactions contemplated herein without Buyer’s prior written approval. Buyer shall provide a copy of any public statement to the Trust prior to the information being made public.

 

(h) Entire Agreement . This Agreement, the exhibits and schedules hereto contains the entire understanding between the Parties hereto with respect to the transactions contemplated hereby and thereby and supersede and replace all prior agreements and understandings, oral or written, with regard to such transactions. All schedules and exhibits hereto and any documents and instruments delivered pursuant to any provision hereof are expressly incorporated herein and made a part of this Agreement as fully as though completely set forth herein. This Agreement shall only be binding on the Parties hereto upon execution and delivery of this Agreement by each of the Parties.

 

(i) Parties in Interest . Nothing in this Agreement is intended to confer any rights or remedies under or by reason of this Agreement on any persons other than the Parties hereto and their respective successors and permitted assigns. Nothing in this Agreement is intended to relieve or discharge the obligations or liability of any third persons to any of the Parties hereto. No provision of this Agreement shall give any third persons any right as a third party beneficiary of this Agreement or provide any right of subrogation or Action over or against a Party hereto.

 

(j) Section and Paragraph Headings . The section and paragraph headings in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Agreement.

 

(k) Counterparts . This Agreement may be executed in counterparts and via .pdf, each of which shall be deemed an original, but all of which shall constitute the same instrument.

 

(l) Fulfillment of Obligations . Any obligation of any Party to any other Party under this Agreement, which obligation is performed, satisfied or fulfilled by an Affiliate of such Party, shall be deemed to have been performed, satisfied, or fulfilled by such Party.

 

(m) Remedies . Except as expressly provided in this Agreement, any Person having any rights under any provision of this Agreement, including, without limitation, Section 7 , shall be entitled to enforce such rights specifically (without posting a bond or other security) and to exercise all other rights granted by Laws. Except as expressly provided in this Agreement, all such rights and remedies shall be cumulative and non-exclusive, and may be exercised singularly or concurrently. The Parties acknowledge that any breach of this Agreement may cause substantial irreparable harm to the other Party. Therefore, this Agreement may be enforced in equity by specific performance, temporary restraining order and/or injunction. The rights to such equitable remedies shall be in addition to all other rights or remedies which a Party may have under this Agreement or under applicable law.

 

(n) Further Actions . In case at any time after the Closing any further action is necessary to carry out the purposes of this Agreement, each of the Parties shall take such further action (including the execution and delivery of such further instruments and documents) as any other Party reasonably may request, all at the sole cost and expense of the requesting Party (unless the requesting Party is entitled to indemnification therefore under Section 8 ). Without limiting the foregoing, after the Closing each Seller will furnish Buyer with such information and documents in such Seller’s possession or under such Seller’s control or that such Seller can execute or cause to be executed to further evidence Buyer’s ownership of the Shares.

 

[Signature pages follow]

 

    38  
     

 

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized as of the date first above written.

 

  /s/ Jordan Eisenberg
  JORDAN EISENBERG
     
  BREAKTHROUGH PRODUCTS, INC.
     
  By: /s/ Jordan Eisenberg
  Name: Jordan Eisenberg
  Title: Chief Executive officer
     
  SYNERGY CHC CORP.
     
  By: /s/ Jack Ross
  Name: Jack Ross
  Title: Chief Executive Officer
     
  URX ACQUISITION TRUST
     
  By: /s/ Michael Valentino
  Name: Michael Valentino
  Title: Trustee

 

Signature Page to Stock Purchase Agreement - 1

 

     
     

  

[Form of Seller Signature Page]

 

Seller:

 

(USE THIS BLOCK IF AN INDIVIDUAL)

 

 
(Signature)

 

Address:    
     
     

 

(USE THIS BLOCK IF AN ENTITY)

 

By:    
Name:    
Title:    
Address:    
     
   

  

Signature Page to Stock Purchase Agreement - 2

 

     
     

 

 

 

 

 

SHARE PURCHASE AGREEMENT

 

THIS SHARE PURCHASE AGREEMENT (the “ Agreement ”) dated as of November 15, 2015, between TPR Investments Pty Ltd ACN 128 396 654 as trustee for Polmear Family Trust (the “ Seller ”), Timothy Polmear and Rebecca Polmear (collectively, the “ Principal Owners ”), NomadChoice Pty Limited ACN 160 729 939 trading as Flat Tummy Tea, an Australian proprietary limited company (the “ Company ”), and Synergy CHC Corp., a Nevada corporation (the “ Buyer ”). Buyer and Seller are sometimes referred to collectively as the “ Parties ” and individually as a “ Party ”.

 

BACKGROUND

 

Seller and the Principal Owners, either directly or indirectly, collectively own, all of the issued fully paid ordinary shares of the Company (the “ Company Shares ”).

 

The Company is engaged in the business of developing, manufacturing, and selling herbal detox tea (the “ Products ”) (the Products and the business related to the Products is collectively the “ Business ”). For the avoidance of doubt, the “Business” shall be limited to the business known as “Flat Tummy Tea” and operated by the Company.

 

Buyer desires to purchase all of the Company Shares (the “ Share Purchase ”), and Seller and the Principal Owners desire to sell such Company Shares to Buyer, in each case upon the terms and subject to the conditions set forth in this Agreement.

 

In consideration of the foregoing and the respective covenants and agreements hereinafter contained, the Parties hereto hereby agree as follows:

 

1. Definitions .

 

As used in this Agreement (including the recitals and Disclosure Schedules hereto), the following selected terms shall have the following meanings (such meanings to be applicable equally to both singular and plural forms of the terms defined):

 

Action ” means any claim, action, cause of action, demand, lawsuit, arbitration, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or otherwise, whether formal or informal, whether public or private and whether at law or in equity;

 

Adjusted EBITDA ” shall mean, with respect to any applicable period, the net income before interest, taxes, depreciation and amortization less any capital expenditures of the Company for such period, all as calculated on a consistent basis with the accounting standards and general accounting principles applied in the financial statements attached as Schedule 4(h) ;

 

Affiliate ” shall mean, as to any Person, any other Person which directly or indirectly controls, or is under common control with, or is controlled by, such Person. As used in this definition, “control” (including, with its correlative meanings, “controlled by” and “under common control with”) shall mean possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by Contract or otherwise) of such Person;

 

1
 

 

Calculation Period ” means the period beginning on November 1, 2015 and ending on June 30, 2016;

 

Calculation Period EBITDA ” means the Company’s Adjusted EBITDA during the Calculation Period;

 

Clients ” means all of the clients of the Company during each of the Company’s 2012, 2013, and 2014 fiscal years and during the period ended as of October 31, 2015;

 

Closing ” shall mean the consummation of the transactions contemplated by this Agreement which shall occur on the Closing Date;

 

“Closing Date” means 12 November 2015;

 

Code ” means the Internal Revenue Code of 1986, as amended;

 

Commercially Reasonable Efforts means the commercially reasonable efforts that a prudent Person desirous of achieving a result and having an incentive to and interest in achieving such result would use to achieve that result as expeditiously as reasonably possible under the circumstances;

 

Contract ” means any agreement, contract, indenture, instrument, obligation, promise or undertaking (whether written or oral and whether express or implied) that is legally binding;

 

Disclosure Schedules ” means the disclosure letter delivered by Seller concurrently with the execution and delivery of this Agreement;

 

Earn-Out Multiple ” means two (2);

 

Employee ” means an employee of the Company employed in connection with the Business;

 

Employee Benefit Plan ” means any pension, profit sharing, retirement, deferred compensation, share purchase, share option or other equity based compensation plans, incentive, bonus, vacation, employment, independent contractor, severance, disability, hospitalization, sickness, death, medical insurance, dental insurance, life insurance and any other employee benefit plan (whether provided on a funded or unfunded basis, or through insurance or otherwise), agreement, program, policy, trust, fund, Contract or arrangement;

 

2
 

 

Environmental Laws ” means all Laws concerning pollution or protection of the environment and natural resources, including without limitation all those relating to the presence, use, production, generation, handling, transportation, treatment, storage, control or cleanup of any hazardous materials, substances or wastes, pesticides, pollutants or byproducts, asbestos, polychlorinated biphenyls, or radiation, each as amended and as now or hereafter in effect;

 

Files and Records ” shall mean all files and records, whether in hard copy or digital, electronic, data, magnetic or other format, of the Company relating to or used in connection with the Business;

 

Event of Insolvency” means, in relation to a corporation:

 

  (a) receiver, manager, receiver and manager, trustee, administrator or similar officer is appointed in respect of a person or any material asset of a corporation;
       
  (b) a liquidator or provisional or interim liquidator is appointed in respect of a corporation;
       
  (c) any application (not being an application withdrawn or dismissed within 7 days) is made to a court for an order, or an order is made, or a meeting is convened, or a resolution is passed, for the purpose of:
       
    (i) appointing a person referred to in paragraphs (a) or (b);
       
    (ii) winding up the relevant corporation; or
       
    (iii) proposing or implementing a compromise with creditors (including a scheme of arrangement, other than to carry out a reconstruction or amalgamation while solvent);
       
  (d) a final order, judgment or award is made against the corporation which it fails to satisfy within 7 days of being required to do so; or
       
  (e) the corporation becomes, or admits in writing that it is, is declared to be, or is deemed under any applicable Law to be, insolvent or unable to pay its debts;

 

Fundamental Representations ” shall mean the representations and warranties set forth in Sections 4(a), 4(b), 4(c), 4(d), 4(e), 4(f), 4(j), 4(l), and 4(o) ;

 

Government ” shall mean any agency, division, subdivision, audit group or procuring office of the Government of Australia or the United States, any state of Australia or the United States, including the employees or agents thereof;

 

GST Act” means as A New Tax System (Goods and Services Tax) Act 1999 (Cth);

 

  3  
 

 

Guarantee ” means any Contract of guarantee, indemnification, assumption or endorsement or any other like commitment of the obligations, liabilities (fixed, contingent or otherwise) or indebtedness of another Person;

 

Intellectual Property ” means all intellectual property rights whether protected, created or arising under the Laws of the United States, Australia, or any other jurisdiction, including the following: (i) patents and patent applications; (ii) trademarks and service marks, including all applications and registrations and goodwill related to the foregoing; (iii) copyrights, including all applications and registrations related to the foregoing (including, without limitation, for all designs); (iv) Internet domain names; (v) telephone numbers, electronic mail addresses and social media accounts and registrations, including but not limited to accounts and registrations with Facebook, LinkedIn, Twitter, and other similar services; and (vi) trade secrets, know-how, ideas, creative works, inventions, discoveries, methods, processes, technical data, specifications, research and development information, technology, software or computer programs, and data base;

 

Knowledge of the Seller ” or “ Seller’s Knowledge ” or a similar phrase shall mean, with respect to any matter, the actual knowledge of the Seller, or the Principal Owners as at the date of this agreement;

 

Laws ” means all statutes, laws, codes, ordinances, regulations, rules, orders, judgments, writs, injunctions, acts or decrees of any Government entity;

 

Liability ” means any liability or obligation of whatever kind or nature (whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued or unaccrued, whether liquidated or unliquidated, and whether due or to become due), including without limitation any liability for Taxes;

 

Lien ” shall mean any mortgage, pledge, security interest, encumbrance, lien (statutory or other) or conditional sale agreement, and including claims on title and liens in favor of contractors, carriers, warehousemen, mechanics, materialmen, and subcontractors and statutory or common law liens to secure claims for labor, materials or supplies, and other similar liens and encumbrances;

 

Material Adverse Effect ” when used in connection with an entity, means any change, event, circumstance, condition or effect that is or is reasonably likely to be, individually or in the aggregate, materially adverse to: (i) the condition (financial or otherwise), capitalization, properties, prospects, products, assets (including intangible assets), Intellectual Property, liabilities, business, operations or results of operations of such entity and its subsidiaries, taken as a whole, or (ii) such entity’s ability to consummate the Share Purchase or to perform its obligations under this Agreement;

 

Material Adverse Event ” means any untoward or negative occurrence (including, without limitation, physical injury) related to the Business or the use of the Products and which has a Material Adverse Effect;

 

Person ” shall mean and include any individual, corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, and any other unincorporated organization or Government;

 

4
 

 

Taxes ” shall mean (i) all federal, state, local or foreign taxes, including, but not limited to, income, gross income, gross receipts, capital, production, excise, employment, sales, use, transfer, transfer gain, ad valorem, premium, profits, license, capital stock, franchise, severance, stamp, withholding, employment, unemployment, disability, worker’s compensation, payroll, utility, windfall profit, custom duties, personal property, real property, environmental, registration, alternative or add-on minimum, estimated and other taxes, governmental fees or like charges of any kind whatsoever, and (ii) any interest, penalties, fines, loss, damages, liability, expense or additions thereto whether disputed or not; and (iii) any transference liability in respect of any items described in clauses (i) or (ii) payable by reason of contract assumption, transference liability, operation of law, or otherwise;

 

Tax Return ” means any return, declaration, report, claim for refund, information return or statement relating to any taxes, including any schedule or attachment thereto and including any amendment therof;

 

Transaction Documents ” shall mean this Agreement, the Share certificates, and the other exhibits and schedules hereto and thereto, and all other agreements, instruments, certificates and other documents to be entered into or delivered by any Party in connection with the transactions contemplated to be consummated pursuant to any of the foregoing;

 

The parties agree that for the purposes of calculating the Australian to US dollar conversion, the exchange rate will be $1.00:US$0.70.

 

2. Share Purchase

 

(a) Purchase and Sale of the Company Shares . Upon the terms and subject to the conditions herein set forth, Seller agrees to sell, convey, transfer, assign and deliver to Buyer and Buyer agrees to purchase and accept from Seller, on the Closing Date, the Company Shares as set forth on Schedule 2(a) , being all of the fully paid ordinary shares in the capital of the Company.

 

(b) Surrender of the Company’s Share Certificates; Further Cooperation . At the Closing, Seller will deliver to Buyer its certificates representing all of Company Shares owned by Seller. From time to time after the Closing Date, without further consideration, Seller will execute and deliver such other instruments of conveyance and transfer and take such other action as Buyer reasonably may request to effectuate the transaction contemplated by this Agreement. Seller will furnish Buyer with such information and documents in Seller’s possession or under Seller’s control or that Seller can execute or cause to be executed as will enable Buyer to prosecute any and all pending claims, applications and the like which that be assigned hereunder.

 

5
 

 

3. Consideration

 

(a) Initial Consideration . Upon the terms and subject to the conditions set forth in this Agreement, in reliance on the representations, warranties, covenants and agreements of Seller contained herein, the consideration payable to Seller for the Share Purchase shall be an amount of (i) Three Million Four Hundred Fifty Thousand Australian dollars ($3,450,000 AUD), which will be paid by Buyer at Closing (the “ Cash Consideration ”); plus (ii) Three Million Five Hundred Seventy One Thousand Four Hundred and Twenty-Eight (3,571,428) shares of the Common Stock of Buyer (the “ Equity Consideration ”) (collectively, the “ Purchase Price ”).

 

(b) Earn-out Payment . As additional consideration for the Company Shares, at such times as provided in this Section 3(b) if the Calculation Period EBITDA is $5,000,000 AUD or more, Buyer shall pay to Seller an amount, if any (the Earn-out Payment ), equal to (i)(A) the Calculation Period EBITDA; multiplied by (B) the Earn-out Multiple; minus (ii) the total of $6,500,000 AUD plus the Top Up EBITDA. In the event that the number produced by the formula above is negative, no payment shall be made. In no event shall Buyer be obligated to pay Seller more than Three Million Five Hundred Thousand Dollars ($3,500,000 AUD) in the aggregate for Earn-out Payment. The parties agree to release the Earn-out Payment from the Escrow Account and pay this amount to Seller pursuant to the terms and conditions of this Agreement and the Escrow Agreement.

 

(c) If the Calculation Period EBITDA is initially less than $5,000,000 AUD (“ Initial Period EBITDA ”) , the parties agree that an amount equal to (A) $5,000,000 AUD, less (B) the Initial Period EBIDTA (“ Top Up EBITDA ”) will count towards the Calculation Period EBITDA for the purposes of the Earn-out Payment calculation in Section 3(b) ; provided, however, in no event will the Top Up EBITDA exceed $2,357,912 AUD.

 

(d) Procedures Applicable to Determination of the Earn-out Payment .

 

  (i) On or before July 15, 2016 Buyer will prepare and deliver to Seller a written statement (an “ Earn-out Calculation Statement ”) setting forth in reasonable detail its determination of the Calculation Period EBITDA as of June 30, 2016 and its calculation of any resulting Earn-out Payment (an “ Earn-out Calculation ”).

 

  (ii) Seller will have twenty (20) days after receipt of the Earn-out Calculation Statement (the “ Review Period ”) to review the Earn-out Calculation Statement. During the Review Period, Seller will have the right to inspect the Company’s books and records for the purposes reasonably related to the determinations of Adjusted EBITDA and the resulting Earn-out Payment. Prior to the expiration of the Review Period, Seller may object to the Earn-out Calculation set forth in the Earn-out Calculation Statement by delivering a written notice of objection (an “ Earn-out Calculation Objection Notice ”) to Buyer. Any Earn-out Calculation Objection Notice must specify the items in the applicable Earn-Out Calculation disputed by Seller and must describe in reasonable detail the basis for such objection, as well as the amount in dispute. If Seller fails to deliver an Earn-out Calculation Objection Notice to Buyer prior to the expiration of the Review Period, then the Earn-out Calculation set forth in the Earn-out Calculation Statement will be final and binding on the Parties and:

 

6
 

 

1. the Earn-Out Payment will be payable to the Seller within ten (10) days (or such other period agreed by the parties) of the expiration of the Review Period; and

 

2. the Buyer and the Seller agree and undertake to immediately provide executed written instruct ions (in accordance with the requirements of the Escrow Agreement) to the Escrow Agent to disburse an amount equal to the Earn-out Payment (in Australian dollars) to the Seller.

 

  (iii) If Seller timely delivers an Earn-out Calculation Objection Notice, Buyer and Seller will negotiate in good faith to resolve the disputed items and agree upon the resulting amount of Adjusted EBITDA and the resulting Earn-out Payment. If Buyer and Seller are unable to reach an agreement within seven (7) days after such Earn-out Calculation Objection Notice has been given, all unresolved disputed items must be promptly referred to an impartial internationally recognized firm of independent certified public accountants, other than Seller’s and Buyer’s accountants (the “ Independent Accountant ”). The Independent Accountant must be directed to render a written report on the unresolved disputed items as promptly as practicable, but in no event greater than seven (7) days after such submission to the Independent Accountant, and to resolve only those unresolved disputed items set forth in the Earn-out Calculation Objection Notice. If unresolved disputed items are submitted to the Independent Accountant, Buyer and Seller must each furnish to the Independent Accountant such work papers, schedules and other documents and information relating to the unresolved disputed items as the Independent Accountant may reasonably request. The Independent Accountant must resolve the disputed items based solely on the applicable definitions and other terms in this Agreement and the presentations by Buyer and Seller, and not by independent review. The resolution of the dispute and the calculation of Adjusted EBITDA that is the subject of the applicable Earn-out Calculation Objection Notice by the Independent Accountant will be final and binding on the Parties and:

 

1. the Earn-Out Payment will be payable to the Seller within 10 days (or such other period agreed by the parties) of the resolution of the dispute and calculation of the Adjusted EBITDA by the Independent Accountant; and

 

2. the Buyer and the Seller agree and undertake to immediately provide executed written instruct ions (in accordance with the requirements of the Escrow Agreement) to the Escrow Agent to disburse an amount equal to the Earn-out Payment (in Australian dollars) to the Seller.

 

  (iv) The fees and expenses of the Independent Accountant will be borne equally by Seller and Buyer.

 

7
 

 

(e) Post-closing Operation of the Company . The Buyer acknowledges that given the method in which the Earn-out Payment is calculated, it is critical that the Buyer preserves the essence and character of the Business during the Calculation Period.

 

(f) Subject to the terms of this Agreement, subsequent to the Closing, Buyer will have sole discretion with regard to all matters relating to the operation of the Company; provided , that, during the Calculation Period (i) Buyer shall not change the name of the Company’s product “Flat Tummy Tea”; (ii) Buyer shall operate the Business in the ordinary course of business in the same or similar manner and style using methods, practices, approaches and policies as have been used (or similar to those that have been used) by the Seller and the Principal Owners in the period prior to Closing; (iii) Buyer shall notify Seller as soon as reasonably practicable of any Material Adverse Effect on the Company or the Business; (iv) Buyer shall not make any capital expenditure payments that are unnecessary or larger than necessary in the context of the needs of the Business; (v) the Buyer shall use all reasonable endeavours to manage and conduct the Business as a going concern with all due care and in accordance with normal and prudent practice (having regard to the nature of the Business and good commercial practice and so as to comply with all applicable Laws), in order to preserve the value of the Company; and (vi) Buyer shall protect and maintain the Business and the assets of the Company, in order to properly preserve and grow their value. Buyer shall not, directly or indirectly, take any actions in bad faith that would have the purpose of avoiding or reducing any of the Earn-out Payments hereunder.

 

(g) Right to Set-off . Buyer will have the right to withhold and set off against any amount otherwise due to be paid pursuant to this Section 3 the amount of Buyer’s Losses to which any of the Buyer Indemnitees are finally determined to be entitled to under Section 12 .

 

(h) Security . The Parties understand and agree that (i) the contingent rights to receive any Earn-out Payment shall not be represented by any form of certificate or other instrument, are not transferable, except by operation of Laws relating to descent and distribution, divorce and community property, and do not constitute an equity or ownership interest in Buyer or the Company, (ii) Seller shall not have any rights as a security holder of Buyer or the Company as a result of Seller’s contingent right to receive any Earn-out Payment hereunder, and (iii) no interest is payable with respect to any Earn-out Payment. However, the Buyer agrees that the amount deposited into the Escrow Account pursuant to clause 3(i) must not be secured by or form part of any secured property in any security document or arrangement granted by either the Buyer or the Company. The Buyer also agrees that any security granted by the Company or the Buyer, and the enforcement of any such security, shall be subject to the Buyer’s obligations to pay the Earn-out Payment and to deposit the amounts in accordance with clause 3(i).

 

8
 

 

(i) Earn-Out Account . During the Calculation Period the Buyer shall, in each month that the Company’s Adjusted EBITDA exceeds four hundred thousand Australian dollars ($400,000 AUD), deposit seventy percent (70%) of such month’s Adjusted EBITDA into an Australian dollar denominated escrow account (the “ Escrow Account ”) established pursuant to the terms and conditions of a customary escrow agreement (the “ Escrow Agreement ”) with Wyrick Robbins Yates & Ponton LLP (the “ Escrow Agent ”) and where the Escrow Agent, Seller and Buyer are parties thereto. Each monthly deposit shall be made within thirty (30) days after the end of such month. The parties agree that the Escrow Agreement shall be provided and executed at Closing. The Escrow Agreement shall reflect in all material respects the terms and conditions of release of the Escrow Amount to Seller or Buyer, as applicable, set forth in this Section 3 . The Escrow Amount shall be held in the Escrow Account until the final determination of the Earn-Out Payment in accordance with this Section 3 . To the extent that there is a shortfall between the Earn-out Payment and the amount in the Escrow Account, for any reason, including as a result of foreign currency exchange, the Buyer must pay the difference to the Seller at the same time as the Earn-out Payment is released by the Escrow Agent.

 

4. Representations and Warranties of Seller and the Company.

 

As a material inducement to Buyer to enter into this Agreement and to consummate the transactions contemplated hereby, Seller, the Principal Owners, and the Company jointly and severally represent and warrants as of the date hereof, except as set forth on the Disclosure Schedules (or as disclosed in any other section, subsection or clause of the Disclosure Schedule to the extent that the applicability to such other section, subsection or clause is reasonably apparent on its face) to Buyer as set forth below.

 

(a) Corporate Organization. The Company is a proprietary limited company duly organized, validly existing and in good standing under the laws of its jurisdiction of formation. The organizational documents which have been furnished to Buyer reflect all amendments made thereto at any time prior to the date of this Agreement and are correct and complete. The minute books and other books and records of the Company, to the extent such minutes exist, have been furnished to Buyer.

 

(b) Qualification to Do Business . The Company has full corporate power and authority to carry on its business as now being conducted and is entitled to own, lease, or operate the properties and assets now owned, leased, or operated by it. The Company is qualified to do business, is in good standing, and to the Seller’s Knowledge has all required and appropriate licenses in each jurisdiction except jurisdictions in which failure to obtain or maintain such qualification, good standing, or licensing (i) would not, individually or in the aggregate, have or reasonably could be expected to have a Material Adverse Effect or (ii) would result in a material breach of any of the other representations, warranties, or covenants set forth in this Agreement. The Company is duly qualified to conduct the Business as presently conducted by the Company as an Australian corporation. No consent, waiver, approval, order, or authorization of, or registration, declaration, or filing with, any court, administrative agency, or commission or other governmental authority or instrumentality (“ Governmental Entity ”), or any third party, is required to be made or obtained by Seller or the Company in connection with the execution and delivery of this Agreement by Seller or the consummation by Seller of the transactions contemplated hereby, except for such consents, authorizations, filings, approvals and registrations that, if not obtained or made, would not have a Material Adverse Effect on the Company or such consents, authorizations, filings, approvals and registrations that must occur following Closing.

 

9
 

 

(c) Authorization and Validity of Agreement . Seller and the Principal Owners have all requisite power and authority to enter into the Transaction Documents and to carry out their obligations thereunder. The execution and delivery of the Transaction Documents and the performance of Seller’s and the Principal Owners’ obligations thereunder have been duly authorized by all necessary corporate, shareholder or member action of Seller and the Principal Owners, and no other proceedings on the part or in respect of Seller or the Principal Owners is necessary to authorize such execution, delivery and performance. The Transaction Documents have been duly executed by Seller and the Principal Owners and constitute its valid and binding obligations, enforceable against Seller and the Principal Owners in accordance with their respective terms, except as may be limited by applicable bankruptcy, insolvency, moratorium or similar laws of general application relating to or affecting creditors’ rights generally and except for the limitations imposed by general principles of equity.

 

(d) No Conflict or Violation . Subject to obtaining any consents and approvals set forth in Schedule 4(d) , the execution, delivery and performance by Seller of the Principal Owners of the Transaction Documents does not and will not to the Seller’s Knowledge (i)(A) conflict with or result in a breach of the terms, conditions, or provisions of, (B) constitute a default under (whether with or without the passage of time, the giving of notice or both), (C) give any third party the right to modify, terminate or accelerate any obligation under, (D) result in a violation of, or (E) require any consent, exemption or other action by or notice or declaration to, or filing with, any third party of any Government entity pursuant to (1) any organizational documents of the Company; (2) any provision of law, rule or regulation, or any order, judgment or decree of any court or other governmental or regulatory authority; or (3) any Contract, lease, sublease, occupancy agreement, loan agreement, mortgage, security agreement, trust indenture or other agreement or instrument to which the Company is a party or by which the Company is bound or to which any of the Seller’s or Principal Owners’ properties or assets is subject; (ii) result in the creation of any Lien or Tax upon the equity or assets of Seller or the Principal Owners; or (iii) otherwise interfere in any material manner with the Business.

 

10
 

 

(e) Capitalization . The Company Shares are paid up. All of the Company Shares are duly authorized, validly issued and fully paid. There are no outstanding or authorized options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other Contracts or commitments that could require the Company to issue, sell, or otherwise cause to become outstanding any of its shares. There is no outstanding or authorized share appreciation, phantom shares, profit participation, or similar rights with respect to the Company. There are no voting trusts, proxies, or other agreements or understandings with respect to the voting of the shares of the Company.

 

(f) Assets. The Company has good and marketable title to, or a valid leasehold interest in, all of its assets and properties, free and clear of all Encumbrances, except for liens for Taxes not yet due and payable, and mechanics’ liens, materialmen’s liens, and other liens arising by operation of law, which liens do not in any case materially and adversely affect the Company’s title to its assets, the Company’s use of its assets or the value of such assets. The Company’s assets which are tangible personal property are in reasonably good and serviceable condition, normal wear and tear excepted, have been maintained in accordance with normal industry practice, and are suitable for the purposes for which they are presently used. The Company owns or leases all equipment or other tangible assets that are necessary for the conduct of the Business as presently conducted. No assets are used in the Business that are not owned or leased by the Company and not included in the Assets. The Company operates no business other than the Business and related activities.

 

(g) Subsidiaries. The Company does not own, directly or indirectly, any shares or other interests in any other entity.

 

(h) Financial Statements . Attached hereto as Schedule 4(h) are: the Company’s most recent balance sheet, and income statement as of October 31, 2015 (the “ Financial Statements ”). The Financial Statements have been prepared using consistent accounting principles, presentations, methods, standards, policies, practices, classifications, estimation and adjustment methodologies, assumptions, and procedures. The Company’s books of account and records are complete and correct and accurately reflect all of the assets, liabilities, transactions, and results of operations of the business of the Company. The Financial Statements fairly present in all material respects the results of operations of the Business as of the dates thereof. Seller has delivered to Buyer or its representatives copies of the Financial Statements.

 

(i) Absence of Certain Changes or Events . Since October 31, 2015, the Company has conducted the Business only in the ordinary course consistent with past practices. Without limiting the generality of the foregoing, since October 31, 2015:

 

  (i) there has been no increase in the compensation or benefits paid or payable by the Company, other than in the ordinary course of business and consistent with past practices, to any of its officers, directors, employees, agents, consultants or shareholders, including any grant of severance or termination pay to any director, officer or employee of the Company, or any deferred compensation or similar agreement (or any amendment to any such existing agreement) with any director, officer or employee of the Company;

 

11
 

 

  (ii) there has been no declaration, setting aside, or payment of dividends or distributions in respect of the Company Shares, any split up or other recapitalization in respect of the Company Shares or any direct or indirect redemption, purchase by the Company, or other acquisition by the Company of any such shares, except dividends declared and paid, or distributions made, prior to the Closing Date to Seller in the ordinary course of business consistent with the past practices of the Company;

 

  (iii) the Company has not waived or compromised any right of material value or any payment, direct or indirect, of any material debt, liability, or other obligation;

 

  (iv) there has been no Material Adverse Effect on the Company;

 

  (v) there has been no issuance, transfer, sale, or pledge by the Company of any Company Shares or other securities or any commitment, option, right, or privilege under which the Company is or may become obligated to issue any shares or other securities; there has been no indebtedness for borrowed money incurred by the Company except such as may have been incurred or entered into in the ordinary course of business; no loan has been made or agreed to be made by the Company, nor has the Company become liable or agreed to become liable as a guarantor with respect to any loan or other indebtedness of the Company or Seller, or any third party;

 

  (vi) there has been no sale, assignment, or transfer of, or royalty arrangement with respect to the Company’s trade names, trademarks, service marks, domain names, web addresses, copyrights (or any interest therein), patent, or logos of material value, or any patent, trademark, service mark, domain name or web address or copyright applications (or any interest therein) used (or that were, or are intended to be used) in the operations of the Business;

 

  (vii) there has been no sale, lease or disposition of, any material property or asset, tangible or intangible, of the Company;

 

  (viii) there has been no actual or, to any Seller’s Knowledge, threatened termination or loss of any (A) material contract, lease, license, permit or other agreement to which the Company was or is a party other than terminations of contracts upon completion of work; (ii) certificate, license, or other authorization required for the continued operation by the Company of any material portion of the Business; or (B) customer or other revenue source, which termination or loss could reasonably be expected to result in loss or revenues to the Company in excess of Twenty-five Thousand Dollars ($25,000.00) per year, and there is no event known to Seller (including, without limitation, the transactions contemplated hereby) that could reasonably be expected to result in any such termination or loss;

 

12
 

 

  (ix) there has been no resignation or termination of employment of any key officer or employee of the Company or, to any Seller’s Knowledge, any impending resignation or termination of employment of any such officer or employee other than the Principal Owners which will resign following the Calculation Period;

 

  (x) there has been no agreement or commitment by the Company or Seller to do any of the things described in this Section 4(i) .

 

(j) Tax Matters

 

  (i) the Company has timely filed all material Tax Returns that it was required to file. All such Tax Returns as so filed disclose all Taxes required to be paid for the periods covered thereby. All material Taxes due and owing by the Company (whether or not shown on any Tax Return) have been paid or provided for in the Company’s balance sheet. The Company is not currently the beneficiary of any extension of time within which to file any Tax Return. There are no Liens for Taxes (other than Taxes not yet due and payable) upon any of the assets of the Company. The Company has withheld and paid, or made provision in its balance sheet for, all Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, shareholder, or other third party, and all Tax Returns and forms required with respect thereto have been properly completed and timely filed. Upon and after the acquisition of the Company Shares by Buyer, Buyer will have no, and will not be subject to any, liability, as a successor or otherwise, for or with respect to any Taxes of or pertaining to (i) the Company or (ii) the Business for any period or transactions arising before the Closing other than as provided for on its balance sheet. For the avoidance of doubt, the Seller and Principal Owners do not represent or warrant that there will not be any taxes payable or liabilities arising on or after Closing in relation to the Share Purchase.

 

  (ii) There is no material dispute or claim concerning any Tax liability of the Company either (A) claimed or raised by any authority in writing or (B) to the Knowledge of the Company.

 

(k) Absence of Undisclosed Liabilities; Indebtedness . Except as set forth in the Company’s balance sheet , the Company has no indebtedness or liability, absolute or contingent, involving, affecting or relating to the Business, the Products, or the transactions contemplated by the Transaction Documents.

 

13
 

 

(l) Intellectual Property.

 

  (i) IP Assets ” shall mean all of the following materials owned or licensed by the Company with respect to the Business: (A) the proprietary formulas for the Products; (B) the domain names listed on Schedule 4(l) (collectively, the “ Domain Names ”); (C) all the content on and accessible through the websites associated with the Domain Names, including demos (collectively, the “ Website Content ”); and (D) the entire Business marketing database consisting of all available customer information and all marketing, advertising and promotional materials, including logos, colors, videos, booklet designs, catalogs, solicitations, email templates, advertisements and all other Business marketing materials (whether in draft or final form) (collectively, the “ Marketing Materials ”).

 

  (ii) Schedule 4(l) lists all patented, registered, applied-for, and other Intellectual Property used in the Business, and all Intellectual Property of the Company licensed to any third Person (collectively, the “ Business Intellectual Property ”), including the registration and application information, date of application or issuance and relevant jurisdiction as to each, and whether or not the Business Intellectual Property is owned or licensed. Business Intellectual Property that is licensed by the Company from a third party is “ Licensed Intellectual Property ”.

 

  (iii) The Company owns, or will own at Closing, all right, title and interest in and to or has a valid and enforceable license or right to use, all IP Assets, Business Intellectual Property, and the Licensed Intellectual Property, free and clear of all Liens, and all patented or registered Business Intellectual Property is valid and enforceable. The Company has taken commercially reasonable steps to maintain the confidentiality of all information that constitutes a trade secret of the Business. The Company has the valid right to transfer the Intellectual Property included in the Business to Buyer as contemplated hereunder.

 

  (iv) Except as set forth on Schedule 4(l) , (A) to the Knowledge of the Seller, the conduct of the Business, including the delivery and distribution of the Products, has not infringed and does not infringe on any Intellectual Property or any other proprietary rights of any Person, including but not limited to the rights of privacy or publicity; (B) to the Knowledge of the Seller, no Person is infringing, violating or misappropriating any Business Intellectual Property; (C) to the Knowledge of the Seller the Company, has not taken any action, or failed to take any action, during prosecution of any application that could reasonably be expected to result in the invalidation or unenforceability of any registered Business Intellectual Property; (D) the Company is not currently a party to any pending suit, claiming any alleged infringement or misappropriation of any Business Intellectual Property; (E) the Company has not received within the prior three (3) years any written notice, and is not currently a party to any pending suit, claiming any alleged infringement or misappropriation of the Intellectual Property rights of other Persons with respect to its or their use of Intellectual Property or the Products; (F) the Company has not entered into any Contract that includes a forbearance to sue or settlement Contract with respect to any Intellectual Property and (G) the Company has not received any written notice of any claim within the prior three (3) years, and is not currently a party to any pending suit, which challenges the validity or enforceability of, the Company’s ownership of or right to use, any Intellectual Property (excluding, for clarity, office actions) or the Products. With respect to the material Intellectual Property of the Company (e.g., product formulas, etc.), Seller has secured valid written confidentiality Contracts and assignments of Intellectual Property from all consultants, contractors, Employees, and customers who contribute or have contributed to the creation, conception, reduction to practice or other development of such Intellectual Property developed on behalf of Seller.

 

14
 

 

  (v) To the Knowledge of the Seller, no Product provided or distributed by Seller in its conduct of the Business: (A) violates any Law in any material respect; (B) includes any information or material that is defamatory in any material respect; or (C) infringes any right of publicity, privacy, or other right of any Person in any material respect.

 

(m) Compliance with Law . To the Knowledge of the Seller, the manufacture and sale of the Products and the operation of the Business has been conducted in material compliance with all applicable Laws and other requirements of all courts and other governmental or regulatory authorities having jurisdiction over the Company and its assets, properties and operations. The Company has not received notice of any violation (or possible violation) of any such Law or other legal requirement, and the Company is not in default with respect to any order, writ, judgment, award, injunction or decree of any federal, state or local court or Governmental or regulatory authority, applicable to the Company, the Business, or the Company Shares. To the Seller’s Knowledge, the Company holds all Permits required for the conduct of the Business and the ownership of its properties. No written notices have been received by the Company alleging the failure to hold any Permit. To the Seller’s Knowledge, the Company is in compliance with all terms and conditions of all such Permits. All of such Permits shall be available for use by Buyer immediately after the Closing. Without limiting the foregoing, the Company has not received any warning letter or untitled letter, report of inspectional observations, establishment inspection reports, notices of violation, clinical holds, enforcement notices or other documents from the any governmental entity or any institutional review board or independent ethics committee alleging a lack of material compliance by Company with any Laws. No “bulk sales” or similar Law applies to the transactions contemplated by this Agreement .

 

15
 

 

(n) Litigation . There are no claims, Actions, suits, proceedings, complaints or investigations pending or, to the Knowledge of the Seller, threatened before any court or governmental or regulatory authority, domestic or foreign, or before any arbitrator of any nature, brought by or against the Company or any of its officers, directors, employees, agents or Affiliates, or the Principal Owners, involving, affecting or relating to the Company, the Business, the Company Shares, or the transactions contemplated by the Transaction Documents.

 

(o) Brokerage . Except for payment to be made to Go Capital set forth on Schedule 4(o) , the Company has not incurred, and shall not incur, any brokerage, finder’s or similar fee in connection with the transactions contemplated by this Agreement.

 

(p) Insurance . The Company is currently insured by insurers unaffiliated with the Company with respect to its properties, assets and operation of the Business in such amounts and against such risks which are appropriate and customary for the type of business conducted by the Company with customary deductibles and retained amounts. With respect to each insurance policy held by the Company (the “ Insurance Policies ”) (i) such Insurance Policy is legal, valid, binding and in full force and effect; (ii) the Company is not in default under such Insurance Policy; and (iii) the Company has delivered a true and correct copy of such Insurance Policy to Buyer. There are no claims by the Company pending under any such Insurance Policies and the Company has not been informed that coverage has been questioned, denied or disputed by the underwriters of such Insurance Policies with respect to any such claims.

 

(q) Employment Matters . Schedule 4(q) separately sets forth all of the Employees as of the date hereof, including for each such Employee: name, job title, designation, work location (identified by street address), current compensation paid or payable, all wage arrangements, fringe. No Employee is a party to, or is otherwise bound by, any Contract or arrangement, including any confidentiality or non-competition Contract, that in any way adversely affects or restricts the performance of such Employee’s duties. Each current Employee has executed, or will have executed as of Closing, a nondisclosure and assignment-of-rights Contract for the benefit of the Company vesting all rights in work product created by the Employee, during the Employee’s employment or affiliation with the Company, in the Company. To the Knowledge of the Seller and except as set forth on Schedule 4(q) , no Employee other than the Principal Owners intends to terminate his or her employment with the Company. The Company has, or will have no later than the Closing Date, included provision for all accrued salaries, bonuses, commissions, wages, severance and accrued vacation pay of the Employees due to be paid through the Closing Date in the Company’s accounts / financial statements. The Company is in compliance, in all material respects, with all Laws governing the employment of labor.

 

16
 

 

(r) Contractor Matters . The Seller has or will, prior to the Closing Date, disclose a list of the name (if an entity, including the name of the individuals employed by or providing service on behalf of such entity) and contact information of each material independent contractor, consultant, freelancer or other service provider (collectively, “ Contractors ”) used by the Company at any point during the prior one (1) year. A copy of each Contract relating to the services any Contractor provides to the Business has been provided to the Company. To the Knowledge of the Seller, no Contractor used by the Company is a party to, or is otherwise bound by, any Contract or arrangement with any third party, including any confidentiality or non-competition Contract, that in any way adversely affects or restricts the performance of such Contractor’s duties for the Company. To the Knowledge of the Seller, no current Contractor used by the Company intends to terminate his or her or its relationship with the Company. The Company has no obligation or Liability with respect to any Taxes (or the withholding thereof) in connection with any Contractor. The Company has properly classified, pursuant to any applicable Law, all Contractors used by the Company at any point.

 

(s) Employee Benefits . The Company does not maintain or contribute to any Employee Benefit Plans other than in respect to the bonus and incentives available to its Employees. .

 

(t) Environmental and Safety Matters . The Company has complied and is in compliance with all Environmental Laws, including but not limited to all Permits required by Environmental Laws for the conduct of the business operations of the Company and the disposition of all hazardous materials in accordance with all applicable Environmental Laws in all material respects. The Company has not received any outstanding and unresolved written or oral notices, reports or other information regarding any actual or alleged violation of Environmental Laws by the Company, or any Liabilities or potential Liabilities, including any remedial obligations, relating to any of them or their facilities arising under Environmental Laws.

 

(u) Real Property . Schedule 4(u) sets forth the address of each leased real property of the Company (the “ Leased Real Property ”), and a true and complete list of all leases (including all amendments, extensions, renewals, Guarantees and other Contracts with respect thereto) for each such Leased Real Property (including the date and name of the parties to such lease or license document) (the “ Leases ”). Seller has delivered to Buyer a true and complete copy of each Lease, and in the case of any oral Lease, a written summary of the material terms of such Lease. With respect to each of the Leases: (i) such Lease is legal, valid, binding, enforceable and in full force and effect; (ii) the transactions set forth in this Agreement do not require the consent of any other Person to such Lease, or such consent has been obtained, shall not result in a breach of or default under such Lease, or otherwise cause such Lease to cease to be legal, valid, binding, enforceable and in full force and effect on identical terms following the Closing; (iii) the Company’s possession and quiet enjoyment of the Leased Real Property under such Lease has not been disturbed, and there are no disputes with respect to such Lease; (iv) the Company, and any other party to the Lease, is not in breach or default under such Lease, and no event has occurred or circumstance exists which, with the delivery of notice, the passage of time or both, would constitute such a breach or default, or permit the termination, modification or acceleration of rent under such Lease; (v) no security deposit or portion thereof deposited with respect to such Lease has been applied in respect of a breach or default under such Lease which has not been redeposited in full; (vi) the Company does not owe, or shall not owe in the future, any brokerage commissions or finder’s fees with respect to such Lease; (vii) the other party to such Lease is not an Affiliate of, and otherwise does not have any economic interest in, the Company; (viii) the Company has not subleased, licensed or otherwise granted any Person the right to use or occupy such Leased Real Property or any portion thereof; (ix) the Company has not collaterally assigned or granted any other security interest in such Lease or any interest therein; (x) there are no Liens on the estate or interest created by such Lease; and (xi) all buildings, structures, improvements, fixtures, building systems and equipment, and all components thereof, included in the applicable Leased Real Property are in good condition and repair (fair wear and tear excepted). The Company does not own any real property, nor has it ever owned any real property.

 

17
 

 

(v) Affiliate Transactions . No shareholder, officer, director, member or Affiliate of the Company or any individual related by blood, marriage or adoption to any such individual or any entity in which any such Person or individual owns any beneficial interest, is a party to any Contract or transaction with the Company or has any interest in any real, tangible or intangible asset or property used by the Company.

 

(w) Product and Service Warranties; Adverse Events . The Company has made no express warranty or Guarantee to any customer or Client as to services or goods provided by the Company other than those required to be provided by Law. There is no pending or, to the Knowledge of the Seller, threatened claim alleging any breach of any warranty or Guarantee. There have not been any Material Adverse Events with respect to the Products or the Business.

 

(x) Guaranties . The Company is not a guarantor or otherwise liable for any liability, indebtedness or other obligation of any other Person.

 

(y) Status . Seller represents and warrants that (i) it has had an opportunity to discuss the business, management and financial affairs of Buyer, has had access to, the management of Buyer, and has had the opportunity to review the information set forth in Buyer’s public filings and any other information requested by Seller, (ii) Buyer will be relying upon Seller’s representations and warranties set forth herein in offering the Company Shares to it, and (iii) it has retained and consulted with a “Purchaser Representative,” as such term is defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended (the “ 1933 Act ). Seller further represents and warrants that: (i)(A) it recognizes that ownership of the Equity Consideration involves substantial risks, including a risk of total loss of the value of the Equity Consideration, and has taken full cognizance of and understands all of the risk factors related to the ownership of the Equity Consideration; (B) it has sufficient knowledge and experience in business and investments, including financial, business and tax matters, to be capable of evaluating the merits and risks of ownership in the Buyer and making an informed decision about ownership in the Buyer, and (C) it has an adequate net worth and means of providing for its current needs and possible contingencies to sustain a complete loss in the Equity Consideration; or (ii) it is an “accredited investor” as such term is defined in Rule 501 of Regulation D.

 

18
 

 

(z) Acquisition for Own Account . This Agreement is made with Seller and Principal Owners in reliance upon such parties’ representations to Buyer, which by its execution hereof Seller and the Principal Owners hereby confirm that the Equity Consideration to be received by it will be acquired for investment for Seller’s own account, not as a nominee or agent, and not with a view to the sale or distribution of any part thereof other than as permitted under the 1933 Act and that it has no present intention of selling, granting participation in, or otherwise distributing the same other than what is permitted under the 1933 Act. By executing this Agreement, Seller further represents that it does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person, or to any third person, with respect to the Equity Consideration.

 

(aa) No Intention to Distribute . Seller and the Principal Owners understand that the Equity Consideration shares have not been registered under the 1933 Act on the grounds that the sale provided for in this Agreement and the issuance of securities hereunder is exempt from registration under the 1933 Act, and that Buyer’s reliance on such exemption is predicated in part on the representations set forth herein. Seller and the Principal Owners realize that the basis for the exemption may not be present if, notwithstanding such representations, Seller or the Principal Owners have in mind merely acquiring the Equity Consideration shares for a fixed or determined period in the future, or for a market rise, or for sale if the market does not rise. Seller and the Principal Owners do not have any such intention.

 

(bb) No Registration . Seller and the Principal Owners understand that the Equity Consideration may not be sold, transferred or otherwise disposed of without registration under the 1933 Act or an exemption therefrom, and that in the absence of an effective registration statement covering the shares or an available exemption from registration under the 1933 Act, the Equity Consideration must be held indefinitely. In particular, Seller and the Principal Owners are aware that the shares may not be sold pursuant to Rule 144 promulgated under the 1933 Act unless all of the conditions of that Rule are met. Among the conditions for use of Rule 144 may be the availability of current information to the public about Buyer. The Seller and Principal Owners represent that, in the absence of an effective registration statement covering the Equity Consideration shares, it will sell, transfer, or otherwise dispose of such shares only in a manner consistent with its representations set forth herein and then only in accordance with the provisions of this Agreement.

 

(cc) Restrictions on Transfer . Seller agrees that in no event will it make a transfer or disposition of any of the Equity Consideration (other than pursuant to an effective registration statement under the 1933 Act or a Rule 144 sale in compliance with the terms of such Rule or pursuant to an exemption from the 1933 Act. Buyer shall cooperate with Seller and Seller’s transfer agent in the removal of any legend on the shares constituting the Equity Consideration to permit the trade or liquidation thereof in the marketplace as permitted under Rule 144 of the 1933, if requested by Seller.

 

19
 

 

(dd) Inventory . All inventory of the Company, whether or not reflected in the Balance Sheet, consists of a quality and quantity usable and salable in the ordinary course of business consistent with past practice, except for obsolete, damaged, defective or slow-moving items that have been written off or written down to fair market value or for which adequate reserves have been established. All such inventory is owned by the Company free and clear of all encumbrances, and no inventory is held on a consignment basis. The quantities of each item of inventory are not excessive, but are reasonable in the present circumstances of the Company.

 

(ee) Customers . The due diligence materials provided by the Company to Buyer includes information regarding each customer who has paid consideration to the Company for goods or services rendered for each of the last two (2) most recent fiscal years, and the amount of consideration paid.

 

(ff) Contracts; Agreements .

 

  (i) Except as disclosed in Schedule 4(ff), the Company is not a party to or bound by any oral or written Contract or obligation that individually has a value in excess of $15,000, has a term of greater than two (2) years or is otherwise material to the Company or its businesses, operations, financial condition, properties or assets.

 

  (ii) Each agreement, contract, plan, lease, arrangement or commitment required to be disclosed pursuant to this Section 4(ff) (each, a “Material Contract”) is a valid and binding agreement the Company and is in full force and effect with respect to the Company and, to the Knowledge of the Seller, each other party thereto, and neither the Company, nor to the Knowledge of the Seller, any other party thereto, is in default or breach in any material respect under the terms of any such Material Contract, and, to the Knowledge of the Seller, no event or circumstance has occurred that, with notice or lapse of time or both, would reasonably be expected to constitute any event of default thereunder. True and complete copies of each such Material Contract have been made available to Buyer. The Company has fulfilled all material obligations required pursuant to each Material Contract to have been performed by the Company prior to the date hereof, and, to the Knowledge of the Seller, without giving effect to the Share Purchase and the other transactions contemplated by this Agreement, the Company will be able to fulfill, when due, all of its obligations under the Material Contracts that remain to be performed after the date hereof.

 

  (iii) No Person is renegotiating or seeking to renegotiate, or, to the Knowledge of the Seller, has a right (absent any default or breach of a Material Contract) pursuant to the terms of any Material Contract to renegotiate, any material amount paid or payable to the Company under any Material Contract or any other material term or provision of any Material Contract. The Company has not received any written indication or, to the Knowledge of the Company, verbal indication of an intention to terminate or renegotiate the terms of any of the Material Contracts by any of the parties to any of the Material Contracts.

 

20
 

 

(gg) Seller is a “non-U.S. Person” (as defined in Regulation S promulgated under the 1933 Act) and (i) the transaction contemplated by this Agreement constitutes an “offshore transaction” (as such term is defined in Regulation S) and (ii) the Equity Consideration will be for investment for the Seller’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof in the U.S. or to a U.S. resident, and that Seller has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, Seller further represents that it (A) does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer, or grant participations to such person, or to any third person in the U.S. or to a U.S. resident, with respect to any of the Equity Consideration; (B) agrees to resell the Equity Consideration only in accordance with the provisions of Regulation S of the 1933 Act, pursuant to registration under the 1933 Act, or pursuant to an available exemption from registration under the 1933 Act; and (iii) agrees not to engage in hedging transactions with respect to such Equity Consideration unless otherwise in compliance with the 1933 Act. Seller acknowledges that, to its knowledge, neither the Buyer, nor any of its affiliates, nor any person acting on its or their behalf has engaged in any directed selling efforts in violation of the requirements of Regulation S.

 

5. Limitations to representations and warranties of the Seller and the Company and Actions

 

(a) The Buyer acknowledges and agrees that the Seller, the Principal Owners and the Company have disclosed or are deemed to have disclosed against the representations and warranties of Seller and the Company, and the Buyer is aware of, and will be treated as having actual knowledge of, all facts, matters and circumstances that:

 

  (i) are within the actual knowledge of the Buyer or its advisers in relation to the Share Purchase; and

 

  (ii) are fairly disclosed in the Disclosure Schedules and the due diligence material in relation to the Business and the Company that have been provided to the Buyer.

 

(b) The warranties and representations of the Seller and Principal Owners are given subject to the disclosures or deemed disclosures described in Section 5(a). The Seller and the Principal Owners will have no liability under the representation and warranty of Seller and the Principal Owners to the extent that disclosure is made or is deemed to have been made against the representations and warranties given under Section 4.

 

21
 

 

(c) It shall not be a breach of a representation and warranty of Seller and the Company, if the facts, matters or circumstances giving rise to such Action are fairly disclosed or are deemed to have been fairly disclosed under Section 5(a).

 

(d) Neither the Seller nor the Principal Owners are liable under an Action for any Liability to the extent that the Buyer recovers, or is compensated for by any other means, from another source whether by way of contract, indemnity or otherwise (including under a policy of insurance or from a government agency).

 

(e) This Section 5 does not prevent the Buyer being entitled to commence an Action under this Agreement or a Transaction Documents. However, if for any reason more than one amount is paid in respect of the same Liability, the Buyer must procure that the amount in excess of the amount of the Liability (less the costs and expenses of making the claim or commencing the Action) is immediately repaid to the Seller to give full effect to this Section 5.

 

(f) The Buyer must:

 

  (i) take all reasonable actions (subject to being indemnified by Seller against all reasonable costs and expenses incurred) to mitigate any Liability that may give rise to an Action, including, if the Buyer is entitled to recover, or be compensated for by any other means, any Liability from another source the Buyer must use all reasonable endeavours to recover or be compensated for or procure that such Liability is recovered or compensated for as soon as practicable from that source. The Buyer must notify its insurers of this Section 5(f).

 

  (ii) not omit to take any reasonable action that would mitigate any Liability that may give rise to an Action.

 

(g) Neither the Seller nor the Principal Owners are liable under any Action, other than Action in respect of Tax, for any Liability to the extent that Liability:

 

  (i) ( provisions in accounts ) has been included as a provision, allowance, reserve or accrual in the Company’s accounts or financial statements that have been provided to the Buyer or that arises in respect of a matter that has been noted in the Company’s accounts or financial statements that have been provided to the Buyer;

 

  (ii) ( contingent losses ): is contingent, unless and until the Liability becomes an actual Liability and is due and payable;

 

  (iii) ( change of law or interpretation ): arises from:

 

22
 

 

  (iv) the enactment or amendment of any legislation or regulations;

 

    (1) a change in the judicial or administrative interpretation of the law; or
         
    (2) a change in the practice or policy of any governmental agency,

 

after the date of Closing, including legislation, regulations, amendments, interpretation, practice or policy that has a retrospective effect;

 

  (v) ( consequential loss ): is special, indirect or consequential loss or damage including loss of profit or loss of reputation;

 

  (vi) ( post Closing conduct ):arises from anything done or not done after Closing by or on behalf of the Buyer or its Affiliates that is outside the ordinary course of the Business and the Buyer was aware or ought reasonably be aware would give rise to an Action against the Seller or the Principal Owners;

 

  (vii) ( promoted claims): arises from an Action initiated by a third party that is attributable to anything done or not done after Closing by or on behalf of the Buyer or its Affiliates that was calculated or intended to cause the Action initiated by the third party to be made;

 

  (viii) ( change in accounting policy ): would not have arisen but for a change after Closing in any accounting policy or practice of the Buyer that applied before Closing;

 

  (ix) ( change of Business ): arises out of the cessation or alteration of the Business after Closing;

 

  (x) ( legal costs ): is not a reasonable legal cost; and

 

  (xi) ( remediable loss ): is remediable, provided it is remedied to the satisfaction of the Buyer, acting reasonably, within 45 days after the Seller or Principal Owners receives written notice of an Action or a Direct Claim in accordance with this Agreement.

 

6. Representations And Warranties Of The Buyer .

 

Buyer hereby represents and warrants to Seller as follows:

 

(a) Corporate Organization . Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada, and has all requisite power and authority and all necessary governmental authority to own, operate or lease the properties that it purports to own, operate or lease and to carry on its businesses as now conducted. Buyer is duly qualified to do business as a foreign company, and is in good standing in each jurisdiction where the character of its properties owned, operated or leased or the nature of its activities makes such qualification necessary.

 

(b) Authorization and Validity of Agreement . Buyer has all requisite power and authority to enter into the Transaction Documents and to carry out its obligations thereunder. The execution and delivery of the Transaction Documents and the performance of Buyer’s obligations thereunder have been duly authorized by all necessary company action by Buyer, and no other proceedings on the part of Buyer are necessary to authorize such execution, delivery and performance. Each of the Transaction Documents has been duly executed by Buyer and constitutes its valid and binding obligation, enforceable against it in accordance with its terms, except as may be limited by applicable bankruptcy, insolvency, moratorium or similar laws of general application relating to or affecting creditors’ rights generally and except for the limitations imposed by general principles of equity.

 

23
 

 

(c) No Conflict or Violation . Subject to obtaining all consents and approvals set forth herein, the execution, delivery and performance by Buyer of the Transaction Documents, to the knowledge of Buyer, (i) does not and will not violate or conflict with any provision of the organizational documents of Buyer; (ii) does not and will not violate any provision of law, rule or regulation, or any order, judgment or decree of any court or other governmental or regulatory authority; (iii) does not violate or will not result in a breach of or constitute (with due notice or lapse of time or both) a default under, or give rise to any acceleration of remedies or any right of termination under, any Contract, lease, sublease, occupancy agreement, loan agreement, mortgage, security agreement, trust indenture or other agreement or instrument to which Buyer is a party or by which Buyer is bound or to which any of Buyer’s properties or assets is subject, except for such breaches, defaults and accelerations as would not have a Material Adverse Effect on the ability of Buyer to consummate the transactions contemplated hereby.

 

(d) No Event of Insolvency : no Event of Insolvency has occurred in relation to the Buyer, nor is there any act which has occurred or to the best of its knowledge, is anticipated to occur which is likely to result in an Event of Insolvency in relation to the Buyer.

 

(e) No litigation : the Buyer is not a party to any investigation, prosecution, litigation, legal proceeding, arbitration, mediation or any other form of dispute resolution, and to the best of its knowledge no such proceedings are pending or threatened and there is no circumstance or fact that is likely to give rise to any such proceedings.

 

(f) Compliance with Applicable Law : To the knowledge of Buyer, Buyer is in compliance in all material respects with the applicable Laws; and

 

(g) Securities Law: the Buyer:

 

  (i) is a “reporting company” that is subject to the reporting requirements of the Securities Exchange Act of 1934;
       
  (ii) has complied with the periodic reporting requirements of the Securities Exchange Act of 1934; and
       
  (iii) has otherwise complied the requirements of Rule 144 promulgated under the 1933 Act so as to ensure that the Equity Consideration to be received by the Seller will be eligible for exemption from registration under Rule 144 of the 1933 Act and will be freely tradable on the date which is 6 months following the issue of the Equity Consideration, provided that Seller owns less than 10% of the voting securities of Buyer.

 

24
 

 

7. Covenants

 

(a) Seller Covenants: The Seller covenants as follows:

 

  (i) Consents and Approvals. Seller shall, at its cost and expense, use Commercially Reasonable Efforts to obtain all necessary consents, waivers, authorizations and approvals of all governmental and regulatory authorities, and of all other Persons required to be obtained in connection with the execution, delivery and performance by it of the Transaction Documents.
       
  (ii) Post-Closing Operation of Business. Following the Closing, Seller shall fully cooperate with Buyer to transfer the Business assets and liabilities to Buyer in such a manner as to preserve the value thereof.

 

(b) Buyer Covenants: The Buyer covenants as follows:

 

  (i) that on the date which is 6 months following the issue of the Equity Consideration, it will take such action as is required to ensure that the Equity Consideration is freely tradable, including, without limitation, requesting removal of any restrictive legend attaching to the Equity Consideration; and

 

  (ii) that the Buyer must pay all relevant taxes for which the Company is liable for and which relate to the period prior to Closing but which are due after Closing has occurred, on or before the due date, subject to the sufficient provision being made for the tax/es in the Company’s Financial Statements.

 

8. Noncompetition, Nonsolicitation and Nondisparagement.

 

(a) Noncompetition . Seller and the Principal Owners acknowledge that (i) Buyer would not have entered into this Agreement but for the agreements and covenants contained in this Section 8 ; and (ii) the agreements and covenants contained in this Section 8 are essential to protect the Business and are reasonable and appropriate in scope; (iii) the Business is international in scope; and (iv) the business of Buyer is international in scope. To induce Buyer to enter into this Agreement, Seller and the Principal Owners covenant and agree that during the period commencing on the Closing Date and ending on the fifth (5th) anniversary of the Closing Date (the “ Restricted Period ”), Seller, the Principal Owners, and their respective Affiliates shall not, directly or indirectly, (A) engage in any business or activity that competes with the Business ; (B) render any services to any Person for use in competing with Buyer in connection with the Business; (C) have an interest in any Person engaged in any business that competes with Buyer in connection with the Business, directly or indirectly, in any capacity, including, without limitation, as a shareholder, officer, director, principal, agent, trustee or consultant or any other relationship or capacity but, for the avoidance of doubt, this shall not include the Seller or the Principal Owners’ engagement of a non-Employee blogger or any other service provider or person for a purpose not related to a business or activity that competes with the Business but who may promote a product for a business that competes with the Business; provided , however , Seller or the Principal Owners may own, directly or indirectly, solely as an investment, securities of any Person which are publicly traded if Seller or the Principal Owner (I) is not a controlling Person of, or a member of a group which controls, such Person and (II) does not, directly or indirectly, own two percent (2%) or more of any class of securities of such Person; or (III) interfere with business relationships (whether formed heretofore or hereafter) between Buyer or any of its Affiliates and customers, suppliers or prospects of the Business.

 

25
 

 

(b) Employees of the Business . During the Restricted Period, Seller, and the Principal Owners, and their respective Affiliates shall not, directly or indirectly, (i) solicit or encourage any Employee or consultant performing services in connection with the Business to leave the employment or retention of Buyer or any of its Affiliates, or (ii) hire any such Employee or consultant who was performing services in connection with the Business and who has left the employment or retention of Buyer or any of its Affiliates within one (1) year of the termination of such Employee’s employment or consultant’s retention with Buyer or any of its Affiliates.

 

(c) Customers of the Business . During the Restricted Period, the Principal Owners and Seller, its employees, officers, and directors shall not, directly or indirectly, (i) persuade or attempt to persuade any customer, prospective customer, client, prospective client, supplier or vendor of Buyer or any of its Affiliates not to hire or do business with Buyer or any of its Affiliates or any successor thereto; (ii) solicit for himself or any Person other than Buyer or any of its Affiliates, the business of any Person who is a customer, client, supplier or vendor of Buyer or any of its Affiliates, or was its customer or supplier within one (1) year prior to the time of such solicitation to the extent that such business is similar to the business conducted by such customer or supplier with Buyer. For the avoidance of doubt, this clause shall not prevent the Seller or the Principal Owners from conducting such advertising or marketing for a business that does not compete with the Business nor shall it prevent a previous customer, client, supplier or vendor of the Business from initiating contact with and utilizing the services of any business which is operated by the Seller or the Principal Owners which does not compete with the Business.

 

(d) Confidential Information . From and after the Closing, the Principal Owners and Seller, its shareholders, employees, officers, and directors shall keep secret and retain in strictest confidence, and shall not use for the benefit of itself or others, all confidential matters relating to the Business or Buyer and its Affiliates, including, but not limited to, “know how”, trade secrets, customer lists, supplier lists, details of consultant and employment Contracts, pricing policies, operational methods, marketing plans or strategies, product development techniques or plans, business acquisition plans, technical processes, designs and design projects, processes, inventions, software, source codes, object codes, systems documentation and research projects and other business affairs (“ Confidential Information ”), and shall not disclose them to anyone outside of Buyer and its Affiliates; provided , however , this covenant shall not apply to any information which is or becomes generally available to the public other than as a result of disclosure by the Principal Owners or Seller or its respective Affiliates. The Principal Owners and Seller and its respective Affiliates may disclose Confidential Information if required to do so in any legally required government or securities filings, legal proceedings, subpoena, civil investigative demand or other similar process; provided , that Seller and the Principal Owners (i) provides Buyer with prompt notice of such required disclosure so that Buyer may attempt to obtain a protective order, (ii) cooperates with Buyer, at Buyer’s expense, in obtaining such protective order, and (iii) only discloses that Confidential Information which it is absolutely required to disclose as advised by counsel. Notwithstanding anything to the contrary in this Section 8(d), the Principal Owners and Seller, its shareholders, employees, officers, and directors shall be free to use for any purpose the residuals resulting from access to or work with the Confidential Information, provided that such party shall not disclose the Confidential Information except as expressly permitted pursuant to the terms of this Agreement. The term “residuals” means information in intangible form (i.e., not written or other documentary form, including tape or disk), which is incidentally and unintentionally retained in memory by persons who have had access to the Confidential Information, including ideas, concepts, know-how or techniques contained therein and where the source of the Confidential Information has become remote (e.g., as a result of the passage of time or the person’s subsequent exposure to information of a similar nature from other sources) such that the person can no longer identify the Confidential Information’s confidential source; provided, however, that no license to any Company intellectual property is granted under this Section, this Section 8(d) will not supersede or alter any separate agreement between such party and the Company, unless that agreement is acknowledged to be expressly subject to this clause, and residuals do not include any Product formulations.

 

26
 

 

(e) Nondisparagement . After the Closing Date, Seller and the Principal Owners will not disparage Buyer, any of Buyer’s Affiliates or any of such parties’ shareholders, directors, officers, employees or agents.

 

(f) Tolling of Covenant Periods . The Restricted Period provided in this Section 8 shall not include and shall be extended beyond, any time during which a party is failing to comply with any provision of this Section 8 with respect to such party.

 

(g) Blue Penciling . If any term or other provision of this Section 8 is invalid, illegal, or incapable of being enforced by any rule of Law or public policy, all other conditions and provisions of this Section 8 shall nevertheless remain in full force and effect. Upon determination that any term or other provision is invalid, illegal, or incapable of being enforced, the Parties hereto shall negotiate in good faith to, or the arbitrator making such a determination shall, modify this Section 8 so as to effect the original intent of the Parties as closely as possible in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible.

 

9. Employees .

 

During the Calculation Period, the Buyer must retain all Employees including all management Employees with the Company and shall not terminate their employment without the prior written consent of the Seller, such consent shall not be unreasonably withheld, except that Buyer can terminate Employees for cause. Seller shall make all salary, commission, bon u s, incentive, vacation pay or other benefit accrual payments, in each case that relate to periods prior to and through the Closing, to Employees as they become due. Buyer shall not be required to provide continuations of any of Seller’s salary arrangements, bonus or incentive pay or other plans, commission arrangements or commission agreements or wage or salary or compensation incentives after the Closing Date.

 

10. Conditions to Obligations of Seller.

 

The obligations of Seller to effect the Closing and to consummate the transactions contemplated by the Transaction Documents are subject to the fulfillment, at or before the Closing Date, of each of the following conditions, any one or more of which may be waived by Seller in its sole discretion:

 

(a) Representations and Warranties of the Buyer . All representations and warranties made by Buyer in this Agreement shall be true and correct in all material respects (except as to representations and warranties which are qualified as to materiality, which representations and warranties shall be true and correct in all respects) as of the date of this Agreement and on and as of the Closing Date as if again made by Buyer on and as of such date.

 

(b) Performance of the Obligations of the Buyer . Buyer shall have performed in all material respects all obligations required under this Agreement to be performed by it on or before the Closing Date.

 

(c) Buyer Closing Deliverables . At the Closing, Buyer will:

 

  (i) Deliver to Seller the Cash Consideration in immediately available AUS funds;
       
  (ii) Deliver to Seller the Equity Consideration, including certificates therefor;
       
  (iii) Deliver a certificate executed by the authorized person of the Buyer certifying as to the truthfulness, completeness and accuracy of attached copies of resolutions of the directors of the Buyer authorizing this Agreement and the transactions contemplated hereby; and
       
  (iv) Deliver to the Seller the Escrow Agreement executed by the Buyer and the Escrow Agent.

 

27
 

 

(d) Pay to Go Capital Pty Ltd the payment set forth on Schedule 4(o) in immediately available funds ;
     
(e) Deliver to Seller a certificate of the Secretary of the State of Nevada, dated reasonably close to the Closing Date, as to the legal existence and good standing of the Buyer in Nevada.

 

11. Conditions to Obligations of Buyer .

 

The obligations of Buyer to consummate the transactions contemplated by the Transaction Documents are subject to the fulfillment, at or before the Closing Date, of each of the following conditions, any one or more of which may be waived by Buyer in its sole discretion:

 

(a) Representations and Warranties of Seller . All representations and warranties made by Seller in this Agreement shall be true and correct in all material respects (except as to representations and warranties which are qualified as to materiality, which representations and warranties shall be true and correct in all respects) as of the date of this Agreement and on and as of the Closing Date as if again made by Seller on and as of such date.
     
(b) Performance of the Obligations of Seller . Seller has performed in all material respects all agreement, covenants, and obligations required under this Agreement to be performed by it on or before the Closing Date.
     
(c) Satisfaction of Liabilities and Obligations . All debts, fees, liabilities, payables, Taxes, claims, costs and expenses of or against the Company including, without limitation, all costs, expenses, payables, debts and liabilities arising out of the operations of the Company incurred or arising prior to the Closing will be paid or satisfied by the Company at or before Closing or the Purchase Price will be adjusted therefor at the Closing, except with respect to creditors in the day-to-day operation of the Business with no Lien or security interest in any of the Company’s assets. All cash in excess of zero working capital requirements will have been paid into the Escrow Account established for the segregation of Adjusted EBITDA from July 1, 2015 to October 31, 2015.
     
(d) Seller Closing Documents . Seller shall have delivered to Buyer the following documents:

 

  (i) all certificates representing all of the Company, duly endorsed in blank or with appropriate share powers;

 

28
 

 

  (ii) a certificate executed by the authorized person of Seller certifying as to the truthfulness, completeness and accuracy of attached copies of resolutions of the of Seller authorizing this Agreement and the transactions contemplated hereby;
       
  (iii) such other documents relating to the transactions contemplated by the Transaction Documents to be consummated at the Closing as counsel to Buyer shall reasonably request in order to complete the share purchase by Buyer;
       
  (iv) a extract of the register maintained by the Australian Securities and Investments Commission, dated reasonably close to the Closing Date, as to the legal existence and good standing of the Company in Australia;
       
  (v) resignations of the officers and directors of the Company in office immediately prior to the Closing; and
       
  (vi) deliver to the Buyer the Escrow Agreement executed by the Seller.

 

12. Indemnification .

 

(a) Indemnification by Buyer . Buyer shall indemnify and save and hold the Seller and Principal Owners, successors, and assigns (the “ Seller Indemnitees ”), harmless from and against any and all damages, claims, demands, obligations, liabilities, losses, costs, expenses (including all reasonable attorneys’ fees and expenses of investigation incurred by the Seller Indemnitees in any Action or proceeding between Buyer and the Seller Indemnitees or between the Seller Indemnitees and any third party or otherwise), deficiencies, interests, penalties, impositions, assessments and/ or fines (collectively, “ Seller Losses ”), whether or not in connection with a third-party claim, arising out of, resulting from or related to (each “ Buyer’s Events of Breach ”):

 

  (i) any breach of any representation or warranty made by the Buyer in this Agreement or the other Transaction Documents; and
       
  (ii) all acts and omissions in the conduct of the Company and the Business on and after Closing and indemnifies, and must keep indemnified, the Seller Indemnitees against any loss arising in respect of any such acts or omissions after Closing including liability arising out of defects in products sold or services provided by the Buyer after Closing. This indemnity extends to liability that may arise as a result of any of the products so sold or advice given being defective;
       
  (iii) any breach of any covenant or other agreement made by Seller in Section 7(b) of this Agreement,

 

29
 

 

provided , however , that Buyer shall not be liable to make any payment in respect of a claim for indemnification in respect of any breach of any representation or warranty made by the Buyer in this Agreement or the other Transaction Documents until the aggregate of such Seller Losses shall exceed $5,000 (“ Threshold ”). Once such Seller Losses shall exceed such $5,000 Threshold (“ Basket ”), the Seller Indemnitees shall have the right to indemnification hereunder, and Buyer and/or its members shall be required to make payment to the Seller Indemnitees in respect of such claim to the full extent of such Seller Losses without reference to or deduction for the $5,000 Threshold up to an aggregate liability cap equal to the value of Cash Consideration as set out in this Agreement (“ Cap ”), provided , however , that the Basket and Cap shall not apply (and Buyer and its members shall be fully liable) in the case of any claims based on fraud, bad faith, criminal conduct, intentional misrepresentation, or willful misconduct (“ Bad Conduct ”) or (ii) indemnification under Sections 12(a)(ii) and 12(a)(iii). Notwithstanding anything to the contrary in this Agreement, Seller Indemnitees’ right to indemnification in this Section 12(a) will not apply to the extent that the Seller Losses arise out of or in connection with a Seller Event of Breach.

 

(b) Indemnification by Seller . Seller and each of the Principal Owners, jointly and severally, shall indemnify and save and hold the Buyer, any Affiliate of the Buyer and their respective directors, officers, managers, employees, successors, and assigns (the “ Buyer Indemnitees ”), harmless from and against any and all damages, claims, demands, obligations, liabilities, losses, costs, expenses (including all reasonable attorneys’ fees and expenses of investigation incurred by the Buyer Indemnitees in any Action or proceeding between Seller and the Buyer Indemnitees or between the Buyer Indemnitees and any third party or otherwise), deficiencies, interests, penalties, impositions, assessments and/ or fines (collectively, “ Buyer Losses ”), whether or not in connection with a third-party claim, arising out of, resulting from or related to any and/or all of Seller’s Events of Breach.
     
(c) As used herein, “ Seller’s Events of Breach ” shall be and mean any one or more of the following:

 

  (i) any breach of any representation or warranty made by Seller or the Principal Owners in this Agreement or the other Transaction Documents;
       
  (ii) any Seller employee benefit plan in existence prior to the Closing Date, whether such Liability arises before, on or after the Closing Date, including, without limitation, unfunded Liabilities, Liability with respect to the termination of any such plan, any retiree from employment with Seller, any unfunded Liability under any such plan, or any accrued but unpaid claim under such Seller employee benefit plan;
       
  (iii) the employment (including the initial hiring and all terms, conditions, and events relating to the ongoing employment prior to the Closing Date) or termination of employment (including constructive termination) by Seller of any individual (including without limitation the Principal Owners and any current or former employee of Seller), including any compensation due to the Employees or Contractors relating to periods ending on or prior to the Closing Date, including, without limitation, severance, salary, commission, bonus, incentives, vacation pay or other benefit accruals or any termination liability; and

 

30
 

 

  (iv) any Liability relating to common law or statutory dissenter’s rights, appraisal rights, or any similar rights of the shareholders or owners of Seller,
       
  (v) any breach of any covenant or other agreement made by Seller in Section 7(a) or Section 8 of this Agreement,

 

provided , however , that neither Seller nor the Principal Owners shall be liable to make any payment in respect of a claim for indemnification in resp e ct of any Seller’s Events of Breach until the aggregate of such Buyer Losses shall exceed $5,000 (“ Threshold ”). Once such Buyer Losses shall exceed such $5,000 Threshold (“ Basket ”), the Buyer Indemnitees shall have the right to indemnification hereunder, and Seller and/or its members shall be required to make payment to the Buyer Indemnitees in respect of such claim to the full extent of such Buyer Losses without reference to or deduction for the $5,000 Threshold up to an aggregate liability cap equal to the Cash Consideration (“ Cap ”), provided , however , that the Basket and Cap shall not apply (and Seller and its members shall be fully liable) in the case of any claims based on (i) a breach of any Fundamental Representations, (ii) fraud, bad faith, criminal conduct, intentional misrepresentation, or willful misconduct (“ Bad Conduct ”), or (iii) indemnification under Sections 12(c)(ii) through 12(c)(v).

 

(d) All representations, warranties, covenants and obligations of Buyer, Seller and/or the Principal Owners, and all other agreements or instruments contemplated hereby to which Buyer or Seller, or the Principal Owners, is a party shall survive the Closing Date for twelve (12) months, except that: (i) all covenants and agreements which by their terms contemplate performance after the Closing Date shall survive the Closing for a period of four (4) years, unless specified otherwise by their terms; and (ii) for breaches of any Fundamental Representations or Bad Conduct, the survival period shall be four (4) years. Notwithstanding the above, any claim for indemnification made in accordance with this Section 12 prior to the expiration of the applicable indemnification period set forth in this paragraph shall survive until such matter is resolved. For the avoidance of any doubt, a Buyer’s Claim Notice must have been received in accordance with clause Error! Reference source not found.Error! Reference source not found. prior to the expiration of the applicable indemnification period set forth in this paragraph in order for the claim to survive the applicable indemnification period.
     
(e) Following the Closing, the indemnification afforded by this Section 12 shall be the sole and exclusive remedy of the Buyer Indemnitees in respect of claims for Seller’s Events of Breach.

 

31
 

 

(f) For purposes of this Section 12, any inaccuracy in or breach of any representation or warranty shall be determined without regard to any materiality, Material Adverse Effect or other similar qualification contained in or otherwise applicable to such representation or warranty.
     
(g) Procedures for Indemnification by the Seller.

 

  (i) Notice of Claims . If a Seller’s Event of Breach occurs or is alleged and a Buyer Indemnitee asserts that Seller has become obligated to such Buyer Indemnitee pursuant to Section 12 hereof (“ Direct Claim ”), or if any suit, Action, investigation, claim or proceeding (a “ Third Party Proceeding ”) is threatened, begun, made or instituted by a third party as a result of which Seller may become obligated to a Buyer Indemnitee hereunder, such Buyer Indemnitee shall give written notice thereof to Seller which must contain full details of the Direct Claim or Third Party Proceeding then known to the Buyer of the events, matters or circumstances giving rise to the claim (the “ Buyer’s Claims Notice ”). The Buyer’s failure or delay in providing the Buyer’s Claim Notice shall not relieve Seller or its obligations under this Section except to the extent that Seller is materially prejudiced as a result thereof. If a Buyers’ Event of Breach occurs or is alleged and a Seller Indemnitee asserts that Buyer has become obligated to such Seller Indemnitee pursuant to Section 12 hereof (“ Seller Direct Claim ”), or if any Third Party Proceeding is threatened, begun, made or instituted by a third party as a result of which Buyer may become obligated to a Seller Indemnitee hereunder, such Seller Indemnitee shall give written notice thereof to Buyer which must contain full details of the Seller Direct Claim or Third Party Proceeding then known to the Seller of the events, matters or circumstances giving rise to the claim (the “ Seller’s Claims Notice ”). The Seller’s failure or delay in providing the Seller’s Claim Notice shall not relieve Buyer or its obligations under this Section except to the extent that Buyer is materially prejudiced as a result thereof.
       
  (ii) Response to Direct Claims . Seller shall have thirty (30) days after receipt of the Buyer’s Claim Notice for a Direct Claim to reject or accept the claim as an indemnifiable claim for Buyer Losses under Section 12 . If, within thirty (30) days after receipt by Seller of such a Buyer’s Claim Notice, Seller delivers notice to the Buyer Indemnitee containing a written objection to the claim (or a portion thereof) by the Buyer Indemnitee, stating the nature of and grounds for such objection in reasonable detail, then such claim (or portion thereof) shall be deemed to be a “ Disputed Claim ” and such claim shall be resolved in accordance with Section 12 . If, within thirty (30) days after actual receipt by Seller’s of the Buyer’s Claim Notice for a Direct Claim, Seller delivers notice to the Buyer Indemnitee containing a written acceptance of the claim, (or a portion thereof) then such claim (or portion thereof) shall be deemed an indemnifiable claim under this Section 12 (the “ Indemnifiable Claim ”), and Seller will be conclusively deemed to have consented to recovery by the Buyer Indemnitee of the full amount of Buyer Losses subject to offset for the Basket in connection with the claim, if applicable.

 

32
 

 

(h) Dispute Resolution . Any disputes arising under this Section 12 shall be resolved as follows: (i) first, the Parties shall attempt in good faith for thirty (30) days to resolve the dispute, and (ii) if the dispute remains unresolved after such thirty (30) day period, the Parties agree that Section 14(c) will apply .
     
(i) Third Party Proceeding . Seller shall have twenty (20) days from receipt of a Buyer’s Claim Notice for a Third Party Proceeding to provide the Buyer Indemnitee with notice that it wishes to assume the defense in the Third Party Proceeding and acknowledges liability for such damages, in which event the Buyer Indemnitee shall have the right to participate in the defense at its own expense; provided , however , that the Buyer Indemnitee is hereby authorized prior to and during such time to file any motion, answer or other pleading that it shall deem necessary or appropriate to protect its interests and that is not prejudicial to Seller. If Seller fails to give the Buyer Indemnitee timely notice as provided herein, the Buyer Indemnitee shall have the right to defend against such Third Party Proceeding. If Seller assumes the defense in a Third Party Proceeding, (i) the Indemnifying Party shall not agree to any settlement, compromise or discharge of a Third-Party Claim without the Indemnified Party’s prior written consent; and (ii) the Buyer must provide the Seller and the Principal Owners with all reasonable assistance requested by them in relation to the Third Party Proceeding, including providing access to witnesses and documentary or other evidence relevant to the Third Party Proceedings, allow them and their advisers to inspect and take copies of all relevant books, records, files and documents, and providing them with reasonable access to the personnel, premises and chattels of the Seller for the purposes of obtaining information in relation to the Third Party Proceeding.
     
(j) If the Indemnifying Party does not assume the defense of a Third-Party Claim, the Indemnified Party shall be entitled to undertake any settlement, compromise or discharge of such Third-Party Claim without the Indemnifying Party’s prior consent. Notwithstanding anything herein to the contrary, Seller and the Principal Owners shall not be entitled to assume control of the defense in a Third Party Proceeding, and shall pay the reasonably documented fees and expenses of legal counsel retained by the Buyer Indemnitees if: (i) Buyer reasonably believes that an adverse determination of such claim could be detrimental to the Buyer’s business; (ii) Buyer reasonably believes that a conflict of interest exists or could reasonably arise which, under applicable principles of legal ethics, could prohibit a single legal counsel from representing both the parties in such proceeding, other than a conflict which may exist due to the underlying nature of the duty to indemnify; (iii) a court of competent jurisdiction rules that Seller has failed or is failing to prosecute or defend such claim; (iv) such claim seeks damages other than monetary damages; or (v) such claim involves conduct of the Business both before and after the Closing.

 

33
 

 

(k) Notwithstanding the provisions of Section 12(g) , Seller hereby consents to the nonexclusive jurisdiction of any court in which an Action or claim in respect of a Third Party Proceeding is brought against any Buyer Indemnitee for purposes of any claim that a Buyer Indemnitee may have under this Agreement with respect to such Action or claim or the matters alleged therein and agrees that process may be served on Seller with respect to such a claim anywhere in the world.
     
(l) Indemnification Binds Successors and Assigns . All of the indemnification rights of the Buyer and obligations of Seller arising pursuant to this Section 12 shall apply to and bind each and every successor and assign of Buyer and Seller.
     
(m) Dispute Resolution Costs . Each Party shall bear all its own costs of any court Action or other dispute resolution proceeding hereunder, including without limitation, the fees and expenses of its own legal counsel and other filing fees and expenses of such Party for such proceeding.

 

13. Termination .

 

(a) Conditions of Termination . Notwithstanding anything to the contrary contained herein, this Agreement may be terminated at any time before the Closing:

 

  (i) By mutual consent of Seller and Buyer;
       
  (ii) By either Seller or Buyer if the other Party shall have breached this Agreement in any material respect and such breach continues for a period of ten (10) days after the receipt of written notice of the breach from the non-breaching Party; or

 

(b) Effect of Termination . If this Agreement is terminated in accordance with Section 13 hereof, this Agreement shall become null and void and have no effect, with no liability on the part of Seller or Buyer, or their Affiliates and their respective directors, managers, officers, agents, members or shareholders, except for the obligations set forth in this Section 13 , Section 11 , which shall survive any termination; and provided , however , that notwithstanding the foregoing, nothing herein and no termination hereof shall relieve any Party from liability for any breach of any of its representations, warranties, covenants or agreements set forth in this Agreement which arise prior to termination.

 

34
 

 

14. Miscellaneous .

 

(a) Successors and Assigns . Any Party hereto may assign this Agreement or any rights or obligations hereunder without the prior written consent of the other Parties hereto; provided that this Agreement shall inure to the benefit of and shall be binding upon the successors and assigns of the Parties hereto.
     
(b) Governing Law; Jurisdiction . This Agreement shall be construed, performed and enforced in accordance with, and governed by, the laws of the State of New York, United States, without giving effect to the principles of conflicts of laws thereof.
     
(c) Dispute Resolution . Subject to Section 3(c)(iii), any dispute or Action arising in connection with this Agreement shall be referred to and finally resolved under the then applicable rules of the Singapore International Arbitration Centre ( SIAC ) , which SIAC Rules are deemed to be incorporated by reference into this clause. There shall be 3 (three) arbitrators. The seat of the arbitration shall be Singapore. The language to be used in the arbitral proceedings shall be English.
     
(d) Expenses . Except as otherwise provided herein, each of the Parties hereto shall pay all its own expenses in connection with this Agreement and the transactions contemplated hereby, including, without limitation, any legal and accounting fees, whether or not the transactions contemplated hereby are consummated. Buyer shall be responsible for and shall pay all applicable state and local sales, transfer, excise, value-added or other similar Taxes, and all recording and filing fees that may be imposed by reason of the Share Purchase (collectively, the “ Transfer Taxes ”). Each party agrees to cooperate with such other party in the timely completion, execution and filing of any documentation required by any local, state, federal or other Tax authority in connection with the Transfer Taxes, including any documentation as may be requested to establish an exemption from (or otherwise reduce) or make a report with respect to the Transfer Taxes.
     
(e) Goods and Services Tax .

 

    (i) In this Section 14(e), the expressions Input Tax Credit , Supply , Tax Invoice , Recipient and Taxable Supply have the meanings given to those expressions in the GST Act.
       
    (ii) With the exception of any amount payable under this Section 14(e), unless otherwise expressly stated, all amounts stated to be payable in this Agreement are exclusive of GST.
       
    (iii) If GST is imposed on any Supply made under or in accordance with this Agreement, the Recipient of the Taxable Supply must pay to the Supplier an additional amount equal to the GST payable on or for the Taxable Supply. Payment of the additional amount will be made at the same time as payment for the Taxable Supply is required to be made in accordance with this Agreement, subject to the provision of a Tax Invoice.
       
    (iv) If this Agreement requires a party to pay for, reimburse or contribute to any expense, loss, indemnity or outgoing ( Reimbursable Expense ) suffered or incurred by another party, the amount required to be paid, reimbursed or contributed by the first party will be the sum of:

 

35
 

 

    (1) the amount of the Reimbursable Expense less the Input Tax Credits (if any) to which the other party is entitled in respect of the Reimbursable Expense; and
         
    (2) if the other party’s recovery from the first party is a Taxable Supply, any GST payable in respect of that Supply.

 

(f) Severability . In the event that any part of this Agreement is declared by any court or other judicial or administrative body to be null, void or unenforceable, said provision shall survive to the extent it is not so declared, and all of the other provisions of this Agreement shall remain in full force and effect.

 

(g) Notices . All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) on the date of service if served personally on the Party to whom notice is to be given, or (ii) on the day of delivery by Federal Express or similar overnight courier or the Express Mail service maintained by the U.S. Postal Service, to the Party as follows:

 

If to Seller or any Principal Owner:    
   
  NomadChoice Pty Limited trading as Flat Tummy Tea
  LVI 330 Churchill Ave.
  Subiaco WA 6008 Australia
   
Copy to: Steinepreis Paganin
  Level 4, the Read Buildings
  16 Milligan Street
  Perth, WA 6000 Australia
    
If to Buyer: Synergy CHC Corp.
  865 Spring Street
  Westbrook, ME 04092
  Attn: President
   
Copy to: Wyrick Robbins Yates & Ponton LLP
  4101 Lake Boone Trail, Suite 300
  Raleigh, North Carolina 27607
  Attention: W. David Mannheim

 

Any Party may change its address for the purpose of this Section by giving the other Party written notice of its new address in the manner set forth above.

 

36
 

 

(h) Amendments; Waivers . This Agreement may be amended or modified, and any of the terms, covenants, representations, warranties or conditions hereof may be waived, only by a written instrument executed by the Parties hereto, or in the case of a waiver, by the Party waiving compliance. Any waiver by any Party of any condition, or of the breach of any provision, term, covenant, representation or warranty contained in this Agreement, in any one or more instances, shall not be deemed to be nor construed as further or continuing waiver of any such condition, or of the breach of any other provision, term, covenant, representation or warranty of this Agreement.

 

  (i) Public Announcements . Seller shall not make any public statement regarding this Agreement or the transactions contemplated herein without Buyer’s prior written approval. Buyer shall provide a copy of any public statement to Seller prior to the information being made public.
       
  (ii) Entire Agreement . This Agreement, the exhibits and schedules hereto contains the entire understanding between the Parties hereto with respect to the transactions contemplated hereby and thereby and supersede and replace all prior agreements and understandings, oral or written, with regard to such transactions. All schedules and exhibits hereto and any documents and instruments delivered pursuant to any provision hereof are expressly incorporated herein and made a part of this Agreement as fully as though completely set forth herein. This Agreement shall only be binding on the Parties hereto upon execution and delivery of this Agreement by each of the Parties.
       
  (iii) Parties in Interest . Nothing in this Agreement is intended to confer any rights or remedies under or by reason of this Agreement on any persons other than Seller and Buyer and their respective successors and permitted assigns. Nothing in this Agreement is intended to relieve or discharge the obligations or liability of any third persons to Seller or Buyer. No provision of this Agreement shall give any third persons any right as a third party beneficiary of this Agreement or provide any right of subrogation or Action over or against Seller or Buyer.
       
  (iv) Section and Paragraph Headings . The section and paragraph headings in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Agreement.
       
  (v) Counterparts . This Agreement may be executed in counterparts and via .pdf, each of which shall be deemed an original, but all of which shall constitute the same instrument.
       
  (vi) Fulfillment of Obligations . Any obligation of any Party to any other Party under this Agreement, which obligation is performed, satisfied or fulfilled by an Affiliate of such Party, shall be deemed to have been performed, satisfied, or fulfilled by such Party.

 

37
 

 

  (vii) Remedies . Except as expressly provided in this Agreement, any Person having any rights under any provision of this Agreement, including, without limitation, Section 8 , shall be entitled to enforce such rights specifically (without posting a bond or other security), to require: (i) Seller and their respective Affiliates to account for and pay over to Buyer; and (ii) Buyer and its respective Affiliates to account for and pay over to Seller, all payments, profits, monies, accruals, increments or other benefits derived by such party by reason of any breach of any provision of this Agreement, to recover damages and to exercise all other rights granted by Laws. Except as expressly provided in this Agreement, all such rights and remedies shall be cumulative and non-exclusive, and may be exercised singularly or concurrently. The Parties acknowledge that any breach of this Agreement may cause substantial irreparable harm to the other Party. Therefore, this Agreement may be enforced in equity by specific performance, temporary restraining order and/or injunction. The rights to such equitable remedies shall be in addition to all other rights or remedies which a Party may have under this Agreement or under applicable law.
       
  (viii) Further Actions . In case at any time after the Closing any further action is necessary to carry out the purposes of this Agreement, each of the Parties shall take such further action (including the execution and delivery of such further instruments and documents) as any other Party reasonably may request, all at the sole cost and expense of the requesting Party (unless the requesting Party is entitled to indemnification therefore under Section 12 ).

 

[Signature page follows]

 

38
 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized as of the date first above written.

 

 

EXECUTED by TPR INVESTMENTS
PTY LIMITED
ACN 128 396 654 AS TRUSTEE FOR
THE POLMEAR FAMILY TRUST
in accordance with section 127 of the
Corporations Act 2001 (Cth):
)
)
)
)
 

 

/s/ Tim Polmear  
Signature of director  
   
Tim Polmear  
Name of director  

 

*please delete as applicable

 

EXECUTED by NOMADCHOICE PTY
LIMITED
ACN 160 729 939
in accordance with section 127 of the
Corporations Act 2001 (Cth):
)
)
)
)
 

 

/s/ Timothy Polmear  
Signature of director  
   
Timothy Polmear  
Name of director  

 

[Signature Page to Stock Purchase Agreement]

 

 
 

 

SIGNED by TIMOTHY POLMEAR
in the presence of:
)
)
)
 
     
/s/ Matthew Hawtin   /s/ Timothy Polmear
Signature of witness   Signature
     
Matthew Hawtin    
Name of witness    

 

SIGNED by REBECCA POLMEAR
in the presence of:
)
)
)
 
     
/s/ Matthew Hawtin   /s/ Rebecca Polmear
Signature of witness   Signature
     
Matthew Hawtin    
Name of witness    

 

  SYNERGY CHC CORP.
     
  By: /s/ Jack Ross
  Name: Jack Ross
  Title: Chief Executive Officer

 

 
 

 

  

FIRST AMENDMENT TO LOAN AGREEMENT entered into as of the 12th day of November, 2015 (the “ First Amendment ”),

 

BETWEEN : KNIGHT THERAPEUTICS (BARBADOS) INC. , a corporation formed under the laws of Barbados;
   
  (hereinafter called the “ Lender ”)
   
AND : SYNERGY CHC CORP. , a corporation formed under the laws of the State of Nevada;
   
  (hereinafter called the “ Synergy ”)

 

WHEREAS Synergy (then known as Synergy Strips Corp.) and the Lender are parties to that certain loan agreement (the “ Loan Agreement ”) made as of the 21st day of January, 2015, pursuant to which the Lender has extended a loan to Synergy in the principal amount of Six Million United States Dollars (US$6,000,000) (the “ Original Loan ”);

 

WHEREAS Synergy has requested an additional loan in the principal amount of Five Million Five Hundred Thousand United States Dollars (US$5,500,000) (the “ Additional Loan ”);

 

WHEREAS the Lender and Synergy desire to amend the Loan Agreement to, inter alia , provide for the Additional Loan on the terms and conditions set forth herein;

 

NOW, THEREFORE, IN CONSIDERATION of these presents and of the mutual covenants hereinafter contained, the parties have agreed as follows:

Article 1

interpretation

 

1.1 Capitalized Terms

 

In this First Amendment, capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Loan Agreement as if amended to include the amendments set out in this First Amendment.

 

Article 2

amendments

 

2.1 Amendments to the Loan Agreement

 

The Borrower and the Lender hereby agree to amend the Loan Agreement as follows:

 

  2.1.1 Section 1.1 of the Loan Agreement is amended by inserting or restating the following definitions (as the case may be).

 

    1  
     

 

2015 First Warrant ” means that certain common share stock purchase warrant to be executed by the Borrower and the Lender to give effect to the Lender’s 2015 Immediate Equity issuance.

 

2015 Second Warrant ” means that certain common share stock purchase warrant to be executed by the Borrower and the Lender to give effect to the Lender’s 2015 Equity.

 

Additional Loan ” means the loan to the Borrower by the Lender in the principal amount of Five Million Five Hundred Thousand United States Dollars (US$5,500,000) pursuant to the First Amendment.

 

Borrower ” means Synergy CHC Corp. (formerly known as Synergy Strips Corp.) a corporation incorporated under the laws of the State of Nevada together with all of its Subsidiaries and also includes their respective permitted successors and assigns.

 

Breakthrough ” means Breakthrough Products, Inc.

 

Breakthrough Acquisition ” means the acquisition by the Borrower of all the issued and outstanding shares of Breakthrough Products, Inc.

 

Business ” means the business of the Borrower including the manufacture, distribution, sale of consumer health products, including the products known as Synergy Strips, Flat Tummy Tea and UrgentRX Products.

 

Equity Financing ” means the completion, on or prior to the first anniversary of the Second Closing Date, of an offering or offerings of the Borrower’s equity securities or securities convertible into equity securities of at least Two Million Dollars in the aggregate.

 

First Amendment ” means the First Amendment to this Agreement entered into as of the 12th day of November, 2015.

 

Lender’s 2015 Equity ” means the issuance to the Lender of a ten (10) year warrant to purchase 5% of the common shares of the Borrower, on a fully diluted basis after giving effect to the Lender’s 2015 Immediate Equity and to both the Breakthrough Acquisition and the Nomad Acquisition, at a price per share equal to $0.70, including a full ratchet clause pegged at $0.70 a share.

 

Lender’s 2015 Immediate Equity ” means the issuance to the Lender, for no additional consideration, of such number of common shares of the Borrower that will result in the Lender receiving, on a fully diluted basis and after giving effect to (i) the Breakthrough Acquisition, (ii) the Nomad Acquisition, and (iii) the Lender’s 2015 Equity, 6.5% of the common shares of the Borrower, which shares will not be subject to any trading restrictions, other than as required under Applicable Law. For clarity, these shares are in addition to shares of Borrower currently being held by Lender.

 

    2  
     

 

Lender’s Nomad Distribution Agreement ” means the proposed license and distribution agreement among the Borrower, Nomad and the Lender by which (i) Lender shall have exclusive distribution rights to all products of Nomad including the “Flat Tummy Tea” products, in each of Canada, Israel, Romania, Russia and Sub Saharan Africa, and (ii) Lender shall sublicense the direct-to-consumer channel for the said territory back to Nomad for a royalty equal to sixty percent (60%) of Gross Sales.

 

Loan ” means, as the context requires, both the Original Loan and the Additional Loan, collectively.

 

Maturity Date ” means: (i) with respect to the Original Loan, January 17, 2017 and (ii) with respect to the Additional Loan, November 11, 2017.

 

Nomad ” means Nomadchoice Pty Ltd (ABN 41 160 729 939).

 

Nomad Acquisition ” means the acquisition by the Borrower of all the issued and outstanding shares of Nomad.

 

Nomad Guarantee ” means a guarantee agreement satisfactory to the Lender executed by Nomad in respect of the Obligations.

 

Nomad Purchase Agreement ” means that certain Stock Purchase Agreement dated November 12, 2015 among the Borrower, Nomad, TPR Investments Pty Ltd CAN 128 396 654, as trustee for Polmear Family Trust, Timothy Polmear and Rebecca Polmear, effecting the Nomad Acquisition.

 

Nomad Security Documents ” means the Security Documents to be granted by Nomad in respect of the Nomad Guarantee.

 

Nomad Vendors ” means the vendor’s of the shares of Nomad pursuant to the Nomad Acquisition.

 

Original Loan ” means the loan to the Borrower by the Lender in the principal amount of Six Million United States Dollars (US$6,000,000) pursuant to this Agreement.

 

Repayment Schedule ” means the Amended and Restated Schedule of Repayment of principal of the Original Loan and the Additional Loan attached this Amendment as Schedule A .

 

Second Closing Date ” means November 12, 2015 or such other date on which the Additional Loan is made concurrently with the closing of the Nomad Acquisition.

 

    3  
     

 

Warrant ” means the 2015 First Warrant and the 2015 Second Warrant, together or separately, as the context requires.

 

  2.1.2 The following definitions set forth in the Loan Agreement are amended:

 

Loan Documents ” is hereby amended to include this First Amendment, any additional, amended or restated Loan Documents delivered to the Lender in connection with this First Amendment or otherwise in connection with the Loan Agreement, including any Loan Document delivered to the Lender as general continuing collateral security for the payment and performance of the present and future Obligations (including obligations relating to the Additional Loan), as well as any amendments, replacements, supplements or other modifications hereto or thereto or any other documents or instruments contemplated hereby or thereby.

 

Permitted Debt ” is amended to include:

 

“(vi) Debt of a maximum of AUD$3,500,000 that may be owed to the Nomad Vendors pursuant to the Nomad Purchase Agreement.”

 

  2.1.3 Section 1 of the Loan Agreement as currently stated shall be renumbered as Section 2.1(a) and refer to the Original Loan only. The following shall be added as Section 2.1(b) in respect of the Additional Loan:

 

“Subject to the terms and conditions of this Agreement and the other Loan Documents, the Lender agrees to loan to the Borrower in lawful money of the United States the Additional Loan on the terms hereof and the Borrower hereby irrevocably authorizes the Lender to make the Additional Loan on the terms hereof. The Additional Loan shall bear interest as set forth in Section 4.1 of this Agreement.

 

The Additional Loan shall be disbursed in two tranches. The first tranche of Three Million Two Hundred Fifty Thousand United States Dollars (US$3,250,000) shall be disbursed upon the satisfaction of the conditions precedent set forth in Section 3.1 of this Agreement.

 

The balance of the Additional Loan, being Two Million Two Hundred Fifty Thousand United States Dollars (US$2,250,000) shall be disbursed upon satisfaction of the conditions precedent set forth in Section 3.2 of this Agreement.”

 

  2.1.4 Section 2.2 of the Loan Agreement as currently stated shall be renumbered as Section 2.2(a) and refers to the Original Loan only. The following shall be added as a new Section 2.2(b) in respect of the Additional Loan:

 

“The Maturity Date of the Additional Loan shall be November 11, 2017.”

 

     
     

 

  2.1.5 Sections 3.2(a) and (b) of the Loan Agreement as currently stated shall be renumbered as Sections 3.2(a)(i) and 3.2(a)(ii) and refer to the Original Loan only. The following shall be added as a new Section 3.2(b) in respect of the Additional Loan:

 

“Subject to the terms hereof, the Borrower may prepay the outstanding principal of the Additional Loan any time following the first anniversary of the Second Closing Date. Such prepayments may only be for a minimum amount of One Million Dollars ($1,000,000) and in additional increments of One Million Dollars ($1,000,000) unless the entire Additional Loan is being prepaid in full. Such prepayment must be accompanied by a prepayment fee of five percent (5%) of the amount of the Additional Loan being prepaid at that time.”

 

  2.1.6 Section 4.3 of the Loan Agreement is hereby amended by deleting the words:

 

“the interest rate otherwise payable pursuant to Section 4.1 plus five percent (5%)” and replacing same by “twenty percent (20%)”

 

  2.1.7 Section 6.1 of the Loan Agreement is hereby amended by adding the following:

 

  “(g) Guarantee Agreement of the Obligations from Breakthrough;
     
  (h) Nomad Guarantee;
     
  (i) General Security Agreement from each of Borrowers’ Subsidiaries including Breakthrough and Nomad;
     
  (j) a collateral assignment from each of Borrower’s Subsidiaries of its interest on all Material Contracts and Material Licenses;
     
  (k) Intellectual Property Security Agreement of each of Borrower’s Subsidiaries;
     
  (l) Subordination Agreement by Nomad Vendors in favour of Knight;
     
  (m) specific security agreement granted by the Borrower in respect of the issued share capital in Nomad.”

 

  2.1.8 Section 7 of the Loan Agreement is amended by adding the following:

 

  “(jj) Nomad Share Purchase Agreement . The accuracy and completeness of each of the representations and warranties set out in the Nomad Purchase Agreement and all such representations and warranties are hereby incorporated into this Agreement by reference as if same were herewith recited at length and made directly by the Borrower for the benefit of Lender. Such representations and warranties shall survive for so long as the Obligations remain outstanding notwithstanding any shorter survival period under the said share purchase agreement.

  

     
     

 

  (kk) Breakthrough Share Purchase Agreement . The accuracy and completeness of each of the representations and warranties set out in the share purchase agreement concerning the Breakthrough Acquisition and all such representations and warranties are hereby incorporated into this Agreement by reference as if same were herewith recited at length and made directly by the Borrower for the benefit of Lender. Such representations and warranties shall survive for so long as the Obligations remain outstanding notwithstanding any shorter survival period under the said share purchase agreement.”

 

  2.1.9 Section 9.1 of the Loan Agreement is amended by adding the following:

 

  “(z) Borrower must maintain separate financial records for the business conducted by Breakthrough (including a separate balance sheet, income statement and cash flow statement);
     
  (aa) following the release of Borrower’s financial statements for the quarter ended March 31, 2015 and at any time thereafter, Borrower shall promptly (and in any event within three (3) Business Days) notify Knight should either (i) the business being conducted by Breakthrough reflect negative EBITDA for the relevant quarter, or (ii) the working capital related to that business fall below Five Hundred Thousand Dollars ($500,000). In such event, Knight may, in its sole discretion, direct Borrower to immediately cease the UrgenRX business. For certainty, failure to do so upon receipt of such direction will be an Event of Default under this Agreement.
     
  (bb) Borrower must ensure that:

 

  (a) Nomad completes a financial assistance whitewash procedure in relation to the Nomad Guarantee and Nomad Security Documents granted in respect thereto in accordance with Section 260B of the Corporations Act 2001 (Cth) by no later than the date that is 30 days after the Second Closing Date; and

 

  (b) the Nomad Guarantee and Nomad Security Documents granted in respect thereto are effective no later than the date that is thirty (30) days after the Second Closing Date.

 

  Failure to comply with this clause will be an Event of Default if not cured within ten (10) Business Days of non-compliance.”

  

     
     

 

  2.1.10 Section 9.1(x)(i) of the Loan Agreement is hereby amended by adding the following at the end of that Section:

 

“Commencing with the six (6) month period ending on June 30, 2016, and for each six (6) month period ending on the last day of each Fiscal Quarter thereafter, Borrower shall maintain a minimum EBITDA of One Million Dollars ($1,000,000).”

 

  2.1.11 Section 9.1(x)(iii) of the Loan Agreement is hereby amended by requiring the amount of minimum cash balance to be One Million Dollars ($1,000,000) commencing on June 30, 2016.

 

  2.1.12 Section 9.2 of the Loan Agreement is amended by adding the following:

 

“(t) Nomad . Make any payment under the Nomad Purchase Agreement if a Default or Event of Default has occurred and is continuing or would occur as a result of making such payment.”

 

  2.1.13 Article 11 of the Loan Agreement is amended by adding the following:

 

  “(u) If the Borrower fails to make any of the “earn-out payments” pursuant to the Nomad Acquisition.
     
  (w) If the Borrower does not complete the Equity Financing by the first anniversary of the Second Closing Date.”

 

  2.1.14 From and after the Second Closing Date, (i) all references in the Loan Agreement to “this Agreement” shall mean the Loan Agreement as amended by this First Amendment, and as may otherwise be amended, restated, supplemented or otherwise modified from time to time, and (ii) all references in the other Loan Documents to the “Loan Agreement” (or words of similar import) shall be deemed to be references to the Loan Agreement as amended by this First Amendment, and as may otherwise be amended, restated, supplemented or otherwise modified from time to time. All references in any of the Loan Documents to the “Loan Documents” shall mean the Loan Documents as amended by this First Amendment and as may otherwise be amended restated, supplemented or otherwise modified from time to time.

 

  2.1.15 Except as expressly amended by this First Amendment, all other provisions of the Loan Agreement and the Transaction Documents not specifically amended hereby shall remain unchanged and in full force and effect.

  

     
     

 

Article 3

CONDITIONS PRECEDENT & closing date

 

3.1 Conditions to Loan by the Lender

 

The effectiveness of this First Amendment and the Lender’s obligation to fund the Additional Loan amount shall be subject to following conditions precedent having been met to the satisfaction of the Lender, or, alternatively, waived in writing by the Lender:

 

  3.1.1 the Borrower will pay to the Lender an origination fee equal to One Hundred Ten Thousand United States Dollars (US$110,000), being two percent (2%) of the Additional Loan amount, on the Second Closing Date;
     
  3.1.2 the Borrower will pay to the Lender a work fee equal to Fifty Five Thousand United States Dollars (US$55,000), being one percent (1%) of the Additional Loan amount, at the earlier of November 12, 2015 and the Second Closing Date, whether or not the Additional Loan is advanced;
     
  3.1.3 this Agreement shall have been executed and delivered by all parties hereto;
     
  3.1.4 the Borrower and each of the Subsidiaries shall have executed and delivered to the Lender the Loan Documents to which each is a party including, without limitation, the Security Documents;
     
  3.1.5 the Lender shall have received certified copies of the resolutions authorizing the execution, delivery and performance of Borrower’s, Nomad’s and Breakthrough’s respective obligations under the Loan Documents to which they are a party and the transactions contemplated therein, and the incumbency of the officers of Borrower, Nomad and Breakthrough;
     
  3.1.6 certificates of status or good standing, as applicable, for all relevant jurisdictions of Borrower shall have been delivered to the Lender;
     
  3.1.7 certificate of incorporation and constituent documents of Nomad;
     
  3.1.8 Borrower shall be in compliance in all material respects with all (if any) Material Contracts and Material Licences to the satisfaction of the Lender and copies of all Material Contracts and Material Licences if any, applicable to Borrower, shall have been delivered to the Lender;
     
  3.1.9 evidence of repayment in full of all Debt that is not Permitted Debt owing by Borrower to any third party lenders to Borrower concurrent with the Loan shall have been delivered to the Lender;
     
  3.1.10 evidence that all necessary or required consents or approvals of any Governmental Authority or other Person in connection with the completion of the Breakthrough Acquisition and the Nomad Acquisition and the delivery of the Loan Documents have been obtained;

 

     
     

 

  3.1.11 releases, discharges, estoppels and postponements with respect to all Liens which are not Permitted Liens, if any, shall have been delivered to the Lender;
     
  3.1.12 payment of all amounts and fees payable to the Lender;
     
  3.1.13 duly executed copies of the Security shall have been delivered to the Lender and such financing statements or other registrations of such Security, or notice thereof, shall have been filed, registered, entered or recorded in all offices of public record necessary or desirable in the opinion of the Lender to preserve or protect the charges and security interests created thereby;
     
  3.1.14 the Borrower shall have delivered to the Lender original share certificates in respect of all of the issued share capital in Nomad together with share transfer forms in respect of the shares in Nomad duly executed by the Borrower;
     
  3.1.15 evidence satisfactory to the Lender that entry into the Security Documents to which Nomad is a party does not materially prejudice the interests of Nomad or its shareholders and does not materially prejudice the ability of Nomad to pay its creditors (and that the board of directors of Nomad have resolved that this is the case);
     
  3.1.16 evidence that immediately prior to the acquisition by the Borrower of all the issued share capital in Nomad, the directors of Nomad will be Jack Ross, Stephen Fryer and Timothy Polmeer and that appointment of such directors has been, or will be, notified to the Australian Securities and Investments Commission;
     
  3.1.17 a currently dated letter of opinion of counsel to the Borrower along with the opinions of local counsel for Borrower shall have been delivered to the Lender. Such opinions shall, amongst other things, confirm that the existing Security delivered in connection with the Original Loan is first ranking security in favour of the Lender in respect to all of the Obligations, including without limitation, the Additional Loan;
     
  3.1.18 the Borrower shall have delivered to the Lender certificates of insurance acceptable to the Lender showing, inter alia, the Lender as a first loss payee as its interest may appear on all insurance policies that insure the assets to be secured by the Security;
     
  3.1.19 no Default or Event of Default has occurred and is continuing on the Second Closing Date or would result from making the Additional Loan and a senior officer of the Borrower shall have certified the same to the Lender;
     
  3.1.20 all representations and warranties made by Borrower, Nomad and Breakthrough in the Loan Documents are true and correct in all material respects;
     
  3.1.21 no Material Adverse Effect has occurred;

 

     
     

 

  3.1.22 a source and use of funds statement and an outline of the flow of funds from the Loan shall have been delivered to the Lender evidencing that the Loan will be used solely for the Nomad Acquisition and for working capital purposes;
     
  3.1.23 the Lender shall have received such additional evidence, documents or undertakings as the Lender shall reasonably request to establish the consummation of the transactions contemplated hereby, and the Breakthrough Acquisition and the Nomad Acquisition and be satisfied, acting reasonably, as to the taking of all proceedings in connection herewith in compliance with the conditions set forth in this Agreement;
     
  3.1.24 the Lender shall have completed all due diligence which it considers necessary or appropriate in its discretion in regard to Borrower and its Property, the Breakthrough Acquisition and the Nomad Acquisition, books and records, operations, prospects and condition (financial or otherwise), including, without limitation, in regards to past and ongoing compliance with Applicable Laws (including Environmental Laws), union and labour relations and pension matters;
     
  3.1.25 the Lender and the Borrower will have entered into, executed and delivered the Lender’s Nomad Distribution Agreement, all on terms satisfactory to the parties, acting reasonably;
     
  3.1.26 concurrently therewith, the Borrower shall complete the Breakthrough Acquisition and the Nomad Acquisition on terms and conditions satisfactory to the Lender;
     
  3.1.27 the execution and delivery of the 2015 First Warrant and the 2015 Second Warrant by the Borrower; and
     
  3.1.28 the Second Closing Date occurs by no later than November 16, 2015;

 

provided that if and to the extent that any Loan Document or other condition precedent set forth in this Section 3.1 and relating specifically and solely to Breakthrough or the Breakthrough Acquisition is not delivered at or prior to the Second Closing Date, then same shall instead become a condition precedent to the Lender advancing the second tranche of the Additional Loan as set forth in Section 3.2 and shall not be a waiver of such unfulfilled condition.

 

3.2 Conditions of Second Tranche

 

The effectiveness of the Lender’s obligation to fund the second tranche of the Additional Loan amount, as set forth in Section 2.1.4 of this Agreement, shall be subject to following conditions precedent having been met to the satisfaction of the Lender, or, alternatively, waived in writing by the Lender:

 

     
     

 

  3.2.1 Borrower must ensure that:

 

  (a) Nomad completes a financial assistance whitewash procedure in relation to the Nomad Guarantee and Nomad Security Documents granted in respect thereto in accordance with Section 260B of the Corporations Act 2001 (Cth) by no later than the date that is thirty (30) days after the Second Closing Date; and
     
  (b) the Nomad Guarantee and Nomad Security Documents granted in respect thereto are effective no later than the date that is thirty (30) days after the Second Closing Date.

 

  3.2.2 Borrower shall have satisfied all those conditions precedent set forth in Section 3.1 that relate to Breakthrough and/or the Breakthrough Acquisition that were not satisfied on or prior to the Second Closing Date;
     
  3.2.3 no Default or Event of Default has occurred and is continuing on the date of disbursement or would result from making the second tranche of the Additional Loan and a senior officer of the Borrower shall have certified the same to the Lender;
     
  3.2.4 all representations and warranties made by Borrower in the Loan Documents are true and correct in all material respects;
     
  3.2.5 no Material Adverse Effect has occurred.

 

3.3 Termination

 

This First Amendment shall automatically be terminated on November 18, 2015 if the conditions precedent set forth under Section 3.1 have not been met.

Article 4

MISCELLANEOUS

 

4.1 Further Assurances

 

Each of the Borrower and the Lender shall, from time to time hereafter and upon any reasonable request of the other party, execute and deliver such further agreements and documents and do all such other acts and things as may be necessary or appropriate to give effect to the foregoing.

 

4.2 Time of the Essence

 

Time shall be of the essence of this First Amendment.

 

4.3 Severability

 

If any provision of this First Amendment is found by final judgment of a court of competent jurisdiction to be invalid or unenforceable in whole or in part, such provision (or part thereof, as the case may be) shall be severable and such finding shall not affect the validity or enforceability of the remainder of such provision or of any other provision hereof.

 

     
     

 

4.4 Enurement

 

This First Amendment shall enure to the benefit of and be binding upon the parties hereto and their permitted assigns.

 

4.5 Counterparts

 

This First Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which, taken together, shall constitute one and the same instrument.

 

4.6 Paramountcy

 

In the event of any conflict or inconsistency between the terms and conditions of this First Amendment and the terms and conditions of any other Transaction Document, including the Loan Agreement, the terms and conditions of this First Amendment shall prevail and be paramount to the extent of such conflict or inconsistency.

 

4.7 Governing Law

 

This First Amendment will be governed by and construed in accordance with the laws of the Province of Quebec and the laws of Canada applicable therein.

 

4.8 Language

 

The parties acknowledge that they have requested that this First Amendment and all ancillary documents be drawn up in the English language only. Les parties reconnaissent avoir exigé que cette convention ainsi que tous les documents y reliés soient rédigés en anglais seulement .

 

(signature page follows)

 

     
     

 

IN WITNESS WHEREOF the parties hereto have duly executed this First Amendment as of the date and at the place first hereinabove set forth.

 

  KNIGHT THERAPEUTICS (BARBADOS) INC.
     
  by: /s/ Michael Loustric
  Name: Michael Loustric
  Title: President

 

  SYNERGY CHC CORP.
     
  by: /s/ Jack Ross
  Name: Jack Ross
  Title: Chief Executive Officer

 

     
 

 

 

EMBARGOED FOR USE BEFORE Contact:  
After 9am (Eastern) Jack Ross, Chairman / CEO
November 16, 2015 Synergy CHC Corp
  Jack@synergychc.com
  615-939-9004

 

 

Synergy CHC Corp Acquires Another Quality Brand in “UrgentRx”

 

Westbrook, Maine, November 16, 2015  – Synergy CHC Corp (OTCQB: SNYR) a consumer health care company, today announced it has acquired a 100% ownership stake in Breakthough Products, Inc. (UrgentRx). UrgentRx is engaged in the business of developing and selling medications for headache, heart burn, allergy attack, ache and pain, and upset stomach in the form of powders.

 

Under the terms of the agreement, Synergy purchased all the issued and outstanding capital stock of UrgentRx in exchange for 6,000,000 shares of Synergy common stock. In addition, Synergy agreed to pay a royalty to a trust for the benefit of the UrgentRx shareholders equal to 5% of gross sales of the UrgentRx products following the first $5,000,000 in gross sales on a quarterly basis for a period of seven years from the closing date.

 

“We believe UrgentRx will continue to thrive as it joins Synergy’s expanding product portfolio while leveraging the momentum of the platform and multiple economies of scale it provides,” said Jordan Eisenberg, CEO of UrgentRx . “This is a tremendous opportunity for UrgentRx to continue to be consumers’ best choice for fast, convenient relief. I am thrilled to join Jack Ross and the Synergy Management Team. I believe we have a real opportunity to build a world-class consumer healthcare business bolstered by the most exciting and innovative brands in the industry.”

 

“We are pleased to add another unique offering to our portfolio; it is consistent with the company’s strategy to grow by further acquisition. We are deliberately seeking to generate shareholder value through the addition of products that help improve the lives of customers while leveraging our existing distribution relationships. We will continue to be active on the acquisition trail,” said Jack Ross, President and CEO of Synergy.

 

About UrgentRx

 

UrgentRx produces a line of fast-acting, portable OTC medications that provide right now relief for today’s busy, on-the-go consumer.  UrgentRx® Fast Powders™ are innovative, fast-acting flavored powder medications in patented credit card-sized packets.  They can be taken without water, providing immediate relief for a wide variety of everyday ailments, whenever and wherever they strike.  UrgentRx produces medications to treat allergy attacks, headaches, aches and pains, heartburn, and upset stomach, as well as a heart attack first aid that has helped save multiple lives.

 

UrgentRx is successfully disrupting and bringing much-needed innovation to the OTC category by offering products that fit contemporary consumers’ lifestyles. Answering these consumers’ unmet needs, UrgentRx is rapidly becoming the “go-to” brand for on-the-go relief. The line is sold in over 35,000 stores nationwide, including many leading national food, drug, mass, convenience and travel retailers. Notably, UrgentRx pioneered the use of “found space” displays that take advantage of previously-unutilized space at checkout.

 

 
 

 

The company was orginally funded by Sam Zell, David Bonderman, Herb Simon, Academy Award-winning actress Hilary Swank, worldwide talent agency WME, as well as multiple family offices.  UrgentRx has been featured on national talkshows The Doctors, Ellen and The View  and has received coverage in The New York Times, Entrepreneur, Fortune, CNN, The Wall Street Journal, CNBC and Forbes. In 2015, UrgentRx won the prestigious Inc 5000 and was ranked as the 168 th fastest-growing company in America.

 

Based in Denver, Colorado, UrgentRx was founded by two-time Goldman Sachs “Most Intriguing Entrepreneur” Jordan Eisenberg.

 

CREO Capital Securities, LLC was the investment bank for UrgentRx and its shareholders in this transaction.  Joel Montminy, President & CEO of CREO said “The Synergy team adeptly analyzed and efficiently closed on this highly complementary combination.  Under their watch, we believe UrgentRX will achieve exciting performance in the years ahead.”   

 

About Synergy CHC Corp.

 

Synergy CHC Corp. is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy's strategy is to grow its portfolio both organically and by further acquisition. Synergy’s diversified portfolio now includes FOCUSFactor , Neuragen , Hand MD , and UrgentRx . For more information, please visit www.synergychc.com.

 

About FOCUSfactor® “Another Synergy Brand”

 

FOCUSfactor is sold at America’s leading retailers such as Costco, Sam’s Club, Wal-Mart, BJ’s Walgreens and The Vitamin Shoppe. FOCUSfactor, America’s leading brain health supplement, is a nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants and other nutrients. In December 2012, the United States Patent and Trademark Office issued US Patent 8,329,227 covering FOCUSfactor’s proprietary formulation “for enhanced mental function.” The issuance of the patent marked one of the few times a patent has been issued for a nationally branded nutritional supplement. FOCUSfactor is clinically tested with results demonstrating improvements in focus, concentration and memory in healthy adults. www.focusfactor.com

 

About Neuragen® “Another Synergy Brand”

 

Neuragen® is a topical product that works directly at the site of the pain as opposed to oral products. Neuragen® reduces the spontaneous firing of damaged peripheral nerves. By calming these firings at the source, Neuragen® is clinically shown to reduce shooting and burning pains quickly and without the side effects of orally taken medications. This is in part due to the small lipophilic molecules found in Neuragen® which rapidly carry the active ingredients through the rough outer layer of the skin to the site of the pain. Neuragen® is available over the counter in most local pharmacies either in the diabetic section or the analgesic (pain) section. For more information, please visit www.neuragen.com .

 

About Hand MD® “Another Synergy Brand’

 

Hand MD is the world’s first anti-aging skincare line formulated specifically for the hands. Hands reveal a woman’s true age and the rejuvenation of the hand has become women’s #1 aging concern. Developed by Kara Harshbarger and renowned celebrity dermatologist Dr. Alex Khadavi, Hand MD’s extensive clinical trials show significant improvement in the appearance of fine lines and wrinkles, skin hydration, hyper-pigmentation and radiance. HAND MD launched on QVC and sold out in an astonishing 5 minutes. www.hand-md.com .

 

     
     

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or Synergy’s prospects should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: Synergy’s ability to integrate the Urgent Rx and other recently acquired product lines into its current operations; Synergy’s dependence on third parties for its research and development, manufacturing and distribution functions; Synergy’s’ dependence on its license relationships; the risks and uncertainties associated with Synergy’s ability to manage its limited cash resources; obtaining additional financing to support Synergy’s operations; protecting the intellectual property developed by or licensed to Synergy; and Synergy’s ability to build its operations to support its business strategy and promote its products. These and other risks are described in greater detail in Synergy’s filings with the SEC, copies of which are available free of charge at the SEC's website ( www.sec.gov ) or upon request from Synergy. Synergy may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Synergy assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

 

 
 

 

EMBARGOED FOR USE BEFORE Contact:
After 9am (Eastern) Jack Ross, Chairman / CEO
November 16, 2015 Synergy CHC Corp
  Jack@synergychc.com
  615-939-9004

 

 

 

Synergy CHC Corp Acquires “Flat Tummy Tea”, an Australian Company With Significant Social Media Presence

 

Westbrook, Maine, November 16, 2015 – Synergy CHC Corp (OTCQB: SNYR), a consumer health care company, today announced it has acquired a 100% ownership stake in Nomad Choice PTY LTD, an Australian company who owns the brand Flat Tummy Tea, which has significant social media presence.

 

Under the terms of the agreement, Synergy purchased of all the issued and outstanding capital stock of Flat Tummy Tea for a total purchase price of $10,000,000, comprised of $4,000,000 (Australian dollars, AUD) in cash, 3,571,428 shares of its common stock, and possible earn-out payments of up to $3,500,000 (AUD) in aggregate if certain EBITDA thresholds are met as of June 30, 2016.

 

“We are excited to be partnering with Synergy through this acquisition” said Tim Polmear, Director at Flat Tummy Tea. “Over the last few years, we’ve developed an innovative, unique and very effective way to reach targeted consumers through social media. We see great potential for Synergy’s existing and future brands to tap into this intellectual property and extend their consumer reach into the online world. On top of this, Synergy’s expertise and resources to take Flat Tummy Tea into a retail environment make this a great match.”

 

“We are pleased to add another unique offering to our portfolio which now gives Synergy global reach across multiple distribution platforms. It is consistent with the company’s strategy to grow both organically and by further acquisition. We are deliberately seeking to generate shareholder value through the addition of products that help improve the lives of customers while leveraging our existing distribution relationships. We will continue to be active on the acquisition trail” said Jack Ross, CEO of Synergy.

 

About Flat Tummy Tea

 

Flat Tummy Tea’s uniquely formulated two-step herbal detox tea works to naturally help speed metabolism, boost energy and reduce bloating to flatten your tummy. It’s currently sold exclusively online to a global, 20-30 year old female, predominantly American market.

 

Since being founded in 2013, Flat Tummy Tea has grown rapidly, largely attributed to the strength of their branding and their innovative and effective use of social media. Their secret is a very specific process and ROI based algorithm used on various online platforms. To date, Flat Tummy Tea has built a targeted social media following of over 500,000, many of whom are now customers.

 

Flat Tummy Tea has proven month on month growth since inception at a rate of over 400% annually.

 

Flat Tummy Tea now has over 3000+ positive written reviews on their website, flattummytea.com or visit their Instagram page.

 

 
 

 

Go Capital Pty Ltd was the corporate advisor for Flat Tummy Tea and its shareholders in this transaction. Derek Gerrard, Director of GoCap said “Both Synergy and Flat Tummy Tea worked with a can-do attitude through this transaction. This demonstrated the capability of both teams that will now create a strong combination to accelerate the growth performance of the business moving forward.”

 

About Synergy CHC Corp.

 

Synergy CHC Corp. is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition. Synergy’s diversified portfolio now includes FOCUSFactor , Neuragen , Hand MD , UrgentRx and Flat Tummy Tea For more information, please visit www.synergychc.com.

 

About FOCUSfactor® “Another Synergy Brand”

 

FOCUSfactor is sold at America’s leading retailers such as Costco, Sam’s Club, Wal-Mart, BJ’s Walgreens and The Vitamin Shoppe. FOCUSfactor, America’s leading brain health supplement, is a nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants and other nutrients. In December 2012, the United States Patent and Trademark Office issued US Patent 8,329,227 covering FOCUSfactor’s proprietary formulation “for enhanced mental function.” The issuance of the patent marked one of the few times a patent has been issued for a nationally branded nutritional supplement. FOCUSfactor is clinically tested with results demonstrating improvements in focus, concentration and memory in healthy adults. www.focusfactor.com .

 

About Neuragen® “Another Synergy Brand”

 

Neuragen® is a topical product that works directly at the site of the pain as opposed to oral products. Neuragen® reduces the spontaneous firing of damaged peripheral nerves. By calming these firings at the source, Neuragen® is clinically shown to reduce shooting and burning pains quickly and without the side effects of orally taken medications. This is in part due to the small lipophilic molecules found in Neuragen® which rapidly carry the active ingredients through the rough outer layer of the skin to the site of the pain. Neuragen® is available over the counter in most local pharmacies either in the diabetic section or the analgesic (pain) section. For more information, please visit www.neuragen.com .

 

About Hand MD® “Another Synergy Brand”

 

Hand MD is the world’s first anti-aging skincare line formulated specifically for the hands. Hands reveal a woman’s true age and the rejuvenation of the hand has become women’s #1 aging concern. Developed by Kara Harshbarger and renowned celebrity dermatologist Dr. Alex Khadavi, Hand MD’s extensive clinical trials show significant improvement in the appearance of fine lines and wrinkles, skin hydration, hyper-pigmentation and radiance. HAND MD launched on QVC and sold out in an astonishing 5 minutes. www.hand-md.com .

 

About UrgentRx ® “Another Synergy Brand”

 

UrgentRx produces a line of fast-acting, portable OTC medications that provide right now relief for today’s busy, on-the-go consumer. UrgentRx ® Fast Powders™ are innovative, fast-acting flavored powder medications in patented credit card-sized packets. They can be taken without water, providing immediate relief for a wide variety of everyday ailments, whenever and wherever they strike. UrgentRx ® produces medications to treat allergy attacks, headaches, aches and pains, heartburn, and upset stomach, as well as a heart attack first aid that has helped save multiple lives. For additional information, please visit www.urgentrx.com.

 

 
 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or Synergy’s prospects should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: Synergy’s ability to integrate the Flat Tummy Tea, UrgentRx and Hand MD® product lines into its current operations; Synergy’s dependence on third parties for its research and development, manufacturing and distribution functions; Synergy’s’ dependence on its license relationships; the risks and uncertainties associated with Synergy’s ability to manage its limited cash resources; obtaining additional financing to support Synergy’s operations; protecting the intellectual property developed by or licensed to Synergy; and Synergy’s ability to build its operations to support its business strategy and promote its products. These and other risks are described in greater detail in Synergy’s filings with the SEC, copies of which are available free of charge at the SEC’s website ( www.sec.gov ) or upon request from Synergy. Synergy may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Synergy assumes no obligation and does not intend to update these forward-looking statements, except as required by law.